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QUILL ON SCALPEL This section provides a medium through which Canadian surgeons can declare themselves, 
briefly and informally, on the day-to-day affairs of surgery.
n Adrenalin Rush
Nis Schmidt, MD, MSc, FRCSC
Member. Editorial Board. Canadian Journal o f Surgery. Clinical Professor, Department o f  
Surgery, University o f  British Columbia. St. Paul’s Hospital. Vancouver. BC
M anaging a surgical problem of the adrenal gland can get 
one’s adrenalin going. The presen­
tation, pathophysiology, pathologi­
cal features, investigation and treat­
ment of adrenal disease are fascinat­
ing and challenging. Admittedly, 
adrenal tumours are uncommon in 
clinical practice — benign nonfunc­
tioning tumours occur unexpected­
ly in 0.6% of computed tomography 
series1 and in only 1.4% to 8.7% of 
autopsy series,2 and adrenocortical 
carcinomas appear in 0.0006% to 
0.00017% of annual cancer regis­
tries.3-4 Certainly, these rates indi­
cate that the numbers of cases will 
be small.
In this issue (pages 51 to 55), 
Bautista and colleagues describe 
three cases of a fascinating adrenal 
tumour that is benign, nonfunction­
al and may be bilateral. Myelolipo­
mas of the adrenal gland are real 
tumours in that they are discovered 
as an adrenal mass. Bautista and 
colleagues present an interesting 
debate regarding etiology in their 
development as a tissue composed 
of hematopoietic and fatty ele­
ments. The real question for the 
clinician on discovering a tumour of 
the adrenal gland is what to do with 
it; fortunately most adrenal tu­
mours found incidentally are non­
functional and benign. But these
must be proven, and therein lies the 
challenge.
The widespread use of ul­
trasonography and computed to­
mography has fortuitously uncov­
ered many previously unsuspected 
adrenal lesions and at the same time 
eliminated the use of many invasive 
and potentially harmful diagnostic 
procedures. Gone are the days of 
retroperitoneal air insufflation, and 
the use of adrenal gland arteriogra­
phy for tumour diagnosis is de­
creasing. For patients who present 
with a clinical syndrome of hyper­
tension, Cushing’s syndrome or vi­
rilization, and endocrinologic inves­
tigation indicates a tumour, the
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treatment is clearly surgical. When 
adrenal tumours are discovered in 
the absence of clinical syndromes, 
careful biochemical investigation is 
necessary to uncover subclinical 
pheochromocytoma or androgen/ 
estrogen-producing tumours sug­
gesting malignancy.
Tests basic to this investigation 
include measurement of plasma 
concentrations of cortisol, aldoster­
one, epinephrine, norepinephrine, 
testosterone and estrogen, levels of 
vanillylmandelic acid, catechola­
mines, 17-hydroxycorticosteroids, 
17-ketosteroids and dehydroepian- 
drosterone sulfate. Dexamethasone 
and metyrapone suppression tests 
are used to distinguish between 
pituitary Cushing’s disease and 
adrenal adenomas or carcinomas 
causing Cushing’s syndrome. Col­
laboration with an endocrinologist 
is important because interpretation 
of the results of these tests can be 
confusing and subject to error. Ra­
dionuclide scanning may also help 
in locating and distinguishing pheo- 
chromocytomas and aldosterone- 
producing Conn’s adenomas. Adre­
nal venous samplings may be im­
portant to discriminate between the 
two glands, particularly in uncom­
mon conditions of bilateral adrenal 
adenomas associated with clinical 
syndromes or in adrenal hyperplasia 
and hyperfunction.
Because an adrenal tumour can 
be malignant, its pathological fea­
tures may be of more concern to 
the surgeon than the presentation 
and pathophysiology. Although ma­
lignant adrenal tumours supposedly 
start small and increase in size, few 
adrenal tumours less than 6 cm in
diameter are malignant. Adrenal tu­
mours 4 cm or greater in diameter, 
functioning or not, must be consid­
ered for surgical removal. When the 
tumour is less than 4 cm in diame­
ter, has been carefully evaluated 
and is clearly nonfunctional, it 
should be followed up closely. If no 
changes occur on ultrasonography 
or computed tomography over 12 
to 18 months, the tumour is proba­
bly unimportant. A tissue diagnosis 
will give the best assurance that it 
is benign.
Fine-needle aspiration biopsy 
with good radiologic control has 
proven effective and safe. Simple 
cysts can be aspirated; bloody fluid 
indicates the need for surgical re­
moval. Benign cytologic patterns 
can be recognized and cortical ade­
noma, nodular hyperplasia, myeloli­
poma and pheochromocytoma diag­
nosed. Biopsy of functioning adre­
nal tumours associated with clinical 
syndromes is usually not necessary. 
Primary adrenocortical and second­
ary carcinomas, functioning or not, 
have been diagnosed and a few 
fungal infections of the adrenal 
glands identified using fine-needle 
aspiration biopsy.
When the clinical picture, histo­
ry, physical examination, biochemi­
cal investigation and possible patho­
logical findings are established, a 
surgical approach can be formulat­
ed, dictated mainly by the type of 
syndrome and tumour suspected. I 
prefer to approach Conn’s tumours 
and benign unilateral nonfunction­
ing tumours through the flank. A 
bilateral flank or posterior approach 
is used in bilateral adrenalectomy 
for Cushing’s disease. Pheo-
chromocytomas need an anterior 
approach to permit scrutiny for 
multiple tumours and to eliminate 
the possibility of a malignant tu­
mour. Larger, more complex tu­
mours and those that are likely 
malignant may require extensive ex­
posure and possible vascular by­
pass; for these I prefer a long 
midline laparotomy incision with 
extension to a midline sternotomy.
Surgery in the investigation of 
adrenal clinical syndromes and tu­
mours can be challenging, particu­
larly in the planning and perfor­
mance of procedures that technical­
ly may be demanding. What ap­
peared to be potentially serious may 
prove to be an innocent benign 
nonfunctional tumour, like a myelo­
lipoma, requiring simple removal, 
much to the relief of surgeon and 
patient. Results can be extremely 
satisfying, since postoperative re­
covery from these endocrine syn­
dromes can be dramatic.
References
1. Belldecrun A, Hussain S, Seltzer SE, et 
al: Incidentally discovered mass of the 
adrenal gland. Surg Gynecol Obstet 
1986; 163: 203-208
2. Hedeland H, Ostberc G, HOkfelt B: On 
the prevalence of adrenocortical adeno­
mas in an autopsy material in relation to 
hypertension and diabetes. Acta Med 
Scand 1968; 184: 211-214
3. Flannery JT: Connecticut Tumor Regis­
try, 1976-80, Connecticut State Dept, of 
Health. Hartford, Conn., 1980
4. Copeland PM: The incidentally discov­
ered adrenal mass. Ann Intern Med 1983; 
98: 940-945
4 VOL. 32, NO. 1, JANU ARY 1989
QUILL ON SCALPEL
A Plea for Standard Methods of Reporting 
Studies on Lower Extremity Ischemia
Nathan M. Sheiner, MD, FRCSC
Member. Editorial Board. Canadian Journal o f  Surgery. Professor. Department o f  Surgery.
McGill University. Surgeon-in-Chief. Sir Mortimer B. Davis-Jewish General Hospital. Montreal.
PQ
I n this issue (pages 48 to 50) is an article by my colleagues Lau- 
rendeau and Lassonde entitled 
“Above-knee femoropopliteal recon­
struction with polytetrafluoro- 
ethylene: a good alternative to sa­
phenous vein bypass”. I do not 
intend to criticize the article, debate 
the selection of patients for surgery 
or the conclusions of the authors, 
but rather to point out that this and 
most other reports in the vascular 
surgery literature cannot be as­
sessed appropriately because there 
is a complete lack of standardized 
reporting practices. For example, in 
their article Laurendeau and Lass­
onde claim that of the 64 femoropo­
pliteal bypasses performed, 34 were 
for ischemic problems with rest 
pain and trophic changes and 30 
for claudication alone. There is no 
objective categorization of the se­
verity of claudication as could be 
achieved by treadmill testing in a 
vascular laboratory, nor is there any 
attempt to further categorize isch­
emic rest pain or trophic changes. 
As a result it is virtually impossible 
to compare this group of patients 
with others reported in the litera­
ture.
In terms of outcome, the only 
criterion noted in this article ap­
pears to be graft patency, though it 
is well known that patency does not 
necessarily imply success. Further­
more, there are instances in which 
graft occlusion occurs but does not 
result in limb loss, even when the
bypass grafting is performed for 
so-called “limb salvage”. Conse­
quently, it is essential that patients 
be placed into standardized catego­
ries and that success be gauged by 
a shift into a higher category ac­
companied by an improvement in 
the ankle-brachial index. There 
must be objective criteria for deter­
mining patency, and a distinction 
should be made between primary 
and secondary patency rates. There 
should also be a standardized tech­
nique for identifying and grading 
those features that modify outcome, 
such as diabetes, smoking history, 
hypertension, hyperlipidemia and 
cardiac disease, in addition to a 
standardized method of assessing 
and reporting runoff. The reporting 
of deaths and complications should 
also be standardized as should re­
sults by life-table analyses; this can 
be done in either table or graph 
form. In Laurendeau’s paper, re­
sults are reported by life-table anal­
ysis, but there is no notation of the 
number of grafts at risk or the 
standard deviation in each period.
Aware of the importance of stan­
dardizing reporting methods, the 
joint councils of the Society for 
Vascular Surgery and the North 
American Chapter of the Interna­
tional Society for Cardiovascular 
Surgery appointed an ad hoc com­
mittee to deal with this issue. The 
first report,1 issued by a subcommit­
tee, deals with reporting in lower 
extremity ischemia. In this report,
terms are defined and criteria pre­
sented for uniformly gauging sever­
ity of disease, the findings of diag­
nostic studies, the types of thera­
peutic intervention and their out­
come. The authors conclude: “We 
feel confident that most readers will 
appreciate that precisely defined 
and uniformly adopted reporting 
practices will allow us to better 
understand the data presented in 
the articles we read, be able to 
compare them with reliance, depend 
more confidently on their conclu­
sions, and base our practices on the 
more solid foundations of fact and 
the proper perspectives they will 
provide.”
Although acceptance of the rec­
ommendations in this report will 
result in considerably more work 
for vascular surgeons and necessi­
tate the use of computers, the po­
tential gains are enormous. Local, 
regional and national vascular so­
cieties should accept these recom­
mendations, or at least their broad 
principles and insist that they be 
followed when presentations are 
made at their meetings.
Reference
1. Suggested standards for reports dealing 
with lower extremity ischemia. Prepared 
by the Ad Hoc Committee on Reporting 
Standards, Society for Vascular Surgery/ 
North American Chapter, International 
Society for Cardiovascular Surgery. J 
Vase Surg 1986: 4: 80-94
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SESAP V Question
Item 218
The arteriogram of a 74-year-old man is shown above. Which of the following statements about this lesion is 
NOT true?
(A) The incidence of bilaterality is 35% to 70%
(B) It may be associated with ischemic symptoms in the toe even in the presence of good pedal pulses
(C) Spontaneous rupture may occur
(D) Abdominal aortic aneurysms occur in 30% to 50% of cases
(E) This disease is seen with equal frequency in both sexes
For the critique of Item 218 see page 68.
(Reproduced by permission from SESAP V Syllabus: Surgical Education and Self-Assessment Program No. 5. 
The Surgical Education and Self-Assessment Program No. 6 is now available. For further information and 
enrolment in SESAP VI, please apply to the American College of Surgeons, 55 East Erie St., Chicago, IL 
60611.)
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CORRESPONDENCE Contributions to the Correspondence section are welcome. They should be typewritten 
and double spaced.
Primary Omental Torsion
To the editors. Primary torsion of 
the greater omentum is a rare cause 
of abdominal pain. Since it was first 
described by Eitel1 in 1899, fewer 
than 250 cases have been reported.2 
It occurs when a segment of omen­
tum twists on its vascular pedicle, 
producing congestion, ischemia and 
eventual necrosis of the distal seg­
ment. Since the condition is rarely 
diagnosed preoperatively, its pres­
ence must be recognized at laparot­
omy. It should be distinguished 
from the more common secondary 
omental torsion, caused by attach­
ment of the free edge of the omen­
tum to cysts, tumours, inflammato­
ry foci, postoperative wounds or 
scarring, and to internal or external 
hernias.
We recently treated two such 
patients. Both had tenderness and 
guarding in the right lower quad­
rant of the abdomen, diagnosed as 
acute appendicitis preoperatively.
At laparotomy, the appendix ap­
peared normal in both patients and 
was removed. There was approxi­
mately 250 ml of serosanguineous 
fluid in the peritoneal cavity in one 
patient, and further exploration re­
vealed a 10 X 15-cm mass in the 
right upper quadrant. The mass 
comprised an edematous, cyanotic 
piece of greater omentum with 
areas of necrosis. By twisting on 
itself, an attached pedicle caused 
infarction of the distal segment 
which was easily excised. Patholog­
ical examination confirmed a nor­
mal appendix and necrosis of omen­
tum.
In the second case, a smaller 3 X 
3.5-cm segment of infarcted omen­
tum was found and excised. Again, 
pathological examination confirmed 
the diagnosis. Both patients made
smooth recoveries and were dis­
charged after 5 days.
In an extensive review of primary 
omental torsion by Mainzer and 
Simoes,3 the commonest preopera­
tive diagnosis was acute appendici­
tis (82%), followed by acute chole­
cystitis (12%). An abdominal mass 
was palpable in approximately 50% 
of the patients.
The finding of sterile serosan­
guineous fluid in the peritoneal cav­
ity is almost universal.3 4
The etiology of primary omental 
torsion is unknown; however, in 
1951, Leitner and colleagues5 clas­
sified possible predisposing and pre­
cipitating factors. The former in­
cluded anatomical variations in the 
omentum, obesity and redundancy 
of omental veins leading to kinking 
and twisting around the shorter, 
more tense arteries. Precipitating 
factors are those causing displace­
ment of the omentum; they include 
trauma, violent exercise and hy­
perperistalsis with resultant in­
creased passive movement of the 
omentum.
Treatment is resection of the in­
farcted segment; if it is not excised, 
the mass becomes atrophied and 
fibrotic and, on rare occasions, au- 
toamputated. Associated morbidity 
and mortality are extremely low.
James P. Appleby, MD 
Resident VI.
Division o f General Surgery.
University o f British Columbia.
Vancouver. BC
William T. Simpson, MB, FRCSC, 
FACS
T.E. Abraham, MD. FRCSC
Department o f Surgery,
Prince George Regional Hospital. 
Prince George. BC
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Immediate Thrombosis of 
Carotid Endarterectomy
To the editors. In the September 
1988 issue of the Journal (pages 
368 to 371), Egan and Walker 
documented symptomatic thrombo­
sis of carotid endarterectomy in 5 of 
325 procedures (1.5%). Four of the 
five patients were symptomatic 
within 2 hours and one within 9 
hours after operation. Although 
they indicated that the condition 
will be recognized only in patients 
with symptoms, the authors cited 
one reference1 in which asymptom­
atic postoperative thrombosis, doc­
umented by digital subtraction angi­
ography, was found in 1.2% of 
patients.
In a series of 864 carotid endar­
terectomies, in which all patients 
were monitored in the recovery 
room by ocular pneumoplethysmo­
graphy (OPG-Gee), 26 patients were 
considered to have early throm­
boses, all of which were confirmed 
by immediate reoperation without 
interval arteriography.2 These 
thromboses were symptomatic on 
the side appropriate in 9 patients; 
they were asymptomatic in 17 pa­
tients.
Although direct testing and other
VOL. 32. NO. 1. JANUARY 1989 7
CORRESPONDENCE
forms of indirect noninvasive test­
ing are difficult to apply in the 
recovery room, the OPG-Gee is a 
simple, economical procedure for 
identifying thrombosed carotid re­
pairs, both symptomatic and asymp­
tomatic.
William Gee. MD, FACS
Vascular Laboratory.
Lehigh Valley Hospital Center,
1200 S. Cedar Crest Blvd.,
Allentown. PA 18103
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STATE OF THE ART
Dilatation and Curettage
Mark E. Boyd, MD, FRCSC
The most important role of dilatation and curettage is in the evacuation of retained 
products of conception; its diagnostic value is mostly limited to the detection of 
cancer of the endometrium. The procedure is associated with a number of 
complications, the majority of which occur during dilatation of the cervix. Vabra 
curettage is suggested as an alternative to diagnostic dilatation and curettage; it is 
efficient, is associated with fewer complications and is less expensive. Hysteroscopy 
is a useful supplement to Vabra curettage, especially in diagnosing focal lesions.
L’indication principale de la dilatation et du curetage est l’evacuation des restes des 
produits de conception; son interet diagnostique se limite a la detection des cancers 
de l’endometre. L’intervention est associee a un certain nombre de complications, 
dont la majorite survient durant la dilatation du col. Le curetage par la methode 
Vabra est recommande comme alternative a la dilatation et au curetage diagnosti- 
ques; il est efficace, comporte moins de complications et est moins couteux. 
L’hysteroscopie complemente bien le curetage Vabra, surtout pour diagnostiquer les 
lesions focales.
As a result of new understanding of its diagnostic and therapeu­
tic worth and concerns over its 
cost, dilatation and curettage (D & 
C) is no longer the mainstay of 
gynecologic practice. In this review, 
the value of D & C will be discussed 
and the surgical technique de­
scribed; the diagnosis and avoid­
ance of complications will be em­
phasized. Alternatives to D & C for 
diagnosing gynecologic conditions 
will be suggested.
Indications
The most important diagnostic 
use of D & C is in cancer of the 
endometrium, presenting as post­
menopausal, intermenstrual or ex­
cessive menstrual bleeding. The 
only patients at high risk of har­
bouring the disease are those with
postmenopausal bleeding (8%).12 It 
is surprising, therefore, to find that 
the majority of D & Cs are per­
formed on women under 34 years of 
age when cancer of the endometri­
um is almost nonexistent.3 The pro­
cedure is not a perfect diagnostic 
tool; initial curettage fails to identi­
fy 10% of endometrial cancers and 
repeat curettage is often necessary 
for a definitive diagnosis.3-4 Dilata­
tion and curettage infrequently es­
tablishes other causes of abnormal 
bleeding.1 Information regarding 
ovulation and its timing may be 
important in the investigation of 
infertility; although ovulation can 
be confirmed by progesterone as­
says, its timing depends on histo­
logic examination of the endometri­
um.
There are important, albeit limit­
ed, therapeutic uses for curettage.
It is curative when bleeding is 
caused by retained products of con­
ception or submucous polyps, but 
unexpected discovery of the former 
has declined as preoperative preg­
nancy tests have become more sen­
sitive.
Curettage may also be useful in 
cases of acute vaginal bleeding not 
associated with pregnancy. The he­
morrhage is arrested by removing 
endometrium, which is rich in pros­
taglandins, and by causing throm­
bosis of endometrial arterioles and 
sinuses. Endometrial disease is 
found in only one-third of such 
cases.2
In all other circumstances, D & C 
is unlikely to have any therapeutic 
effect,1-5 particularly in patients who 
complain of menorrhagia.6 In select­
ed cases, medical curettage, using 
progesterone to initiate withdrawal 
bleeding, would be a more logical 
alternative.
Surgical Technique
Preoperatively, routine perineal 
shaving, catheterization and ene­
mas are not necessary; detailed hor­
mone studies are not worthwhile, 
but pregnancy tests should be 
done.1 The size and position of the 
uterus and adnexa are confirmed by 
pelvic examination. Local anesthe­
sia is known to be safer than gener­
al anesthesia, and efforts should be 
made to use it in the operation.7
The anterior lip of the cervix is 
grasped with a single-toothed tenac­
ulum and downward tension is ex­
erted; the degree of mobility deter­
mines the feasibility of vaginal hys­
terectomy and this should be re­
corded.
If cancer of the endometrium is
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suspected, endocervical curettage is 
indicated. The endocervix is first 
sampled, using a Kevorkian curet, 
care being taken to avoid the lower 
uterine segment. Firm pressure on 
the curet is necessary. The patholo­
gist will wish to see endocervical 
stroma in the specimen which is 
collected on a separate Tulfa pad. 
Although endocervical curettage is 
done to diagnose extension of can­
cer of the body of the uterus into 
the cervix (thus marking the pro­
gression of endometrial cancer from 
stage I to stage II), the information 
gathered is often unreliable. Tu­
mour fragments in the endocervix 
correlate best with a large tumour 
in the body of the uterus or with 
involvement of its lower segment 
but not with cervical invasion. One- 
half of the cases diagnosed preoper- 
atively as stage II on endocervical 
curettage are found to be stage I 
when the operative specimen is ex­
amined.8 Conversely, 13% of cases 
initially classified as stage I are 
found to be stage II.8-10 The stage 
of endometrial cancer is altered by 
extension to the endocervix and 
although this finding should 
change the choice of therapy, it 
seldom does.
The length of the uterine cavity, 
used in staging endometrial cancer, 
is estimated with a sound. The 
procedure is made easier and safer 
when the angle between the uterus 
and cervix is obliterated by down­
ward tension on the cervix. If it 
catches in an endocervical crypt the 
instrument may be impossible to 
insert, in which case a slightly 
larger probe, capable of bypassing 
the crypt, should be used.
The cervix is then dilated. Most 
complications associated with D &
C occur at this time. It is imperative 
that there is minimal thrust on the 
dilators which should be held by the 
finger tips in a pencil grip. The 
dilatation should allow the passage 
of only the smallest curet — a no. 7
Hegar — not nos. 10 to 12 Hegar 
as advocated in the past.
It has been proposed that the 
uterine cavity should now be ex­
plored with Randall stone forceps to 
remove any polypoid lesions pres­
ent.11 Searching for polyps in this 
manner is inefficient and is support­
ed only by a single, uncontrolled 
30-year-old paper.1213 In order to 
pass stone forceps, the cervix must 
be dilated to an inappropriate and 
dangerous degree.
The curettage is done with a 
sharp curet exploring the anterior 
and posterior walls, the cornua and 
the fundus. Despite the seeming 
thoroughness of the curettage, later 
examination will show that only 
halt the endometrium has been 
sampled.314 Accurate histologic di­
agnosis cannot be made from gross 
examination of the tissue, and even 
frozen-section examination can be 
misleading.1415 In 6% of cases the 
sample of endometrium is such that 
the pathologist is unable to give a 
histologic diagnosis.1
Complications
The frequency of major complica­
tions is similar to that with which 
endometrial cancer is found.1-2 Per­
foration is the most serious compli­
cation, caused by improper dilata­
tion of the cervix;18 this begins 
when the proper axis between the 
cervix and uterus is not found and a 
false passage is created.
Perforation of the pregnant uter­
us with a suction curet is particu­
larly dangerous and necessitates 
laparotomy.7 If the perforation is in 
the cervix, the uterine artery may 
be torn, and the ensuing hemorrh­
age into the broad ligament can be 
massive.17 If the fundus of the preg­
nant uterus is perforated with a 
dilator, the curettage may be com­
pleted under laparoscopic control.
In the nonpregnant uterus, the 
fundus is usually perforated and
there is seldom excessive in- 
traperitoneal hemorrhage. When 
perforation is diagnosed, the proce­
dure is discontinued and the patient 
closely observed for 3 to 4 hours. 
The D & C can be repeated later.
Laceration of the whole thickness 
of the cervix is caused by use of too 
large a dilator and is diagnosed by 
the sudden release of resistance to 
the instrument. Substantial vaginal 
or retroperitoneal hemorrhage may 
follow; the injury is best managed 
by laparotomy since vaginal mani­
pulations are unsatisfactory.
There is some suggestion that D 
& C contributes to infertility.18 A 
long-term ill effect is cervical in­
competence.19 An unusual compli­
cation is obliteration of the en­
dometrial cavity by postoperative 
adhesions (Asherman’s syndrome), 
most often a sequel to curettage of 
a postpartum uterus.
Complements and Alternatives 
to Dilatation and Curettage
Endometrial Cytologic Examination
Endometrial cytologic techniques 
do not ensure a definitive diagnosis, 
therefore they are not an alternative 
to D & C. They can, however, be 
used in screening when curettage is 
not justified; for example, in high- 
risk asymptomatic women (estrogen 
users) or symptomatic low-risk pa­
tients (premenopausal women with 
irregular bleeding).
The cytologic sample may be ob­
tained directly by aspiration, lavage, 
brush or direct smear tech­
niques.20-21 Two appropriate instru­
ments are the EndoPap and En- 
docyte.22-23 These techniques allow 
endometrial cancer to be diagnosed 
in 94% of cases with a false-positive 
rate of 8%.24 In 10% of cases no 
diagnosis was possible because the 
specimen was too small and in 50% 
there was failure to diagnose en­
dometrial hyperplasia.24
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Endometrial Biopsy
Definite determination of en­
dometrial disease depends on direct 
biopsy of the endometrium rather 
than cytologic smears. Endometrial 
biopsy is an incomplete curettage, 
customarily done with a small curet 
and without anesthesia. Since its 
introduction some 40 years ago its 
efficacy, compared with that of D & 
C, has been questioned.25 Reported 
series attest to its accuracy (91% to 
92%) in diagnosing cancer of the 
endometrium.25-26 However, these 
studies have been criticized for fail­
ing to indicate the percentage of 
cases in which endometrial biopsy 
was not possible and for failure to 
perform control curettage.27
In recent years, the technologic 
aspects of endometrial biopsy have 
been refined, as exemplified by the 
development of the Vabra curet 
(Berkeley Medevices Inc., Berkeley, 
Calif.). This disposable suction de­
vice allows thorough curettage 
without dilatation of the cervix. The 
procedure is more expensive than 
endometrial biopsy, but in a fairer 
cost comparison with D & C it is 
only 10% of the cost.29 Its diagnos­
tic value has compared favourably 
to D & C.3'28'29 The procedure is 
96% to 98% accurate in diagnosing 
cancer of the endometrium and 95% 
in the diagnosis of benign disease.29 
Also, it is associated with fewer 
complications. Its main weakness is 
a failure to diagnose endometrial 
or fibroid polyps, a shortcoming 
also noted with D & C.129-30
The sensitivity and specificity of 
endometrial biopsy and Vabra curet­
tage compared with D & C are 
unavailable because information on 
the true incidence of endometrial 
cancer and the diagnostic error of 
the D & C is lacking. A problem in 
comparing Vabra curettage with D 
& C is that the former may remove 
the lesion and thus hinder the diag­
nostic accuracy of the latter.3
Hysteroscopy
Hysteroscopy is the definitive 
method of diagnosing abnormal 
uterine bleeding caused by focal 
lesions, especially submucous fi­
broids, but it is equally efficient in 
diagnosing endometrial cancer.511
Hysteroscopy is done with disten­
sion (panoramic hysteroscopy) or 
without distension (contact hys­
teroscopy) of the uterine cavity. 
Both require expertise and are sub­
ject to disruption because of techni­
cal problems. It has been suggested 
that hysteroscopy be used routinely 
before endometrial biopsy to detect 
lesions that may be missed by curet­
tage and then to direct the curet 
toward a lesion.31 Curettage is a 
necessary supplement to hysteros­
copy since a histologic diagnosis 
cannot be made with this technique 
and biopsy through the instrument 
is unsatisfactory.5
Summary
Dilatation and curettage has 
changed from one of the most fre­
quently used to one of the least 
frequently used procedures in gyne­
cology. It is a useful diagnostic tool 
for detecting endometrial cancer 
but its therapeutic value in control­
ling uterine hemorrhage is limited. 
Complications relate to dilatation of 
the cervix. Under local anesthesia 
Vabra curettage supplemented by 
hysteroscopy is the most attractive 
alternative to D & C.
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Fate of the Gallbladder With 
Cholelithiasis After Endoscopic 
Sphincterotomy for Choledocholithiasis
D. David Lamont, MD; Ronald B. Passi, MD, FACS, FRCSC
Endoscopic sphincterotomy is the treatment of choice for choledocholithiasis after 
cholecystectomy. Its role has been expanded to treat choledocholithiasis in patients 
with gallbladders still in place. The authors report their experience with endoscopic 
sphincterotomy, with emphasis on the safety of the procedure, in high-operative-risk 
patients with choledocholithiasis and gallbladder in situ. Stones were successfully 
removed in 72 of 75 patients (96%); I required an emergency operation and 2 an 
elective one. Complications included bleeding, pancreatitis and cholangitis; there 
were no associated deaths. Follow-up of 54 of the patients, who had associated 
cholelithiasis at the time of endoscopic sphincterotomy, showed that 14 died of 
causes unrelated to the biliary tract. Of the others, 14 underwent cholecystectomy 
for failure of endoscopic sphincterotomy (2), acute cholecystitis (4) or persistent 
biliary tract symptoms (8). The other 26 patients were well after a mean follow-up of 
30.4 months; 1 had mild biliary tract symptoms. Ultrasonography in 16 of the 26 
patients showed persistent cholelithiasis in 12. Life-table analysis revealed a 15% 
probability of acute cholecystitis within 5 years of endoscopic sphincterotomy.
La sphincterotomie endoscopique est le traitement de premier choix de la 
choledocholithiase post-cholecystectomie. Son role s’est etendu au traitement de la 
choledocholithiase chez les patients qui ont conserve leur vesicule biliaire. Les 
auteurs commentent l’utilisation qu’ils ont faite de la sphincterotomie endoscopique 
et ils soulignent l’innocuite de cette technique chez les patients a risque eleve 
souffrant de choledocholithiase et ayant conserve leur vesicule. Des calculs purent 
etre retires chez 72 patients sur 75 (96%); 1 necessita une operation d’urgence et 2, 
une intervention differee. On compta parmi les complications une hemorragie, une 
pancreatite et une cholangite; il n’y eut aucun deces relie a l'intervention. Suite 
d’observation de 54 patients qui souffraient aussi de cholelithiase au moment de la 
sphincterotomie endoscopique, revele que 14 sont decedes de causes etrangeres a 
l'affection des voies biliaires. Parmi les autres, 14 ont subi une cholecystectomie, 
soit apres echec de la sphincterotomie endoscopique (2), soit pour cholecystite aigue 
(4) ou a cause de la persistance des symptomes biliaires (8). Apres un suivi moyen 
de 30.4 mois, les 26 autres patients etaient en bonne sante; 1 presentait de legers 
symptomes biliaires. Les analyses actuarielles revelent un risque de 15% de 
cholecystite aigue dans les 5 ans qui suivent une sphincterotomie endoscopique.
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Endoscopic sphincterotomy (ES) was introduced in 1974 as a 
method of treating choledocholi­
thiasis.1'2 Its success rate now ex­
ceeds 90%, which is comparable to 
that of choledochotomy.3 The com­
plication and death rates are less 
than 10% and 3% respectively, 
which are superior to the rates for 
choledochotom y.4-6 Endoscopic 
sphincterotomy is now the treat­
ment of choice for retained or re­
current common-duct stones after 
cholecystectomy. As a result of ex­
perience, the role of endoscopic 
sphincterotomy has expanded to in­
clude the management of choledo­
cholithiasis with gallbladders in 
place. It is also used in patients 
with ascending cholangitis and se­
lectively in early gallstone pan­
creatitis.7 Interest is now focused 
on whether the gallbladder can 
safely remain in situ after endoscop­
ic sphincterotomy.812 This question 
centres on two groups of patients 
— those with primary common-duct 
stones and no gallbladder disease 
and those with both common-duct 
stones and cholelithiasis. We report 
on the clinical follow-up of 75 pa­
tients with gallbladders in situ after 
endoscopic sphincterotomy per­
formed for choledocholithiasis; 54 
had associated cholelithiasis.
Patients and Methods
Between January 1981 and Au­
gust 1987, 363 endoscopic sphinc-
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terotomies were performed at Uni­
versity Hospital, London, Ont., for 
the management of choledocholi- 
thiasis or its complications. Seven­
ty-five high-operative-risk patients 
(48 men, 27 women) had their 
gallbladders left in place. Coronary 
artery disease and poor pulmonary 
function were the most commonly 
encountered risk factors (Table I). 
The patients ranged in age from 32 
to 98 years (mean 74.3 years). The 
indications for endoscopic sphinc­
terotomy were: obstructive jaundice 
(38), cholangitis (24) and pancreati­
tis (5). Eight sphincterotomies were 
performed at the time of diagnostic 
endoscopic retrograde cholangio­
pancreatography when common- 
duct stones were identified. The 
technique used in this study has 
been described previously.13
Complete follow-up was obtained 
for all 75 patients, either from their 
referring physician or by direct per­
sonal contact. The period from en­
doscopic sphincterotomy to follow­
up ranged from 5 to 68 months 
(mean 31.8 months). The causes of 
death were determined from death 
certificates or autopsy.
Life-table analysis was performed 
on the data from 52 patients in
Table 1. C o n d it io n s  in  7 5  H ig h -R isk  
P a tie n ts  W h o  U n d e rw e n t E nd o s co p ic
S p h in c te ro to m y
Disease/condition Nc. of patients
C o ro n a ry  a rte ry  d isease  
C h ro n ic  o b s tru c tiv e
29
p u lm o n a ry  d isease 20
M y o c a rd ia l in fa rc t io n 3
C e re b ro va sc u la r a cc id e n t 3
M is ce lla n e o u s 20
whom cholelithiasis was document­
ed at the time of endoscopic sphinc­
terotomy and who underwent recent 
ultrasonography.
Results
The common bile duct was suc­
cessfully cleared in 72 patients 
(96%). The procedure could not be 
completed in one uncooperative pa­
tient who was mentally retarded. He 
underwent elective cholecystectomy 
2 days later. One patient had large 
common-duct stones that could not 
be extracted and were removed sur­
gically 1 week later. The third fail­
ure was in a patient who had a 
large stone impacted in the ampul­
la; ascending cholangitis developed 
after the procedure and he under­
went emergency cholecystectomy 
and duct decompression. This case 
represents the only cholecystectomy 
performed in a patient without doc­
umented cholelithiasis.
In the 75 patients there were 
three complications (4%): a minor 
hemorrhage that did not require 
transfusion, a mild pancreatitis and 
an ascending cholangitis that re­
quired cholecystectomy and duct 
exploration. There were no associ­
ated deaths.
The follow-up after endoscopic 
sphincterotomy ranged from 2 
weeks to 43 months (mean 16.7 
months) in 16 patients who died. 
No death was related to sphinc­
terotomy or biliary sepsis. The 
causes were myocardial infarction 
(six patients), carcinoma of the lung
(three), chronic obstructive lung 
disease (two), carcinoma of the 
prostate (one) and mesenteric in­
farction (one). Although death was 
reported as due to carcinoma of the 
gallbladder in three, this was con­
firmed in only one. All patients who 
died had their gallbladders in situ.
Patients With Acalculous 
Gallbladders
Of the 75 patients, 21 (mean age 
73.9 years) had no documented 
evidence of cholelithiasis at the time 
of endoscopic sphincterotomy. Fol­
low-up in this subgroup ranged 
from 5 to 68 months (mean 33.6 
months). Two of the 16 deaths 
occurred in this group. One patient 
underwent cholecystectomy for fail­
ure of endoscopic sphincterotomy; 
the remaining 18 are well with no 
further biliary tract symptoms.
Patients With Cholelithiasis
Fifty-four patients (mean age 75 
years) had documented cholelithia­
sis at the time of endoscopic sphinc­
terotomy. The follow-up in this sub­
group ranged from 5 to 68 months 
(mean 30.4 months). Fourteen of 
the 16 patients who died were in 
this subgroup. Of the remaining 40 
patients, 14 (35%) underwent chole­
cystectomy, in 2 cases, as noted 
earlier, for failure of endoscopic 
sphincterotomy. Four patients suf­
fered from acute cholecystitis, an 
average of 4 months after endo­
scopic sphincterotomy. Eight pa­
tients who had persistent biliary 
tract symptoms were medically re­
habilitated before elective cholecys­
tectomy, which was performed a 
mean of 3 months after the proce­
dure (Table II). Twenty-six patients 
with their gallbladders in situ re­
main well and all but 1 are asymp­
tomatic.
Ultrasonography in 16 of the 26
Table II. S u m m a ry  o f  O u tcom e  in 7 5  P a tie n ts  W ith  G a llb ladde rs  In  S itu  A fte r  E nd o s co p ic  
S p h in c te ro to m y  (E S)
With gallstones Without gallstones
Outcome (n =  54) (n =  2 1 )
D eath 14 2
C h o le c y s te c to m y 14 1
F o r fa ile d  ES 2 1
F o r acu te  c h o le c y s t it is 4 -
For p e rs is te n t s y m p to m s 8 -
A liv e  and w e ll 26 18
16 VOL. 32, NO. 1, JANUARY 1989
NEED FOR CHOLECYSTECTOMY AFTER SPHINCTEROTOMY
patients revealed persistent choleli­
thiasis in 12, but no stones in 4; 
these may represent false-negative 
results, but the stones could have 
passed from the gallbladder into the 
duodenum through the sphinc­
terotomy (Fig. 1).
By life-table analysis the probabil­
ity of a patient having acute chole­
cystitis within 5 years of endoscopic 
sphincterotomy was found to be 
15% (Fig. 2).
Discussion
Recent emphasis has been placed 
on the fate of the gallbladder after 
endoscopic sphincterotomy.8"12 
Most patients who undergo the pro­
cedure, leaving the gallbladder in 
situ, are elderly and high operative 
risks.
Because of altered gallbladder ki­
netics and free intestinal reflux into 
the biliary system, it has been sug­
gested that there is an increased 
risk of acute cholecystitis develop­
ing after endoscopic sphincteroto­
my, even without cholelithiasis.11 
Tanaka and colleagues11 presented 
a long-term follow-up report on 91 
patients who underwent endoscopic 
sphincterotomy with acalculous 
gallbladders left in situ. None of 
these patients suffered from acute 
cholecystitis. This is in keeping 
with an earlier study by Choi and 
associates14 who reported on 271 
patients with acalculous gallblad­
ders followed up for 7 years after 
endoscopic sphincterotomy; 2 suf­
fered from cholecystitis. Our results 
are in keeping with those in the 
literature, and it is apparent that 
endoscopic sphincterotomy is in­
deed the treatment of choice for 
primary common-duct stones. The 
acalculous gallbladder can safely be 
left in situ.
The management of the calcu­
lous gallbladder is more controver­
sial. Tanaka and colleagues11 re­
ported 16 of 31 patients (51%) with 
cholelithiasis who had acute chole­
cystitis after endoscopic sphinc­
terotomy and advocated cholecys­
tectomy whenever feasible. Howev­
er, the incidence of acute cholecys­
titis after endoscopic sphincteroto­
my in patients with gallstones has 
been reported as 6.2%.s Rosseland 
and Solhaug12 reported a follow-up 
study of 77 patients, 10 (12.9%) of 
whom had acute cholecystitis, but 
only 7 required cholecystectomy. 
They believed that the gallbladder 
which contains stones can safely be 
left in situ after endoscopic sphinc­
terotomy in elderly high-risk pa­
tients.
FIG. 2. Life-table analysis performed 
on patients with associated cholelithia­
sis, revealing probability of acute 
cholecystitis in this group. GB =  gall­
bladder, E.S. =  endoscopic sphinc­
terotomy.
FIG. 1. Patient was 53-year-old man who had cirrhosis and previous placement of portacaval shunt. He underwent endoscopic 
sphincterotomy for management of ascending cholangitis. Initial x-ray film at endoscopic sphincterotomy (A) reveals radiopaque 
stones in gallbladder. X-ray film 5 days later (B) shows that stones had migrated to common duct alongside nasobiliary catheter. 
Follow-up x-ray film 3 weeks later (C) shows no evidence of stones, suggesting that they had passed.
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Our results are in agreement with 
those of Rosseland and Solhaug. In 
our series, the common duct was 
successfully cleared in 96% with a 
4% rate of complications; only one 
complication was serious and re­
quired operative intervention.
Life-table analysis revealed a 15% 
probability of acute cholecystitis de­
veloping within 5 years of endo­
scopic sphincterotomy. This is 
lower than the reported 29% death 
rate with acute cholecystectomy 
and duct exploration.15 Duron and 
associates5 have shown that endo­
scopic clearance of the bile duct 
before cholecystectomy in the elder­
ly reduces the operative mortality 
associated with duct exploration 
from 21% to 6%.
We believe that in elderly high- 
risk patients, endoscopic sphinc­
terotomy is the treatment of choice 
for common-duct stones or their 
complications and that the calcu­
lous gallbladder can safely be left in 
situ. These patients are likely to die 
of underlying medical conditions be­
fore acute cholecystitis develops, 
but should it do so, common-duct 
exploration will not be required at 
the time of cholecystectomy, thus 
putting them in a lower-risk catego­
ry.45
The unanswered question is 
whether it is safe to manage youn­
ger, healthy patients with choleli­
thiasis in a similar manner. Further 
studies are required in this area.
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Strictureplasty in Crohn’s Disease
Richard E. Silverman, MD, FRCSC; Robin S. McLeod, MD, FRCSC; Zane Cohen, MD, FRCSC
Strictureplasty may eliminate or decrease the extent of resection required in patients 
who have obstructing Crohn’s disease of the small bowel. The authors performed 36 
strictureplasties at 16 operations in 14 patients. Additional bowel resection was 
carried out in 13 of the 16 procedures. Early complications included wound infection 
in one patient, upper gastrointestinal bleeding in one and presumed suture-line 
leak, treated conservatively, in a third patient. At the end of the follow-up period 
(mean 16.1 months), 10 patients were asymptomatic and 4 had symptomatic 
recurrences; 2 of these required reoperation. A number of preoperative factors and 
operative techniques may have contributed to the favourable results.
La stricturoplastie peut eliminer ou reduire l’etendue de la resection que necessitent 
les patients souffrant d’obstruction intestinale causee par la maladie de Crohn de 
l’intestin grele. Les auteurs ont pratique 36 stricturoplasties au cours de 16 
operations chez 14 patients. Des resections intestinales additionnelles ont ete 
effectuees durant 13 de ces 16 interventions. Parmi les complications precoces, on 
compte une infection de plaie chez un patient, une hemorragie gastrointestinale 
haute chez un autre et une fuite presumee au point d’anastomose chez un troisieme, 
laquelle fut traitee de fa?on conservatrice. A la fin de la periode de surveillance des 
suites operatoires (16.1 mois en moyenne), 10 patients etaient asymptomatiques 
alors que 4 presentaient une recidive des symptomes; 2 de ces derniers necessiterent 
une deuxieme intervention. Un certain nombre de facteurs preoperatoires, de meme 
que les techniques operatoires utilisees, peuvent avoir contribue a ces resultats 
favorables.
G oals of surgery for Crohn’s disease are to treat complica­
tions and relieve symptoms. After 
an initial small-bowel resection or 
subsequent ileocolic resection to re­
move all visibly diseased bowel, 
10-year rates of recurrence associ­
ated with reoperation range from 
30.5% to 53%.12 Indeed, there is 
histologic evidence that Crohn’s 
disease may affect the entire gas­
trointestinal tract from the outset.3 4 
These factors dampen any enthusi­
asm for performing radical bowel 
resection for cure. Conservative 
surgery is especially applicable to 
two groups of patients: those who 
have previously undergone small- 
bowel resection and present with 
recurrent disease of an obstructive 
nature and those who have diffuse 
disease and multiple small-bowel
strictures. In these patients, remov­
al of the involved areas of intestine 
may lead to an iatrogenic short- 
bowel syndrome.
Strictureplasty for small-bowel 
strictures was pioneered by sur­
geons in India who successfully 
used the technique in both tubercu­
lous and Crohn’s lesions.5 Lee and 
Papaioannou6 advocated stricture­
plasty as a cornerstone of their 
policy of minimal surgery in pa­
tients having diffuse obstructive 
Crohn’s disease. Their encouraging 
preliminary results led to subse­
quent recent reports7-9 attesting to 
the safety and efficacy of the proce­
dure. In this paper we review our 
experience with strictureplasty be­
tween October 1985 and March 
1988 in the management of 14 
patients who had Crohn’s disease.
Patients and Methods
The 14 patients (3 female, 11 
male) underwent 16 operative pro­
cedures in which 36 strictureplas­
ties were performed. Their average 
age was 28.1 years (range from 17 
to 44 years). As a whole, they had a 
relatively long history of Crohn’s 
disease, with a mean time from 
diagnosis of 9.7 years (range from 1 
to 27 years). Ten patients had previ­
ously undergone a total of 20 bowel 
resections. The indication for stric­
tureplasty in all cases was recurring 
obstructive symptoms refractory to 
medical therapy.
Thirty strictures were short (1 to 
7 cm) and were treated by a Heine- 
ke-Mikulicz procedure using inter­
rupted 3-0 Vicryl sutures (Fig. 1).
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The six longer strictures (7 to 12 
cm) were treated by a Finney-type 
strictureplasty and also sutured
FIG. 1. Heineke-Mikulicz stricture­
plasty. Strictured area is opened along 
antimesenteric border with cautery (A). 
Stay sutures are placed and incision is 
oriented transversely (B). Interrupted 
3-0 Vicryl is used to close stricture­
plasty (C).
with 3-0 Vicryl (Fig. 2). Only 3 
operations consisted of stricture­
plasty alone; the remaining 13 con­
sisted of strictureplasty and small- 
bowel resections in 9, ileocolic 
anastomotic resection in 2, proctec­
tomy in 1 and small- and large-bow­
el resection in 1. We used a Foley 
catheter with the balloon inflated to 
2 cm diameter to calibrate the 
small-bowel lumen internally in 
order to define strictures that were 
not readily apparent. The catheter 
was introduced into the first en- 
terotomy site and passed proximally 
and distally to evaluate the entire 
small bowel.
Results
The mean postoperative hospital 
stay was 12.6 days (range from 9 to 
24 days). Complications occurred 
early after operation in three cases. 
One patient had a wound infection. 
Another, on coumadin therapy for 
preoperative deep wound thrombo­
sis, had an upper gastrointestinal 
hemorrhage which responded to 
conservative measures. The third 
patient complained of localized 
lower abdominal pain and tender­
ness 9 days after five strictureplas­
ties and a bowel resection were 
performed; a presumptive diagnosis 
of a suture-line leakage was made 
and he was given broad-spectrum 
antibiotics and total parenteral nu­
trition infusion. His symptoms re­
solved within 48 hours.
The follow-up ranged from 1 to 
29 months (mean 16.1 months). 
Nine patients had an excellent re­
sult and were asymptomatic, 
though five of them required main­
tenance drug therapy to control 
residual disease (Table I). Two pa­
tients required reoperation for ob­
structive symptoms, 3 and 8 
months postoperatively. One had 
extensive small-bowel and colonic 
disease treated by resection and
strictureplasty. Three months later 
a discrete stricture of the ileocecal 
valve was resected; it had likely 
been present but undiagnosed at 
the time of the original operation. 
The second patient had a resection 
and strictureplasty for extensive je- 
junoileitis. Eight months later, at 
laparotomy for recurrent obstruc­
tive symptoms, a more proximal 
stenosis was treated by stricture­
plasty. Two, who had recurrent 
symptoms due to active disease, 
were being managed medically. The 
remaining patient had no gastroin­
testinal symptoms but remained 
unwell due to unrelated medical 
problems.
Eleven of the 14 patients gained 
a substantial amount of weight 
postoperatively (range from 3.2 to 
22.7 kg, mean 9.8 kg); the others 
had no change in weight or minimal 
weight loss. Serum albumin levels 
and total lymphocyte counts did not 
change greatly after surgery (Table 
I I ) .
Discussion
Lee and Papaioannou6 delayed 
publication of their results of stric­
tureplasty in cases of Crohn’s dis­
ease because of doubts about its 
safety and long-term benefits. In 
fact, on a follow-up of 8 to 42 
months, none of their patients suf­
fered a leak or other major compli­
cation, and only one had recurrent 
obstructive symptoms. In a recent 
review, Alexander-Williams and 
Haynes1" updated their results in 52 
patients with 148 strictureplasties. 
They found an 11% rate of “painful 
episodes” suggestive of a contained 
leak and a 6% rate of enterocutane- 
ous fistula, which is comparable to 
that seen after bowel resection for 
Crohn's disease. In addition, 23% of 
their patients required further sur­
gery, usually for strictures develop­
ing elsewhere in the alimentary
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tract. Fazio and Galandiuk9 de­
scribed three patients with exten­
sive small-bowel Crohn’s disease 
who underwent 12 strictureplasties. 
There were no postoperative leaks 
or symptom recurrences after 6 
months’ follow-up. Whelan and col­
leagues8 performed 15 strictureplas­
ties on three patients. Two recov­
ered without complications and re­
mained well on follow-up. The third 
had symptoms suggestive of a leak 
which healed on conservative man­
agement, but after 12 months this 
patient needed reoperation for re­
currence of an enterovesical fistula.
Kendal and associates11 reported 
on nine patients who had 13 opera­
tive procedures and 45 stricture­
plasties. A high complication rate 
was noted in those with diffuse 
disease, including three who had 
enterocutaneous fistulas and four 
who required early reoperation (2 to 
6 months postoperatively) for recur­
rent obstructive symptoms.
Our experience is further evi­
dence of the safety and utility of 
strictureplasty. Of 16 operations, 
only 1 was associated with a suture­
line leak which responded to con­
servative measures. At last follow­
up, 10 of our patients were free of 
symptoms. Two of four with recur­
rent symptoms had improved on a 
medical regimen and two had un­
dergone reoperation at 3 and 8 
months respectively. These latter 
two continued to fare poorly, due to 
diffuse small-bowel and gas­
troduodenal Crohn’s disease in one 
and to Crohn’s colitis in the other.
An additional benefit has been 
the ability to maintain patient com­
fort without using steroids. Only 
one of nine patients who required 
prednisone preoperatively needed it 
postoperatively. Maintenance drugs 
included Pentasa in five patients 
and a course of azathioprine in 
three patients with ongoing disease.
We used a Foley catheter to 
identify stenotic areas not appreci­
ated by external palpation. As in 
one of our patients, the ileocecal 
valve may be the site of an isolated 
narrowing, so the entire small
T a b le  1. M ain te na n c e  D rug T h e ra p y
Drug
No. of p a tie n ts  
P reop Postop
P re dn isone 9 1
S a la zo p y r in e 2 0
P entasa 3 5
M e tro n id a zo le 9 1
A za th io p rine 0 3
bowel should be carefully evaluated.
In our opinion a number of thera­
peutic maneuvers could have con­
tributed to the effectiveness of stric­
tureplasty in this series.
•  An adequate trial of medical 
therapy preoperatively may decrease 
the number of strictureplasties per­
formed because of resolution of 
stenoses caused by inflammatory 
edema.
•  Many of these patients, initial­
ly hospitalized with marked weight 
loss and nutritional depletion, bene­
fit from the use of total parenteral 
nutrition or an elemental diet, as in 
eight of our patients, for 10 to 14 
days before surgery and thus may 
have fewer complications.
•  The use of a calibrating tech­
nique is important for diagnosing 
distal obstructing lesions which 
might endanger healing of a stric­
tureplasty or anastomotic suture 
lines.
•  It has been our practice to 
resect extensively diseased seg­
ments of bowel in addition to per­
forming strictureplasty. An optimal 
surgical procedure requires salvage
T a b le  II. S erum  A lb u m in  L e v e ls  and T o ta l L y m p h o c y te  C o u n ts  B e fo re  and  A fte r  O p e ra tion
( ±  S E M )
M ea s u re m e n t Preop Postop
S erum  a lb u m in , g /L 3 7 .8  ±  5 .8 4 4 .3  ±  4 .9
T o ta l ly m p h o c y te s , x  10 9/ L 1 .1 3 4  ± 0 .4 9 3 1 .1 0 6  ± 0 . 4 5 4
FIG. 2. Longer strictures are opened longitudinally and folded into two limbs. Back wall is closed with interrupted sutures (B), 
followed by closure of anterior wall.
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of as much bowel as possible while 
removing areas not amenable to 
strictureplasty but which may com­
promise the safety and outcome of 
the procedure.
Symptomatic recurrence occurred 
in four (28%) of our patients and 
appeared to be due to progression 
of disease in three. Based on the 
experience of others,1011 a high 
recurrence rate can be expected in 
patients with extensive disease, and 
it remains to be seen how many of 
our patients will require repeated 
operative procedures, including 
strictureplasty, during long-term 
follow-up.
Strictureplasty in our experience 
has proven to be a safe method of 
relieving obstructive symptoms in 
patients with widespread small-bow­
el Crohn’s disease. Major improve­
ment in symptoms associated with
reversal of weight loss is the usual 
result. An acceptable early rate of 
symptomatic recurrence, usually 
due to progression of disease, has 
been seen associated with a 14% 
reoperation rate.
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Identification and Importance of 
Lymphocyte Subpopulations in the 
Regional Lymph Nodes of Breast Cancer 
Patients
N. Khuri, MD, FRCSC;* S.P. Jothy, MD, PhD, FRCPC;t H.R. Shibata, MD, MSc, FACS, FRCSC*
To determine whether the presence of metastatic cancer cells in lymph nodes is 
accompanied by changes in lymphocyte subpopulations identified in tissue sections, 
the authors studied metastatic and nonmetastatic lymph nodes from eight patients 
with breast cancer and lymph nodes of three control patients. In all metastatic lymph 
nodes, T cells were seen in close contact with infiltrating cancer cells; B cells tended 
to accumulate focally, apart from cancer cell nests. In both metastatic and 
nonmetastatic lymph nodes from breast cancer patients, the fractional areas occupied 
by the T4 (helper) and T8 (suppressor/cytotoxic) lymphocytes were comparable. The 
B-cell fractional area was significantly (p < 0.01) greater in nonmetastatic than in 
metastatic nodes. The fractional area occupied by the T8 lymphocytes in the breast 
cancer patients was significantly (p < 0.01) greater than in the normal lymph nodes, 
but no difference was noted in the fractional area occupied by the T4 cells. These 
findings indicate that all lymph nodes in breast cancer patients are characteristically 
increased in suppressor/cytotoxic lymphocytes, and the presence of metastatic 
cancer cells in the nodes is manifested by a depletion of B lymphocytes.
Les auteurs ont etudie des ganglions metastasies et non metastasies provenant de 
huit patientes souffrant de cancer du sein, ainsi que les ganglions de trois patientes 
temoins, afin de determiner si la presence de cellules cancereuses metastatiques dans 
les ganglions s’accompagne de modifications des sous-populations lymphocytaires 
identifies dans les coupes histologiques. Dans tous les ganglions metastasies, des 
lymphocytes T ont ete vus en contact etroit avec les cellules tumorales infiltrantes; 
les lymphocytes B avaient tendance a s’accumuler en foyers, a l’ecart des nids de 
cellules cancereuses. Dans les ganglions metastasies et non metastasies, les surfaces 
occupees par les lymphocytes T4 (helper) et T8 (suppresseurs/cytotoxiques) etaient 
comparables. La surface des lymphocytes B etait significativement plus importante 
(p < 0.01) dans les ganglions non metastasies que dans les ganglions metastasies. 
Chez les patientes cancereuses, la surface occupee par les lymphocytes Tg etait 
significativement plus grande (p < 0.01) que dans les ganglions normaux, mais 
aucune difference significative n’a ete observee en ce qui a trait a la surface prise par 
les lymphocytes T4. Ces resultats indiquent qu’il y a une augmentation caracteristi- 
que des lymphocytes suppresseurs/cytotoxiques dans tous les ganglions des 
patientes atteintes de cancer du sein et que la presence de cellules tumorales 
metastatiques dans les ganglions se manifeste par une depletion des lymphocytes B.
From the *Department o f  Surgery and fDepartment o f Pathology, Royal Victoria Hospital and 
McGill University, Montreal. PQ
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There is circumstantial evidence of a relationship between im- 
munocompetence and the prognosis 
of malignant disease.1-2 The discov­
ery of monoclonal antibodies, which 
are useful in identifying different 
subsets of lymphocytes,3-4 has made 
it possible to investigate some of 
the complex aspects of the immune 
mechanism as it relates to locore- 
gional immunity.
One of the early clinical applica­
tions of monoclonal antibodies was 
determining lymphocyte subsets in 
normal human lymphoid tissues,5 
and subsequent studies6 shed light 
on the nature of lymphocytes in 
solid tumour tissue. The pattern 
and subtypes of these infiltrating 
cells at the host-tumour interface 
and the types of lymphocytes pres­
ent in malignant and benign tissues 
were identified.
No one has yet accurately identi­
fied the lymphocytes in regional 
lymph nodes or the difference, if 
any, in the amount of T-cell subsets 
in metastatic and nonmetastatic 
lymph nodes and estimated their 
relative distribution. In this study 
we attempt to identify the distribu­
tion of T and B cells in lymph nodes 
of patients with breast cancer, 
using the indirect immunoperoxi- 
dase technique with specific antihu­
man T- and B-cell monoclonal anti­
bodies. We also try to determine if 
there is a difference in the T-cell 
subsets in metastatic and nonmeta­
static lymph nodes.
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Patients and Methods
Eight patients operated on for 
stage I or II breast cancer at the 
Royal Victoria Hospital, Montreal, 
between 1984 and 1985, served as 
the study population. Six lymph 
nodes from three patients who un­
derwent surgery for non-neoplastic 
or noninflammatory disease were 
used as controls to quantitate the 
surface area of different lymphocyte 
subsets in normal lymphoid tissue. 
For breast cancer patients, the
number of lymph nodes with or 
without metastases was determined 
by routine histopathologic methods.
Tissue
Tissue blocks of 12 lymph nodes 
from eight breast cancer patients 
were studied as follows. After exci­
sion, the lymph nodes were serially 
sectioned and fixed in formalin for 
histopathologic assessment. Adja­
cent sections were snap-frozen in
liquid nitrogen and stored at 
-80°C  until immunostaining of 
the lymphocyte subpopulations was 
done. Thick cryostat sections (5 /um 
thick) were prepared and air dried 
for 1 hour.
The functional characteristics of 
the lymphocyte subpopulations de­
fined by monoclonal antibodies is 
listed in Table I (OKT from Ortho 
Diagnostic Systems Inc., Raritan, 
NJ; Bj from Coulter Electronics 
Inc., Hialeah, Fla.)
Immunoperoxidase Staining
Six sections (5 Aim thick) were 
cut from each lymph node. Four 
sections served for identification of 
lymphocyte subsets, one as a nega­
tive control and one for routine 
staining with hematoxylin and eo- 
sin. The negative control section 
included omission of the first layer 
of monoclonal antibodies which was 
replaced by normal mouse serum. 
The staining procedure was per­
formed at room temperature, as 
previously described.7 Briefly, the 
sections are handled as follows: 
placed in pH 7.4, 0.01M TRIS 
(tromethamine) buffer for 10 min­
utes; incubated with saturating con­
centrations of monoclonal antibod-
T a b le  1. Functional Characteristics of Lymphocyte Subsets as Defined by Monoclonal Antibodies
L y m p h o c y te  s u b s e t C D  C la s s if ic a t io n * S p e c if ic ity
Antibody OKT,, CD 2 Pan T lymphocytes
o k t8 CD 8 Suppressor/cytotoxic T lymphocytes
o k t4 CD 4 Helper/inducer T lymphocytes
B, CD 20 B lymphocytes
*lnternational classification of clusters of differentiation (CD).
T a b le  I I .  Fractional Areas Occupied by Lymphocyte Subsets in Normal Lymph Nodes*
L y m p h o c y te  su b se ts
no. T „ t 8 T , B,
1 33(1) 11.4(1) 25(1) 17.5 (2)
2 22 ± 1.4 (2) 11.8 (1) 23.5 ± 0.7 (2) 14(2)
3 23 ± 2.8 (2) 11.6(1) 19.5 ± 4 .9  (2) 17.7(2)
Mean 26 ± 6.0 11.6 ± 8.4 22.6 ± 2.8 16.3
’ Numbers represent % fractional areas, expressed as ± 1 standard deviation, occupied by
lymphocyte subsets in total area of microscope fields. Numbers in parentheses refer to number of
lymph nodes examined.
T a b le  I I I .  Lymphocyte Subsets in Lymph Nodes of Breast Cancer Patients
C a n c e r
n o .
N o . o f n o d e s  
re s e c te d
N o . o f n o d e s  
e x a m in e d
L y m p h o c y te  s u b s e ts *
T „ T , \ V r B B,
1 2 1 + 1 + ND 28 24 1.16 5.5
1 — 1 - ND 24 30.2 0.8 15.6
2 11 1 + 1 + 28 32 28 1.14 ND
10 — 3 - 29.3 39.5 24.8 1.46 19.4
3 10 1 + 0 +
9 - 1 - ND 43 30 1.43 ND
4 18 0 + 0 +
18 - 1 - ND 37 26 1.42 ND
5 17 0 + 0 +
17 - 1 - ND 27 21 1.29 24
6 4 0 + 0 +
4 - 1 - ND 50 48 1.25 ND
7 19 0 + 0 +
19 - 1 - ND 54 32 1.69 ND
8 10 1 + 1 + ND ND ND ND 4.2
9 - 0 -
*% of fractional areas occupied by different lymphocyte subsets in metastatic and nonmetastatic lymph nodes. +  =  metastatic, -  
ND =  not determined.
=  nonmetastatic,
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ies at 37°C for 1 hour; washed in 
TRIS buffer; incubated with peroxi­
dase-conjugated rabbit antimouse 
immunoglobulin (Dakopatts, A/S, 
Glostrup, Denmark) for 20 minutes; 
washed in TRIS buffer; incubated 
with peroxidase-conjugated swine 
antirabbit immunoglobulin (Dako­
patts) for 20 minutes; rinsed with 
TRIS buffer; the peroxidase reac­
tion product developed with the 
dimethylaminobenzidine chromo­
gen, washed with tap water; count­
er stained with hematoxylin; 
washed, dehydrated and mounted.
For each lymph node, photomi­
crographs of immunostained sec­
tions representing different lympho­
cyte subsets were analysed by quan­
titative morphometry, using a mi­
crocomputer and the Bioquant pro­
gram (R and M Biometrics Inc., 
Nashville, Tenn.). The surface area 
of one lymphocyte subset in each 
section was calculated and related 
to the surface area of the total 
microscopic field. The lymphocytes 
corresponding to the various sub­
sets were found to be clustered in 
discrete areas within the lymph 
nodes, as previously documented by 
studies of normal lymph nodes.8 
The fractional area of each subset
was calculated as the ratio of its 
surface area relative to the total 
microscopic field. The mean frac­
tional area of different lymphocyte 
subsets was calculated as the mean 
of at least six photomicrographs. 
The calculated mean for all patients 
in a given group was analysed using 
Student’s f-test for unpaired data.
Results
Individual values of the nodes in 
the control patients are shown in 
Table II and results on the 12 
lymph nodes from the eight cancer 
patients in Table III. The mean 
value for each lymphocyte subset in 
control, nonmetastatic and meta­
static lymph nodes is presented in 
Table IV. Fractional areas occupied 
by lymphocyte subsets in nonmeta­
static lymph nodes from stage I and 
stage II patients are summarized in 
Table V.
When the different lymphocyte 
subsets in nonmetastatic lymph 
nodes of breast cancer patients were 
quantitated and compared with 
those of lymph nodes from normal 
controls, the proportion of T4 cells 
and B cells in the nodes of cancer
Table IV. Fractional Areas Occupied by Lymphocyte Subsets*
Origin of node
Lymphocyte subsets
T„ t8 t4 B,
Control 26 1 1 . 6 22.6 16
Nonmetastatic 29.3 30.1t 40.8 19.6
Metastatic 28.0 2 6 . 0 t 30.0
•H
*
C
O
‘ Numbers represent % area occupied by lymphocyte subsets in total area of microscope fields. 
tStatistically significant (p < 0.01) compared with control nodes, 
fStatistically significant (p < 0.01) compared with nonmetastatic and control nodes.
Table V. Fractional Areas of Lymphocyte Subsets T4and T8 in Nonmetastatic Lymph Nodes in 
Stage I and Stage II Patients
Lymphocyte subsets
Stage T4 T,
I 42.2(5) 31.4(5)
_ l l______  ___________________ 31.75 (2)__________________ 27.5 (2)___________
Numbers represent % fractional areas occupied by lymphocyte subsets in total area of 
microscopic field. Numbers in parentheses refer to number of patients.
patients was found to be slightly, 
but not significantly, larger. How­
ever, the mean of T8 lymphocytes 
was 2.6-fold greater (p < 0.01) in 
nonmetastatic nodes from breast 
cancer patients than in the controls.
When the proportion of different 
lymphocyte subsets in both non­
metastatic and metastatic lymph 
nodes was compared, there was no 
significant difference in the mean 
areas of T8 and T4 cells. However, 
there were four times fewer B cells 
in the metastatic than the nonmeta­
static lymph nodes.
When the different lymphocyte 
subsets in metastatic nodes were 
compared with the control nodes, 
the mean areas occupied by T4 cells 
were not significantly different. 
However, there was a marked deple­
tion of B lymphocytes in the meta­
static nodes and the proportion of 
T8 cells was significantly (p < 0.01) 
greater.
Comparison of different lympho­
cyte subsets in nonmetastatic lymph 
nodes from stage I and stage II 
patients showed no significant dif­
ference in the mean areas of T8 and 
T4 cells.
This study also revealed that the 
majority of lymphocytes infiltrating 
cancer tissue were T cells, which 
were often seen in intimate contact 
with infiltrating cancer cells; how­
ever, there was no predominant 
pattern of the type of T-cell lym­
phocyte subpopulation infiltrating 
these cancers. Apart from cancer 
cell nests, B cells tended to accumu­
late focally.
Discussion
The importance of T and B cell 
infiltrates in primary malignant tu­
mour tissue has been examined in 
both clinical and experimental mod­
els. A discrepancy in the density of 
T and B cell infiltrates in cancerous 
and noncancerous breast tissue has
VOL. 32. NO. 1. JANUARY 1989 25
KHURI, ET AL.
been noted. Shimokawara and col­
leagues9 reported that B cells were 
predominant and T cells scanty in 
noncancerous breast lesions, while 
T cells predominated in cancerous 
breast tissue. They also showed a 
significant inverse correlation be­
tween the intensity of the T-cell 
infiltrate and the clinical stage. The 
infiltrates were dense in breast can­
cer without lymph-node metastases 
but were scanty in advanced clinical 
stages, suggesting that the infiltrat­
ing T cells in cancerous tissue rep­
resent host resistance. Berg10 also 
reported fewer metastases and a 
higher cure rate in breast cancer 
with dense lymphocytic infiltrates. 
Black and colleagues11 suggested 
that patient survival is superior in 
breast cancer with marked lympho­
cytic infiltration. In contrast, 
Schoorl and colleagues, 12 reporting 
on T and B cells in human breast 
cancer, indicated that T cells pre­
dominated in benign breast tissue. 
Giorno6 examined the microanatom- 
ic distribution of different lympho­
cyte subsets in benign and malig­
nant human breast tissue and found 
that in malignant tissue most of the 
T cells were of the T8 subset, 
organized in single cells in the 
tumour stroma or invading tumour 
nests, while T4 cells predominated 
in the lymphoid aggregates associ­
ated with benign tissue. Rowe and 
Beverley13 reported that T lympho­
cytes existed in similar proportion 
in benign and malignant breast tis­
sue.
Our study demonstrated that the 
lymph nodes of breast cancer pa­
tients displayed marked changes in 
their B and suppressor/cytotoxic T 
cells. B-cell depletion was associat­
ed with the presence of metastasis 
in the lymph nodes. The increase in 
suppressor/cytotoxic T cells was 
associated with concomitant breast 
cancer whether or not it had metas­
tasized to the lymph nodes. No 
marked difference was seen in
nodes from stage I and stage II 
patients, but the number in each 
group did not allow a reliable statis­
tical evaluation of possible changes 
in lymphocyte subset populations.
The study also showed that the 
amount of T lymphocytes and their 
different subsets were present in 
similar proportions in metastatic 
and nonmetastatic lymph nodes of 
breast cancer. However, B cells 
were denser in nonmetastatic than 
metastatic lymph nodes, suggesting 
that an effector humoral response 
might be depleted when metastasis 
occurs. We also found that meta­
static and nonmetastatic lymph 
nodes of breast cancer patients con­
tained more T8 (suppressor- 
/cytotoxic) lymphocytes than did 
normal lymph nodes from control 
patients. It remains to be estab­
lished whether the generation of 
these suppressor/cytotoxic lym­
phocytes is directly involved in the 
host’s immune surveillance against 
breast cancer.
It would appear that breast can­
cer cells metastasizing to regional 
lymph nodes cause an increase in 
the number of T-cell subsets as well 
as B cells.
In conclusion, breast cancer is 
accompanied by marked changes in 
lymphocyte subpopulations of asso­
ciated axillary lymph nodes. Most 
remarkably, the recruitment of sup­
pressor/cytotoxic cells, even before 
metastasis occurs, is consistent 
with the notion that breast cancer 
mounts an early cellular immune 
response as a result of unidentified 
factors associated with tumour 
growth.
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Clinical Significance and Measurement of 
the Length of the Right Main Bronchus
C.L.N. Robinson, MD, FRCS, FRCSC;* Nestor L. Muller, MD, FRCPC;f Cameron Essery, MD, FRCSC*
It is important for surgeons, pathologists, anesthetists and anatomists to know the 
length of the right main bronchus. It extends from the carina of the trachea to the 
origin of the right upper lobe bronchus, but an exact method for measuring it has 
never been described.
Using bronchography, the authors measured the length of the right main 
bronchus in 24 patients. The posteroanterior projection taken at a standard distance 
(1.8 m) from the patient was used to minimize distortion due to the technique; if 
present, the distortion would not be more than 5% and would be an increase rather 
than a decrease in length.
The mean length of the right main bronchus was found to be 1.09 cm (range from 
0 to 2.9 cm).
The clinical importance of this measurement is discussed. The authors conclude 
that many anatomy textbooks err in describing the length of the right main 
bronchus as 2.0 to 5.0 cm, but are correct in describing the left main bronchus as 
being about 5 cm long.
II est important que les chirurgiens, pathologistes et anesthesistes connaissent bien 
la longueur du tronc bronchique droit. II s’etend de l’eperon tracheal jusqu’a 
l’origine de la bronche lobaire superieure droite. Toutefois, on n’a jamais decrit de 
methode exacte de le mesurer.
A l’aide de la bronchographie, les auteurs ont mesure la longueur du tronc 
bronchique droit de 24 patients. La projection postero-anterieure prise a distance 
standard (1.8 m) du patient fut utilisee dans le but de minimiser la distorsion due a 
la technique. Si elle etait presente, cette distorsion ne pourrait pas depasser 5%, et 
elle aurait tendance a surevaluer la longueur plutot qu’a la minimiser.
La longueur moyenne mesuree du tronc bronchique droit a ete de 1.09 cm (avec 
un ecart de 0 a 2.9 cm).
On commente l’importance clinique de cette mesure. Les auteurs concluent que 
plusieurs ouvrages d’anatomie sont dans l’erreur quand ils decrivent la longueur du 
tronc bronchique droit comme pouvant varier de 2.0 a 5.0 cm, mais qu’ils sont 
exacts quand ils donnent environ 5 cm comme longueur du tronc bronchique 
gauche.
The right main bronchus — from the carina of the trachea 
to the origin of the right upper lobe
Accepted for publication Sept. 14. 1988
bronchus — is easily seen during 
bronchoscopy and at surgery, but is 
often inaccurately described.
The length of the right main 
bronchus is of great importance to 
pathologists, surgeons and anesthe­
tists during resection of the right 
lung or the upper lobe, or the upper 
lobe with the “sleeve” of the right 
main bronchus, for example. There 
is minimal clearance proximally 
so it is of practical importance 
to know the length of the main 
bronchus.
The established rule for resection 
of bowel cancer is to take at least 5 
cm of macroscopically healthy 
bowel on either side of the malig­
nant lesion. The necessary clear­
ance with respect to the lung or a 
lobe is usually given as 1.5 to 2.0 
cm.
For endobronchial anesthesia, a 
double-lumen tube or an endobron­
chial balloon on the right side 
might cause encroachment on the 
right upper lobe bronchus.
The surgical pathologist must 
carefully examine the proximal re­
section lines of right-sided bron­
chial specimens, even more so than 
those from other areas.
The purpose of this study was to 
re-examine the tracheobronchial 
tree in order to identify accurately 
the take-off point of the right upper 
lobe bronchus.
Methods and Results
The literature does not describe a 
standard technique for consistently 
and accurately measuring distances 
in the tracheobronchial tree. In this 
study, to determine the length of 
the right main bronchus, the carina
From the *Department o f Surgery and f  Department o f  Radiology. Vancouver General Hospital. 
Vancouver. BC
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FIG. 1. Method of measuring right 
main bronchus (vertical distance from 
carina to origin of right upper lobe 
bronchus), which was done from life- 
size bronchograms (adapted from cast 
of bronchial tree by R.C. [Lord] Brock 
depicted in Gray’s Anatomy1).
FIG. 2. Anteroposterior bronchogram.
T a b l e  1. D is ta n c e  o f th e  R ig h t  U p p e r  L o b e
B ro n c h u s  f r o m  C a rin a  in  2 4  P a tie n ts
D is t a n c e ,  c m N o . o f  p a t ie n t s
0  - 0 . 5 6
0 . 6 - 1 . 0 6
1.1  - 1 . 5 7
1 . 6 - 2 . 0 3
2 .1  - 2 . 5 1
2 . 6 - 3 . 0 1
was identified and the vertical dis­
tance between it and the upper 
border of the right upper lobe bron­
chus measured (Fig. 1).
Such measurements were made 
from the bronchograms of 24 pa­
tients, in whom “good filling” was 
obtained. Bronchography was done 
in the posteroanterior projection at 
a standard distance (1.8 m) from 
the patient to minimize distortion 
which, if present, was not more 
than 5% and was an increase rather 
than a decrease in length (Fig. 2).
The results are tabulated in Table 
I. The take-off point ranged from 0 
to 2.9 cm below the carina (mean 
1.09 cm, median 1.10 cm).
Discussion
Many anatomy books, including 
Gray’s and Cunningham’s1-3 de­
scribe the right main bronchus and 
give its length as about 2.5 cm 
(Table II1-10). Grant’s Method of 
Anatomy* states that the right 
upper lobe bronchus arises 2 to 5 
cm from the tracheal bifurcation. 
However, Boyden,8 in an excellent 
work on the segmental anatomy of 
the lung, states that the right upper 
lobe bronchus arises almost at the 
bifurcation of the trachea, that is, 
opposite the carina. He remarked: 
“Unfortunately, it has not been pos­
sible to provide bronchograms, but 
this has been partially compensated 
for by lateral views of a pair of 
lungs that have been injected with 
vinyl acetate and then dissected.”
T a b le  I I .  L e n g th  o f  R ig h t  M a in  B ro n c h u s  R e p o rte d  b y  V a r io u s  A u th o rs
A u t h o r s L e n g th , c m
W il l ia m s  a n d  W a rw ic k  (G ra y ) , 1 9 8 0 1 A b o u t  2 .5
R o m a n e s  (C u n n in g h a m ) ,  1 9 8 1 2 A b o u t  2 .5
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In another text9 the main bron­
chus appeared to have been taken 
from the measurement of one cast 
only of an injected bronchial tree.
The relationship between the 
right upper lobe bronchus and the 
carina can be assessed in a variety 
of ways — during surgery or endos­
copy, by radiologic or imaging tech­
niques, in the cadaver by direct 
inspection or from a cast of the 
bronchial tree. No one method is 
ideal, but bronchography gives 
quite accurate reproductions, is eas­
ily performed and avoids the distor­
tion of postmortem changes. More­
over, the bronchogram gives almost 
life-size definition. Using this meth­
od, we found the mean length of 
the right main bronchus in our 24 
patients to be 1.09 cm, somewhat 
shorter than the length noted in 
most textbooks.
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Acute Scrotal Pain in Children: 
Prospective Study of Diagnosis and 
Management
P.A.M. Anderson, MD;* J.M. Giacomantonio, MD, FRCSC;* R.D. Schwarz, MD, FRCSCf
Forty-eight boys were assessed for an acutely painful scrotum. Thirty-six (75%) of 
them underwent radionuclide scanning of the scrotum; the average age of this group 
was 11 years. The scan revealed epididymitis in 19 cases, spermatic cord torsion in 
9, appendix testis torsion in 7 and acute hernia-hydrocele in 1. The diagnosis was 
confirmed at operation in all nine cases of spermatic cord torsion. Boys who had 
epididymitis received antibiotics only; all were available for short-term follow-up, 
and 16 were also assessed at a mean of 6 months after infection. Only one boy had 
testicular atrophy; he had undergone repair of an inguinal hernia, which could not 
be ruled out as a cause. Bacteriuric epididymitis occurred in three boys; two had 
known predisposing genitourinary anomalies, the third had no abnormalities. Boys 
who had nonbacteriuric epididymitis were investigated by renal and pelvic 
ultrasonography or voiding cystourethrography; no important abnormalities were 
detected. This prospective study indicates that radionuclide scanning can reliably 
differentiate spermatic cord torsion from other acute scrotal disease.
Quarante-huit gar^ons souffrant d’une douleur aigue au scrotum ont fait l’objet de 
cette evaluation. Trente-six (75%) d’entre-eux ont subi une scintigraphie isotopique 
du scrotum; l’age moyen chez ce groupe etait de 11 ans. La scintigraphie a revele 
une epididymite dans 19 cas, une torsion du cordon spermatique dans 9, une torsion 
de l’appendice testiculaire dans 7 et une hernie hydrocele aigue dans 1. Le 
diagnostique ete confirme lors de l’operation dans les neuf cas de la torsion du 
cordon spermatique. Les garfons souffrant d’epididymite ont re?u des antibiotiques 
seulement; tous ont pu etre revu a court terme pour des examens de controle et 16 
ont aussi ete evalue 6 mois, en moyenne, apres l’infection. Un seule gargon a 
presente une atrophie testiculaire. II avait subi la reparation d’une hernie inguinale, 
intervention qui ne peut pas etre mise hors de cause. Trois gar?ons ont eu une 
epididymite avec bacteriurie; deux avaient des anomalies genito-urinaires predispo- 
santes connues, alors que le troisieme en etait exempt. Les gargons ayant eu une 
epididymite sans bacteriurie ont fait l’objet d’examens par echographie renale et 
pelvienne ou par cysto-uretrographie permictionnelle; aucune anomalie importante 
ne fut decelee. Cette etude prospective montre que la scintigraphie isotopique peut 
differencier avec certitude les torsions du cordon spermatique des autres lesions 
aigues du scrotum.
From the *Department o f  Surgery and fDepartment o f Urology, Izaak Walton Killam Hospital 
for Children. Dalhousie University. Halifax. NS
Presented at the annual meeting o f the Canadian Urological Association. Banff. Alta.. June 21 - 
25. 1987
Accepted fo r publication June 16. 1988
Reprint requests to: Dr. R.D. Schwarz. Department o f Urology. Izaak Walton Killam Hospital for 
Children. 5850 University Ave.. Halifax, NS B3J 3C9
A n acutely painful scrotum in a child is of concern to parents 
and physicians, not only because of 
the discomfort it causes, but also 
because of possible impairment of 
fertility. Numerous studies1"4 have 
shown that in torsion of the sper­
matic cord the time between onset 
of symptoms and surgical correc­
tion is inversely related to the sub­
sequent viability of the testicle. 
Since the problem was traditionally 
believed to account for most cases 
of acutely painful scrotum in chil­
dren, immediate surgical explora­
tion was advocated .2-4-6 However, 
recent studies , 1 J -8 including one 
carried out at our institution , 7 have 
indicated that nonsurgical condi­
tions such as acute epididymitis are 
much more common in boys than 
was previously thought. Moreover, 
new imaging techniques provide a 
more accurate diagnosis so that, in 
many cases, surgery can be avoid­
ed.9 With the advent of radionuclide 
scanning of the scrotum, we decid­
ed to institute a prospective study 
to determine the reliability of this 
investigation in diagnosing acute 
scrotal conditions in boys.
Because epididymitis in boys is 
considered bacterial in origin and 
secondary to underlying genitouri­
nary anomalies, standard manage­
ment has been antibiotic therapy 
followed by appropriate investiga­
tions for conditions that result in 
obstruction of the lower urinary 
tract or involve abnormal connec-
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tions between the reproductive and 
urinary tracts. However, several 
studies1011 have indicated that most 
episodes of epididymitis occur in 
boys with normal genitourinary 
tracts and are not associated with 
bacteriuria. In this study we at­
tempted to answer three questions.
•  Is radionuclide scanning a reli­
able means of differentiating epi­
didymitis from spermatic cord tor­
sion?
•  What is the frequency of bac- 
teriuric epididymitis in boys?
•  What is the incidence of un­
derlying genitourinary anomalies in 
boys with epididymitis?
Patients and Methods
All 48 boys less than 16 years old 
who presented to the emergency 
department of the Izaak Walton 
Killam Hospital for Children in Hali­
fax between September 1985 and 
September 1987, suffering from an 
acutely painful scrotum were en­
tered into the study. Those suffer­
ing trauma to the genitalia were 
excluded, as were neonates, who 
were cared for at another institu­
tion. In addition to a routine analy­
sis, the urine specimen was subject­
ed to culture and sensitivity exami­
nation. Whenever the clinical diag­
nosis was in doubt, radionuclide 
scanning of the scrotum was per­
formed. We intended to operate 
without the delay of scanning if 
testicular torsion was the most like­
ly diagnosis. However, in practice, 
there was no case in which scan­
ning did delay surgery; therefore, 
all boys who had an equivocal diag­
nosis underwent radionuclide scan­
ning.
The scanning procedure usually 
took less than 15 minutes. A bolus 
of technetium-99m pertechnetate 
was injected intravenously, then se­
rial images of the scrotum were 
obtained.12 Patients with a diagno-
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sis of epididymitis were not treated 
surgically but were given a course 
of antibiotics effective against most 
enteric pathogens. Repeat physical 
examinations were carried out sev­
eral days after presentation and 
following convalescence, at which 
time the boys were investigated for 
underlying genitourinary anomalies.
Results
Epididymitis
Epididymitis was diagnosed in 19 
boys (Table I), who ranged in age 
from 4 months to 15 years (mean 
10.7 years). All underwent radionu­
clide scanning (Fig. 1). They were 
not explored surgically but were 
given a course of antibiotics effec­
tive against most enteric pathogens. 
Because they did not have surgical 
confirmation of the diagnosis, they 
were followed up closely by clinical 
examination within 2 weeks of the 
onset of their symptoms. If a diag­
nosis of torsion was missed, the 
child would be expected to have 
severe pain over several days, unre­
sponsive to antibiotic therapy, and 
subsequently testicular atrophy 
would develop. However, at 2-week 
follow-up all the children in this 
group were convalescing without 
problems. Three boys were then 
lost to follow-up.
The remaining 16 boys under­
went another clinical examination 
at a mean of 6 months after the 
acute episode (range from 1 to 20 
months). Testicular size and sym­
metry were judged to be normal for 
age in all but one boy in whom the 
testis on the side previously in­
volved by epididymitis was half the 
size of the contralateral testis. He 
had had an inguinal hernia repaired 
2 years before and no postoperative 
record was available to indicate if 
the atrophy was secondary to his 
surgery.
Urinalysis was performed for 16 
boys in this group. In 13 the find­
ings were normal. The other three 
had pyuria; Staphylococcus pyo­
genes was cultured from one speci­
men, that of a 9-year-old boy who 
had undergone repair for hypos­
padias and was known to have a 
penile urethral fistula; Pseudomo­
nas aeruginosa was cultured from 
another specimen, that of an 
11-year-old boy whose history in­
cluded numerous urinary tract in­
fections secondary to imperforate 
anus, sacral agenesis and a neuro­
genic bladder; the third culture was 
sterile. Culture of the urine from 
one boy whose urinalysis was nor­
mal grew Escherichia coli. Voiding 
cystourethrography and renal ul­
trasonography in this 4-month-old 
child did not reveal any anomalies. 
All other cultures were sterile. Two 
15-year-old boys gave a history of 
sexual activity, but urine cultures 
showed no growth of Chlamydia.
Two boys who had normal urina­
lyses and negative cultures received 
no antibiotics; both recovered 
promptly. The others received 7-day 
courses of appropriate antibiotics, 
most commonly co-trimoxazole 
orally, followed by amoxicillin and
Table 1. Diagnosis and Radionuclide Scan in 48 Boys
Diagnosis Total no. (% ) Scan No scan
Acute epididymitis 19 (40) 19 0
Torsion spermatic cord 11 (23) 9 2
Torsion appendages 13 (27) 7 6
Hernia/hydrocele 3 (6) 1 2
Idiopathic scrotal edema 1 (2) 0 1
Tumour 1 (2) 0 1
Totals, no. (%) 48 (100) 36 (75) 12 (25)
30
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tetracycline in dosages appropriate 
for size and age. Two boys who had 
fevers were treated parenterally 
with gentamicin.
Nine of the 13 boys with negative 
urine cultures were investigated to 
rule out predisposing factors for 
epididymitis. Radiologic investiga­
tions were omitted in four boys (in 
two at the parents’ request and in 
the two who had possible sexual 
exposure). Voiding cystourethrog­
raphy and renal ultrasonography 
were carried out in five cases, pelvic 
and renal ultrasonography in three 
and voiding cystourethrography 
and intravenous urography in one. 
None of these studies indicated any 
abnormalities.
Torsion of the Spermatic Cord
In 11 boys a diagnosis of sper­
matic cord torsion was made. These 
boys ranged in age from 7 to 16 
years (mean 12.5 years). Nine un­
derwent radionuclide scanning (Fig.
FIG. 1. Technetium-99m pertechnetate 
scrotal scan from 15-year-old boy with 
24-hour history of right scrotal pain 
and swelling. There was recent sexual 
exposure. Urinalysis was normal and 
subsequent routine culture and culture 
for Chlamydia were negative. Scan 
shows increased activity of right he- 
miscrotum and along cord, in keeping 
with epididymitis. Three days after 
initiating course of tetracycline, swell­
ing and pain had markedly decreased.
2) and all underwent surgery to 
confirm the diagnosis. Four boys 
who delayed seeking medical atten­
tion for more than 24 hours had 
infarcted testes which were re­
moved. In no instance did scanning 
delay operation or lead to misdiag­
nosis.
Torsion of the Appendix Testis
Appendix testis torsion was diag­
nosed in 13 boys, who ranged in 
age from 3 to 14 years (mean 10.1 
years). Seven underwent radionu­
clide scanning. In one of these the 
scan was equivocal; spermatic cord 
torsion could not be ruled out until 
operation was performed. In the 
other cases, the radiologist could 
confidently rule out spermatic cord 
torsion but could not always make 
the diagnosis of appendix testis 
torsion. However, clinical examina­
tion (the “blue dot sign” or point 
tenderness at the appendix) was 
usually diagnostic.
FIG. 2. Technetium-99m pertechnetate 
scrotal scan from 15-year-old boy with 
24-hour history of left scrotal pain and 
swelling. Urinalysis was normal. Scan 
shows ring of increased activity sur­
rounding photopenic defect in middle 
of left hemiscrotum. Diagnosis of sper­
matic cord torsion was made and con­
firmed at surgery. Testicle was not 
viable and orchiectomy and contralat­
eral orchiopexy were carried out.
Eight boys in this group under­
went excision of the infarcted ap­
pendage to relieve the pain, the 
other four were managed conserva­
tively.
Discussion
Previous studies have indicated 
that spermatic cord torsion is the 
most common cause of an acutely 
painful scrotum in boys.245 Howev­
er, other reviews18 have noted the 
increasing frequency of nonsurgical 
conditions, especially epididymitis. 
Only 23% of boys in this study had 
spermatic cord torsion compared 
with 40% who had epididymitis and 
27% who had torsion of the appen­
dix testis. The age distribution was 
of little diagnostic value. Other 
studies47 have also noted this fact 
and the considerable overlap of clin­
ical findings in these conditions. 
Since spermatic cord torsion is 
often difficult to rule out clinically, 
many authors24-6 have advocated 
immediate surgical exploration. 
However, since epididymitis is no 
longer considered a rare cause of 
acute scrotal pain, this policy may 
lead to unnecessary operation. The 
development of radionuclide scrotal 
scanning, therefore, has been a 
major advance in the diagnosis of 
these often clinically confusing con­
ditions.
Because none of the boys with 
epididymitis in this study was surgi­
cally explored, follow-up examina­
tion was essential to rule out the 
possibility of spermatic cord torsion 
being misdiagnosed as epididymitis. 
We reviewed all patients with epi­
didymitis within 2 weeks of their 
acute episodes and none had find­
ings suggestive of a missed torsion. 
At repeat examination, a mean of 6 
months later, all but one boy had a 
palpably normal testis. The tech- 
netium-99m pertechnetate scrotal 
scan is a sensitive and selective
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diagnostic tool in evaluating the 
acutely painful scrotum and at our 
institution has obviated the need for 
surgical exploration in many cases. 
Other studies1-9 have reported simi­
lar encouraging results, so it is 
likely that this imaging technique 
will become common in assessing 
acute scrotal pain in children. How­
ever, when the scan cannot be ob­
tained without delaying patient 
management or if the scan is equiv­
ocal, emergency scrotal exploration 
remains the diagnostic procedure of 
choice.
We found that most boys with 
epididymitis had normal urinalysis 
and sterile urine. This “nonspecific 
epididymitis” is reported1011 to be 
the most common type in boys, and 
our inability to identify any underly­
ing genitourinary anomalies is in 
agreement with these studies. It has 
been postulated that these infec­
tions are of viral origin or are sterile 
inflammation secondary to reflux of 
urine into the genital tract, but 
neither theory has been proven. It is 
important to note that boys with 
epididymitis and sterile urine do not 
have underlying anomalies and
therefore do not require extensive 
genitourinary investigations. Al­
though most of these boys are 
treated with antibiotics, their recov­
ery may be just as successful with 
rest and analgesics, as in two of our 
cases.
Conversely, of the three boys 
with positive urine cultures, two 
had known genitourinary abnormal­
ities, so a positive urine culture 
does appear to warrant a diligent 
search for underlying anomalies.
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Action
In vitro studies indicate that the bacterial action of CLAFORAN (cefotaxime sodium) 
a semi-synthetic cephalosporin antibiotic, results from inhibition of cell wall 
synthesis.
Indications and Clinical Uses
Treatm ent: CLAFORAN (cefotaxime sodium) may be indicated for the treatment 
of infections caused by susceptible strains of the designated micro organisms 
in the diseases listed below.
Lower respiratory trac t in fec tions : pneumonia and lung abscess caused by 
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rhea caused by N. gonorrhoeae including penicillin resistant strains. 
B a c te rem ia /S e p ticem ia : caused by Escherichia coli, unspecified Klebsiella 
strains and Serratia marcescens.
Skin in fec tions : caused by Staphylococcus aureus (penicillinase and non­
penicillinase producing, S. epidermidis, Group A streptococci, Escherichia coli, 
Proteus mirabilis and indole positive Pmteus.
Intra-abdominal in fec tions: caused by Escherichia coli, and unspecified Kleb­
siella species.
Gynecological in fec tions : including pelvic inflammatory disease, endometritis 
and pelvic cellulitis caused by E. coli, Group A streptococci and Staphylococcus 
epidermidis, anaerobic bacteria including unspecified Peptococcus and Peptostrep- 
tococcus strains and some strains of Bacteroides Iragilis. In several cases, although 
clinical cures were achieved, bacteriological follow-up was not available. 
Clinical experience with CLAFORAN in anaerobic infections is limited. CLAFORAN 
has been used with some success in wound and intra-abdominal infections against 
some strains of unidentified Bacteroides and anaerobic cocci.
CLAFORAN has been shown to be active against some strains of Pseudomonas. 
In the treatment of infections encountered in immunosuppressed and granulo­
cytopenic patients, results of therapy with CLAFORAN have not been impressive. 
CLAFORAN should not be considered in the treatment of enterococcal infections, 
i.e. Streptococcus faecalis.
Specimens for bacteriologic culture should be obtained prior to therapy in order 
to isolate and identify the causative organisms and to determine their suscep­
tibilities to CLAFORAN. Therapy may be instituted before results of susceptibility 
studies are known; antibiotic treatment should be re evaluated once these results 
become available.
Prophylactic U se : The administration of CLAFORAN perioperatively (preoperative 
ly, intraoperatively and postoperatively) may reduce the incidence of certain infec 
tions in patients undergoing elective surgical procedures (e.g. abdominal or vaginal 
hysterectomy, gastrointestinal and genitourinary tract surgery) that may be classified 
as contaminated or potentially contaminated.
In patients undergoing caesarian section who are considered to be at increased 
risk of infection, intraoperative (after clamping the umbilical cord) and postoperative 
use of CLAFORAN may also reduce the incidence of certain postoperative infections 
Effective use for elective surgery depends on the time of administration (see Dosage 
and Administration).
For patients undergoing gastrointestinal surgery, preoperative bowel preparation 
by mechanical cleansing as vrell as with a non absorbable antibiotic (e.g. neomycin) 
is recommended
If there are signs of infection, specimens for culture should be obtained for iden­
tification of the causative organism so that appropriate therapy may be instituted.
Contraindications
CLAFORAN is contraindicated in patients who have shown hypersensitivity to 
cefotaxime sodium, the cephalosporin or the penicillin groups of antibiotics.
Warnings
Before therapy with CLAFORAN is instituted, it must be carefully determined whether 
the patient has had previous hypersensitivity reactions to cefotaxime, 
cephalosporins, penicillins or other drugs. CLAFORAN should be given with caution 
to patients with Type 1 hypersensitivity reactions to penicillin. Antibiotics, including 
CLAFORAN should be administered with caution to any patient who has 
demonstrated some form of allergy, particularly to drugs. If an allergic reaction 
to CLAFORAN occurs, the drug should be discontinued and the patient treated 
with the usual agents (e.g. epinephrine, antihistamine, pressor-amines or 
corticosteroids).
Pseudomembranous colitis has been reported with the use of cephalosporins 
(and other broad spectrum antibiotics); therefore, it is important to consider its 
diagnosis in patients who develop diarrhea during the administration of CLAFORAN. 
This colitis can range from mild to life-threatening in severity.
Treatment with broad spectrum antibiotics, such as CLAFORAN, alters the nor­
mal flora of the colon and may permit overgrowth of Clostridium difficile or other 
Clostridia. It has been established that a toxin produced by Clostridium difficile 
is one primary cause of antibiotic-associated colitis.
Mild cases of colitis may respond to discontinuation of CLAFORAN and replace­
ment with a suitable specific antibiotic. Moderate to severe cases should be manag­
ed with fluid, electrolyte and protein supplementation as indicated. When the colitis 
is not relieved by discontinuance of CLAFORAN administration or when it is severe, 
an antibiotic specifically effective in antibiotic-associated pseudomembranous colitis 
(e.g. vancomycin) or other suitable therapy may be indicated. Other possible causes 
of colitis should also be considered (see Adverse Reactions).
Precautions
CLAFORAN (cefotaxime sodium) should be prescribed with caution in individuals 
with a history of lower gastrointestinal disease particularly colitis.
The safety of CLAFORAN in pregnancy has not been established. Consequently, 
use of the drug in pregnant women requires that the likely benefit from the drug 
be weighed against the possible risk to the mother and fetus.
Use of CLAFORAN in women of child-bearing potential requires that the anticipated 
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with the cephalosporin group of antibiotics, including cefotaxime sodium.
In laboratory tests a false positive reaction to glucose may occur with reducing 
substances but not with the use of specific glucose oxidase methods. 
Adverse Reactions
The most frequent adverse reactions with their frequency of occurrence are: 
Hypersensitivity (1.8%): Rash, pruritus, fever. Local (5%): Injection site inflam­
mation with intravenous administration. Pain, induration and tenderness after in­
tramuscular injection. Gastrointestinal (1.7%): Colitis, diarrhea, nausea and 
vomiting. Symptoms of pseudomembranous colitis can appear during or after 
CLAFORAN treatment. Hemic and Lymphatic System (< 1 % ): Mild, reversi­
ble leukopenia, granulocytopenia and thrombocytopenia have been reported. Some 
patients developed positive direct Coomb’s test during treatment with CLAFORAN. 
Genitourinary System ( <  1%): Moniliasis, vaginitis. Liver ( <  1%): Transient 
elevations in SGOT, SGPT, serum LDH and serum alkaline phosphatase levels 
have been reported. Kidney ( <  1%): Increased serum creatinine and BUN have 
occasionally been observed. Central Nervous System (0.2%): Headache. 
Symptoms and Treatment of Overdosage 
Since no case of overdosage has been reported to date with CLAFORAN, no 
specific information on symptoms or treatment is available. Treatment of over­
dosage should be symptomatic.
Dosage and Administration
CLAFORAN (cefotaxime sodium) may be administered intramuscularly or in­
travenously after reconstitution (see Table with recommended mode of reconstitution 
according to route of administration).
Dosage
Adults
The dosage of CLAFORAN should be determined by susceptibility of the causative 
organisms, severity of the infection and condition of the patient.
Guidelines for Dosage of CLAFORAN (cefotaxime sodium)
Type of Infection
Daily Dose
(g) Frequency and Route
Uncomplicated
Gonorrhea
1 1 g IM (single dose)
Uncomplicated
infections
2 1 g every 12 hours 
IM or IV
Moderately 
severe to severe 
infections
3-6 1-2 g every 
8 hours IM or IV
Very severe 
infections (e.g. 
septicemia)
6-8 2g every 
6-8 hours IV
Life-threatening
infections
up to 12 2g  every 
4 hours IV
To prevent postoperative infection in contaminated or potentially contaminated 
surgery, recommended doses are as follows.
(a) 1 g IM or IV administered Vz to 1 Vz hours prior to the initial surgical incision 
to ensure that adequate antibiotic levels are present in the serum and tissues 
at the start of surgery
(b) 1 g IM or IV administered 1 Vz to 2 hours following the first dose; for lengthy 
operative procedures, additional intraoperative doses may be administered, if 
necessary, at appropriate intervals (1V2 to 2 hours) during surgery
(c) 1 g IM or IV administered within 2 hours following completion of surgery 
The total cumulative prophylactic dose should not exceed 6 g in a 12 hour period. 
Caesarian Section Patients
The first dose of 1 g is administered IV as soon as the umbilical cord is clamped. 
The second and third doses should be given as 1 g IM or IV at 6 and 12 hours 
after the first dose.
Neonates, Infants, and Children
The following dosage schedule is recommended:
Neonates. 0-1 week of age 50 mg / kg IV q 12 h
1-4 weeks of age 50 mg / kg IV q 8 h
Infants and children (1 month to 12 years): For body weights less than 50 kg, 
the recommended daily dose is 50 to 100 mg / kg IM or IV of body weight divid­
ed into 4 to 6 equal doses, or up to 180 m g/kg /day for severe infections. 
For body weights 50 kg or more, the usual adult dosage should be used.
The maximum daily dosage should not exceed 12 grams.
Administration of CLAFORAN should be continued for a minimum of 48 to 72 
hours after the patient defervesces or after evidence of bacterial eradication has 
been obtained; a minimum of 10 days of treatment is recommended for infec­
tions caused by Group A beta-hemolytic streptococci in order to guard against 
the risk of rheumatic fever or glomerulonephritis; frequent bacteriologic and clinical 
appraisal is necessary during therapy of chronic urinary tract infections and may 
be required for several months after therapy has been completed, persistent in­
fections may require prolonged treatment. Doses less than those recommended 
should not be employed.
Dosage for Patients with Impaired Renal Function
In patients with estimated creatinine clearance of less than 20 mL / min / 1.73m2 
the dose of CLAFORAN should be halved (see Precautions).
If serum creatinine values alone are available, the following formula (based on 
sex, weight, and age of the patient) may be used to convert these values into 
creatinine clearance.
Males: Weight (kg) x  (140 -  age) Females: 0.85 x above value 
72 x  serum creatinine
Administration
Intram uscular: CLAFORAN should be injected well within the body of a relatively
large muscle such as the upper outer quadrant of the buttock (i.e. gluteus max- 
imus); aspiration is necessary to avoid inadvertent injection into a blood vessel. 
In travenous: The intravenous route is preferable for patients with bacteremia, 
bacterial septicemia, or other severe or life-threatening infections, or for patients 
who may be poor risks because of lowered resistance resulting from such 
debilitating conditions as malnutrition, trauma, surgery, diabetes, heart failure, 
or malignancy, particularly if shock is present or impending.
For bolus administration a solution containing 1 or 2 g of CLAFORAN can be 
injected over a period of 3 to 5 minutes. Using an infusion system, it may also 
be given over a longer period of time through the tubing system by which the 
patient may be receiving other intravenous solutions. Butterfly* or scalp vein type 
needles are preferred for this type of infusion. However, during infusion of the 
solution containing CLAFORAN, it is advisable to discontinue temporarily the ad­
ministration of other solutions at the same site.
Reg’d TM of Abbott Laboratories.
Reconstitution
For Intramuscular U se ; CLAFORAN should be reconstituted with Sterile Water 
for Injection or Bacteriostatic Water for Injection in accordance with the volumes 
recommended in the following table.
Reconstitution Table
Intramuscular
Volume to be 
Added to 
Vial (mL)'
Approximate 
Available 
Vol. (mL)
Approx. Average 
Concentration 
(mg/mL)
500 mg vial 2 2.2 230
1 g vial 3 3.4 300
2 g vial 5 6.0 330
'shake to dissolve.
For direct intravenous injection (bolus) a n d /o r continuous intravenous 
in fu s io n : 500 mg, 1 and 2 g vials should be reconstituted with at least 10 mL 
of Sterile Water for Injection. Reconstituted solution may be further diluted with 
50 to 1000 mL of the fluids recommended for IV infusion.
Reconstitution Table
Intravenous
Volume to be 
Added to 
Vial (mL)*
Approximate 
Available 
Vol. (mL)
Approx. Average 
Concentration 
(mg/mL)
500 mg vial10 10.2 50
1 g vial 10 10.4 95
2 g vial 10 11.0 180
'shake to dissolve.
Solu tions fo r IV In fus ion : CLAFORAN is compatible with the following infu­
sion flu ids:
- Sterile Water for Injection
- 0.9% NaCI injection
- 5% dextrose injection
- 0.9% NaCI and 5% dextrose injection
-  0.45% NaCI and 5% dextrose injection
- 0.2% NaCI and 5% dextrose injection
- Sodium Lactate injection
- 5% dextrose and 0.15% KCI injection
-  Plasma-Lyte 56 Electrolyte Solution in 5% dextrose injection
-  Ringer's injection
- Lactated Ringer’s solution
- Lactated Ringer’s with 5% dextrose injection 
CLAFORAN is also compatible with lignocaine 1%.
A solution of 1 g of CLAFORAN in 14 mL of Sterile Water for Injection is isotonic. 
S tab ility of Solution
S to ra ge : Solutions of CLAFORAN range from light yellow to amber, depending 
on concentration and the diluent used. The solutions tend to darken depending 
on storage conditions and should be protected from elevated temperatures and 
excessive light.
"Reg'd TM of Baxter-Travenol Laboratories.
CLAFORAN reconstituted in the original vial as described under Reconstitution 
maintains satisfactory potency for 24 hours at room temperature (25°C) and for 
48 hours under refrigeration (0-5°C). Only freshly prepared reconstituted solu­
tions may be further diluted with 50 to 1000 mL of the recommended infusion 
fluids in Viaflex" intravenous bags. Such solutions maintain satisfactory poten­
cy for 24 hours at room temperature (25°C) and for 72 hours under refrigeration 
(0-5°C). Any unused solutions should be discarded.
CLAFORAN reconstituted with 1% lignocaine maintains satisfactory potency for 
up to 24 hours at room temperature and 48 hours under refrigeration (reference 
to lignocaine restrictions is advisable).
CLAFORAN solutions exhibit maximum stability in the pH 5-7 range.
Special In s tru c tions : Parenteral drug products should be inspected visually 
for particulate matter and discoloration prior to administration. Solutions of 
CLAFORAN range from light yellow to amber, depending on concentration and 
diluent used. The dry powder as well as solutions tend to darken, depending 
on storage conditions.
Incom patib ilities : Solutions of CLAFORAN must not be admixed with 
aminoglycoside solutions. If CLAFORAN and aminoglycosides are to be ad­
ministered to the same patient, they must be administered separately and not 
as a mixed injection.
Solutions of CLAFORAN should not be prepared with diluents having a pH above 
7.5 such as Sodium Bicarbonate Injection.
Availability
Claforan (cefotaxime sodium) is supplied as a sterile, white to pale yellow powder, 
in vials containing 500 mg, 1.0 and 2.0 g of cefotaxime sodium (expressed as 
acid on a dry basis).
S to ra ge : CLAFORAN in the dry state should be stored at room temperature, 
protected from light and heat.
Product monograph available on request 
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toDiurnal Variation in Admission 
Hospital of Women in Labour
William D. Fraser, MD;*$ Frances H. McLean, BScN;t Robert H. Usher, MD|
In women having spontaneous labour or premature rupture of the membranes there 
is a marked diurnal variation in times of admission to hospital.
Analysis of 4755 nulliparous women with single pregnancies in cephalic 
presentation at term, indicated that they presented in labour or with premature 
rupture of the membranes nearly twice as frequently during the night as during the 
evening. The peak hours for delivery were late morning and afternoon.
The authors discuss previously published reports of similar findings and of a 
diurnal variation in maternal hormone levels in humans and experimental animals. 
The potential clinical importance of this phenomenon is considered.
On constate une variation diurne importante quant au moment d’admission a 
l’hopital pour les femmes qui entrent en travail spontanement ou pour celles qui 
subissent une rupture prematuree des membranes.
L’analyse de 4755 nullipares ayant eu une grossesse simple avec presentation 
cephalique a terme, revele qu’elles arriverent en travail ou apres rupture prematuree 
des membranes pres de deux fois plus souvent durant la nuit que durant la veillee. 
Les periodes de pointe sur l’accouchement furent la fin de la matinee et l’apres-midi.
Les auteurs commentent les publications anterieures signalant des resultats 
similaires ainsi que les rapports d’une variation diurne des taux d’hormones 
maternelles chez l’humain et chez l’animal d’experience. Ils considerent l’importance 
clinique que pourrait avoir ce phenomene.
In this study we review a seren­dipitous observation made during 
investigation of the variation in la­
bour outcomes by time of day 
among nulliparous patients.1 A 
marked diurnal variation was noted 
in the times of admission to hospi­
tal of nulliparous women at term 
who had diagnoses of either sponta­
neous labour or spontaneous rup­
ture of membranes. The tendency 
for labour to begin at certain times
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of day has been described previous­
ly,2 but, as with the regulation of 
labour onset in general, it is not 
well understood. The purpose of 
this report is to emphasize the 
importance of this clinical finding.
Population and Methods
This study was conducted at the 
Royal Victoria Hospital, Montreal. 
A computerized database was used
to record data from all pregnant 
women.3 The time of admission, the 
time of delivery, the duration of 
rupture of membranes, the duration 
of labour, parity and method of 
delivery were among the variables 
entered on the computer.
Between January 1978 and 
March 1984, 4228 pregnant women 
admitted in labour (group 1) and 
527 admitted with ruptured mem­
branes but not in labour (group 2) 
were included in the study. The 
following criteria were necessary: 
nulliparity, gestation period of 37 
or more weeks, singleton pregnan­
cy, cephalic presentation, labour 
not induced. The time of admission 
to hospital was analysed for both 
groups and time of delivery for 
group 1. Rates of admission by time 
of day were compared using the x2 
goodness of fit test (Ryan BF, Jouer 
BL, Ryan TA: Minitab, Duxbury 
Press, Boston, Mass., 1985).
Findings
The number of admissions during 
the night (24:00 to 08:00 hours) 
was significantly greater (p < 
0.001) in group 1 than that during 
the day (08:00 to 16:00 hours) or 
evening (16:00 to 24:00 hours) (Ta­
ble I, Fig. 1). The mean interval 
from admission to delivery did not 
vary by time of admission. Delivery 
rates peaked in the late morning 
and afternoon.
The same pattern of admissions 
was evident in group 2 women as in 
group 1. The actual time of labour 
onset or membrane rupture was less 
accurate because these events oc-
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curred at home and the timing was 
noted from the patient’s recollec­
tion. Women admitted in labour 
stated it had started, on average, 
3.6 hours before. The others 
claimed the membranes ruptured, 
on average, 2.4 hours before admis­
sion. If these intervals are taken 
into account, the peak period for 
onset of labour or rupture of mem­
branes at home would be between 
20:00 and 02:00 hours.
Discussion
Standard obstetric texts, in dis­
cussing the initiation of parturition, 
make no mention of a circadian 
pattern to labour onset.4-6 Malek,7 
in a series of 70 000 women, dem­
onstrated that labour began more 
frequently between 22:00 and 
04:00 hours; Shettles,2 in a series 
of more than 4000 patients, also 
reported that labour onset was 
more common at night. Glattre and 
Bjerkedal8 reviewed all births in 
Norway over a 10-year period and 
found a cyclicity in the timing of 
delivery. As was observed in our 
study, nulliparous patients with 
spontaneous onset of labour more 
commonly delivered during daytime 
hours. They concluded that diurnal 
variation in rate of delivery is proba­
bly mediated by factors that regu­
late the time of labour onset.
How is the rhythmicity of labour 
onset controlled? Ducsay and asso­
ciates9 have described a circadian 
pattern in uterine activity near term 
in the rhesus monkey, a species 
also known to initiate labour at 
night. Peak uterine activity occurs 
between 22:00 and 02:00 hours. 
Further study10 confirmed this cy­
clic uterine activity and demonstrat­
ed a circadian pattern to fetal plas­
ma progesterone and dehydroepian- 
drosterone sulfate levels, with peak 
steroid concentrations correspond­
ing to periods of peak uterine activi­
ty. This suggests that fetal adrenal
glands control the diurnal rhythm 
in uterine contractility.
In the human, maternal plasma 
steroid concentrations have been 
monitored in the third trimester.1112
Both progesterone and estriol dem­
onstrate a circadian pattern before 
term. However, estriol loses its cir­
cadian pattern as term approach­
es.11 While the interactions between
T a b le  1. N u m b e r o f  A d m is s io n s
H o u r o f o n s e t R u p tu re d  m e m b ra n e s ,
o r  ru p tu re In  la b o u r n o t in  la b o u r
N ig h t ( 193 8 ) ( 2 5 4 )
2 4 :0 0 221 37
0 1 :0 0 229 30
0 2 :0 0 256 36
0 3 :0 0 252 32
0 4 :0 0 282 27
0 5 :0 0 250 33
0 6 :0 0 255 37
0 7 :0 0 193 22
D ay ( 1 2 8 8 ) ( 1 4 3 )
0 8 :0 0 211 12
0 9 :0 0 218 19
1 0 :00 180 25
1 1 :0 0 156 27
1 2 :0 0 160 22
13 :00 135 15
14 :00 116 15
15 :00 112 8
E ven ing (1 0 0 2 ) ( 1 3 0 )
16 :00 115 14
17 :00 93 14
18 :00 103 18
19 :00 116 18
2 0 :0 0 148 11
2 1 :0 0 133 13
2 2 :0 0 134 17
2 3 :0 0 160 25
T o ta ls 4228 5 27
x 2 =  32 6 .5 X 2 =  52 .9
p <  0.001 p <  0.001
FIG. 1. Time of admission of term, primiparous patients in spontaneous labour 
(circles) or with premature rupture of membranes (squares).
d
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fetal and maternal steroid rhythms 
and their role in regulating labour 
onset remain to be defined, they 
may provide the basis for an expla­
nation of its rhythmicity.
Further studies are needed to 
determine whether the same diurnal 
variation in labour onset or prema­
ture rupture of membranes exists 
before term. The following ques­
tions need clarification: Should in­
fusion rates for tocolytic agents be 
increased during late evening and 
night hours? Would induction of 
labour be more successful if initiat­
ed in the evening? Does the identi­
cal diurnal variation in onset of 
labour and premature rupture of 
the membranes imply that the latter 
is also the result of increased uter­
ine activity, albeit imperceptible?
Fundamental knowledge regard­
ing the onset of labour, as well as
practical clinical considerations, 
provides incentives to increase our 
understanding of the significance of 
nature’s choice as to when labour 
begins.
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Surgical Treatment of Post-traumatic 
Kyphosis: a Report of 16 Cases
Alain Jodoin, MD, FRCSC;* Philippe Gillet, MD;f Pierre R. Dupuis, MD, FRCSC;t 
Gilles Maurais, MD, FRCSC§
Thoracic and lumbar spine fractures may lead to symptomatic progressive kyphosis 
for which surgery remains a controversial treatment. Sixteen patients with kyphosis 
were treated surgically at the Sacre-Coeur Hospital in Montreal between 1979 and 
1985. The mean follow-up was 38 months.
Initially, treatment of the fractures varied. On average the post-traumatic 
kyphosis was surgically corrected 34 months later.
The corrective procedure consisted of staged anterior and posterior fusion with 
instrumentation (six patients), posterior fusion with instrumentation (five), staged 
anterior fusion, posterior osteotomy and fusion with instrumentation (four), 
posterior osteotomy and fusion with Harrington instrumentation (one). Anterior 
decompression was also performed in 5 of the 10 patients who had anterior fusion.
There was no major perioperative complication.
Pain was relieved in 13 patients and 9 of 11 had substantial neurologic 
improvement. Two patients had nonunion of posterior grafts, but these united after 
revision. The mean loss of correction in the early postoperative period was 3.5°.
The authors conclude that surgical treatment of post-traumatic symptomatic 
progressive kyphosis is effective and safe.
Les fractures des colonnes thoracique et lombaire peuvent mener a une cyphose 
evolutive symptomatique pour laquelle le traitement chirurgical demeure discutable. 
Entre 1979 et 1985, 16 patients souffrant de cyphose ont ete operes a l’Hopital du 
Sacre-Coeur de Montreal. Le suivi s’etend en moyenne sur 38 mois.
Initialement, le traitement des fractures a varie. En moyenne, les cyphoses 
post-traumatiques furent corrigees chirurgicalement au bout de 34 mois.
Les techniques correctives employees furent les suivantes: fusions anterieure et 
posterieure en deux temps avec instruments (six patients), fusion posterieure avec 
instruments (cinq), fusion anterieure en deux temps, osteotomie posterieure et 
fusion avec instruments (quatre), osteotomie posterieure et fusion avec instrument 
de Harrington (un). Une decompression anterieure a aussi ete pratiquee chez 5 des 
10 patients qui eurent une fusion anterieure. Aucune complication peroperatoire 
importante n’a ete enregistree.
La douleur fut soulagee chez 13 patients et une amelioration neurologique 
importante fut obtenue chez 9 patients sur 11. Dans deux cas, il y eut absence de 
soudure d’une greffe posterieure, mais la fusion fut obtenue apres revision. Pendant 
la periode postoperatoire immediate, la perte de correction moyenne etait de 3.5°.
Les auteurs concluent que le traitement chirurgical des cyphoses post-traumati­
ques evolutives symptomatiques est efficace et sur.
F ractures of the thoracic and lumbar spines can lead to pro­
gressive symptomatic kyphosis , 1 ' 8 
which frequently is a result of in­
adequate initial management. 2 3 -7 ' 12 
Although there is controversy over 
whether the initial treatment of a 
fractured spine should be conser­
vative or surgical, there is no doubt 
that failure to correct and stabi­
lize acute post-traumatic kyphosis 
increases the likelihood that the 
deformity will progress . 1 ' 3 -5 -8 ' 1 0 -13 
Post-injury laminectomy is especial­
ly deleterious. 2-3 -8 -1 4 ' 22
Post-traumatic kyphosis can 
cause disabling pain or progressive 
neurologic impairment, due to tent­
ing of the cord over the apex of the 
curve or by direct compression by a 
bony fragment in the neural ca-
n a ]_2,3.8.10.11.14-24
This condition has recently been 
treated surgically by an anterior, 
posterior or even combined ap- 
proach . 3 -7 -1 1 -1 8 -22-25-26 Our study was 
undertaken to establish the indica-
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tions, results and complications of 
this type of surgery.
Patients and Methods
We reviewed the charts of 16 
patients (12 men, 4 women) who 
had progressive, symptomatic, post- 
traumatic kyphosis and were treat­
ed at Sacre-Coeur Hospital in Mon­
treal between 1979 and 1985. Medi­
cal records, preoperative, immediate 
postoperative and follow-up x-ray 
films were reviewed. All patients 
were examined personally, except 
one who was assessed by question­
naire and had x-ray films taken 
elsewhere.
Initial management of the frac­
tures was carefully correlated with 
the patient’s clinical status at cor­
rective surgery, the indications for 
and techniques of which were re­
viewed. The last follow-up consid­
ered pain, curve correction, neuro­
logic deficit and complications.
Findings
The mean age of the 16 patients 
was 33 years (range from 17 to 56 
years).
Fractures involved the thoracic 
spine in five patients, the thoraco­
lumbar junction in eight and the 
lumbar spine in three. Patients were 
treated initially as shown in Table I. 
Eleven received their initial treat­
ment in other medical centres.
Table 1. In itia l T re a tm e n t o f  16  P atien ts
Procedure
No. of 
patients
Bed re s t +  b o d y  ca s t o r  b ra c in g 9
P os te rio r H a rrin g to n  ro d s  +
fu s io n 3
L a m in e c to m y  +  bed re s t 1
+  H a rrin g to n  ro d s 1
A n te rio r d e c o m p re s s io n  +  rib
s tru t g ra ftin g 1
R o y -C a m ille  p la te s  +  p o s te r io r
fu s io n 1
Results o f Initial Management
All nine patients treated by bed 
rest or orthosis subsequently had 
back pain, six (nos. 1, 6, 7, 8, 10, 
16 in Table II) suffered neurologic 
irritation or deficit; patient 1 had 
anesthesia at T4 with motor loss in 
the left leg. Eight patients (nos. 1, 
6, 7, 8, 9, 10, 12, 16) had increas­
ing deformity. In four (nos. 1, 6, 7, 
16), an incomplete myelographic 
block and a central spinal stenosis 
were demonstrated on lateral to­
mography. Computed tomography 
demonstrated a central spinal steno­
sis in patients 9 and 15; the latter 
suffered transient paraplegia.
Of the patients managed by pos­
terior instrumentation and fusion, 
patient 2 had an ataxic gait and a 
pyramidal tract irritation syndrome, 
thought to be caused by dislodge- 
ment of the Harrington rods. Pa­
tient 3 had pain and increasing 
kyphosis as did patient 13 who also 
had spasticity; both these patients 
had dislodgement of their Harring­
ton rods.
Patient 15, managed by Roy- 
Camille plates and posterior fusion 
had a decreased lumbar lordosis. 
Because of the resulting anterior 
projection of the trunk, this patient 
needed crutches to stand and walk, 
even with bilateral long leg ortho­
sis. Patient 16 had anterior im­
pingement of the spinal canal by 
the posterior aspect of L4, docu­
mented by computed tomography.
Delayed posterior fusion in pa­
tient 14 did not prevent increasing 
kyphosis or improve his parapare­
sis.
Patient 5, who underwent ante­
rior decompression and rib strut 
grafting, had neurologic improve­
ment initially, but 5 months later he 
experienced a loss of correction 
with recurrence of his neurologic 
deficit.
The mean time between the ini­
tial injury and surgical correction of
the kyphosis was 34 months (range 
from 5 months to 14 years). Indica­
tions for corrective surgery were 
back pain, neurologic impairment 
or progression of the curve, or a 
combination of these.
Surgical Procedures Used to Treat 
the Kyphosis (Table II)
The surgical technique used de­
pended on the initial treatment, the 
radiologic findings in patients with 
neurologic symptoms and configu­
ration of the deformity.
Posterior Harrington instrumen­
tation and fusion were required in 
five patients; three (nos. 3, 5 and 8) 
required compression Harrington 
rods and two (nos. 9 and 11) dis­
traction rods.
Posterior osteotomy, Harrington 
instrumentation and fusion were re­
quired for patient 2.
Staged anterior and posterior fu­
sion with instrumentation, with or 
without anterior decompression 
were carried out in six patients 
(nos. 1, 4, 6, 7, 12 and 16). Patient 
6 required anterior release and fibu- 
lar strut and intersomatic grafting 
followed by posterior instrumenta­
tion with Harrington distraction 
rods and fusion. In patient 7, an 
anterior release, fibular and rib 
strut grafting were followed by Har­
rington instrumentation and fusion; 
patient 12 required multilevel re­
lease with intersomatic grafting. In 
patient 4, posterior distraction in­
strumentation and fusion resulted 
in posterior nonunion, so 2 years 
later anterior fusion and instrumen­
tation were necessary.
Finally, staged anterior decom­
pression, fibular strut grafting or 
iliac strut grafting and anterior Har­
rington instrumentation, followed 
by posterior osteotomy with instru­
mentation and fusion were carried 
out on patients 10, 13, 14 and 15. 
In patient 15 the Roy-Camille
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plates,
moved.
initially applied, were re- Complications Patient 4 had a serious urinary 
tract infection. Her posterior fusion
Postoperatively, each patient was 
nursed on a Stryker frame. On 
postoperative day 7 a Cotrel brace 
or cast was applied until solid fu­
sion was demonstrated radiological- 
ly, usually after 6 months.
Five patients had problems post­
operatively. In patient 2 the Har­
rington rods became dislodged after 
6 months, but he resumed full 
work, even though the correction 
achieved by the rods was lost.
did not unite and she required an 
anterior fusion 2 years later. Patient 
12 had a pressure sore under a 
Cotrel cast; the sore resolved after 
10 days of bed rest on a Stryker 
frame and another cast was applied
T a b le  II. D ata on 16  P a tie n ts  W ith  P o s t-T ra u m a tic  K yp h o s is
No.
A ge , 
S ex yr
F ractu re
level
In itia l
tre a tm e n t
T im e  from  
in jury  to
correc tion , P reop  
m o sta tu s
Surgical
technique
Postop  
curve, °
Postop  
status  
a t las t 
fo llo w -u p
Follow -up,
mo
1 M  31 T4 H a rris—T a y lo r 
brace
10 3 0 °  curve 
B ack pain 
M usc le  w e a kn e ss  
S p a s tic ity  
H yp o e s th e s ia  
B ladder im p a irm e n t
1. A n t. d e co m pre ss io n
T 3 .T 4
Ilia c  s tru t g ra ft
2 . HD rods  
P os t, fu s io n
32 3 0 °  cu rve  
B ro w n -S e q u a rd  
s y n d ro m e
S p a s tic  p a ra p a re s is  o f 
T4
W a lks  w ith  1 cane 
M ye lo g ra p h ic  b lo c k  
In co m p le te
d e c o m p re s s io n ?
48
2 M 3 4 L1 HD ro d s  and po s t, 
fu s io n
5 3 0 °  curve  
Rod lo o sen in g  
B ack pain 
S p a s tic ity  
A ta x ic  ga it
P os t, o s te o to m y  
HD rods  
P os t, fu s io n
17 3 4 °  cu rve  
M o rn in g  s t if fn e s s  
No n e u ro lo g ic  d e f ic it  
R esum ed  w o rk  
(f ire m a n )
36
3 M  17 T9 HD ro d s  and po s t, 
fu s io n  15°
6 2 5 °  curve 
Rod lo o sen in g  
Increased  pa in
C o m p re s s io n  rods 
P os t, fu s io n
26 2 7 °  cu rve  
N o pain
21
4 F 42 L2 Bed re s t
L a m in e c to m y  L2 , 
L3
144 2 5 °  curve
Pain
L im p
P os to p  n o n u n io n  
Increased  pa in
HD rods  
P os t, fu s io n  
A n t. fu s io n  w ith  ant. 
D w ye r co m p re ss io n  
in s tru m e n ta tio n
20 2 0 °  cu rve  
Pain a t s c a r s ite
60
5 M 53 T 1 2 A nt.
d e co m p re ss io n  
and r ib  s tru t  
g ra ft
7 3 0 °  curve
M usc le  w e a kn e ss  and 
h yp o e s th e s ia  a fte r 
in itia l re co v e ry
HC ro d s  
P os t, fu s io n
25 2 5 °  cu rve  
W a lks  w ith  1 cane 
No pain
42
6 F 32 T 1 2 Brace 36 5 2 °  curve 
B ack pain 
P ares thes ia  
Im pa ired  vo id in g
1. A n t. s tru t  g ra ft
2. HD ro d s  
P os t, fu s io n
45
22
3 0 °  cu rve  
N o pain
B la d d e r n o rm a l 
R esum ed w o rk
32
7 F 23 T12 C ast 12 3 4 °  curve 
B ack pain 
H yp o e sth e s ia  
M ye lo g ra m  +  
T o m o g ra m  +
1. A n t. s tru t  g ra ft
2. HD ro d s  
P os t, fu s io n
17
8
15° cu rve  
No pain 
R esum ed w o rk
72
8 M  22 L3 C ast 15 10° curve 
B ack pain 
R ad icu la r pa in , 
Lasegue 
s ign  +
HC rods  
P os t, fu s io n
7 1 1 ° cu rve  
No pain
R esum ed w o rk
60
9 M  28 L1 Brace 18 1 5 °  curve 
B ack pain 
S p ina l s te n o s is
HD ro d s  
P os t, fu s io n
13 1 5 °  cu rve  
N o pain
R esum ed w o rk  and 
s p o rts
46
HD =  H a rr in g to n  d is tra c tio n , HC =  H a rr in g to n  c o m p re s s io n , an t. =  a n te r io r, p o s t =  p o s te r io r , +  =  po s itive .
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until solid fusion occurred without 
further problems. Posterior fusion 
also failed in patient 13 who needed 
revision with Harrington instrumen­
tation 2 years later; successful 
union resulted. Patient 14 had a 
voiding problem early postopera- 
tively and required catheterization.
Clinical Outcome
The mean follow-up was 38 
months (range from 19 to 72 
months). Pain improved or disap­
peared in 10 patients, 3 showed 
slight improvement but 1 did not 
show any improvement (Table II).
In patients with kyphosis of the 
thoracic spine, the curve was re­
duced from a mean of 38° to 27° 
(range from 20° to 35°). In the 
thoracolumbar spine, the improve­
ment was from a mean of 39° to 
27° (range from 8° to 34°). In the 
lumbar spine, the reduction was
»
►
►
T a b le  II  (C o n tin u e d ). Data on 16 Patients With Post-Traumatic Kyphosis
No. Sex
Age,
yr
Fracture
level
In itia l
trea tm en t
T im e  from  
in ju ry  to
correc tion , Preop  
m o status
S u rg ic a l
te c h n iq u e
Postop  
curve , °
Postop  
status  
at las t 
fo llo w -u p
F o llo w -u p ,
m o
10 M 31 T8-9
10-11
Brace 10 40° curve
Spastic paraparesis 
Hypoesthesia 
Ataxic gait 
Bladder and bowel 
problems 
Myelogram +
1. Ant. decompression 
Fibular strut graft
2. Post, osteotomy 
HC rods and fusion
25 25° curve
Still increased reflexes 
Resumed work and 
sports
36
11 M 56 T7 Brace 22 20° curve 
Back pain
HD rods 
Post, fusion
20 20° curve
Solid fusion but pain
19
12 M 18 T6-7 Brace 15 75° curve 
Back pain
Unable to work or run
1. Ant. release and graft
2. HC rods 
Post, fusion
35 35° curve
Pain at upper hooks 
Resumed work
33
13 M 24 T12 HD rods 
Post, fusion
22 40° curve 
Paresthesia 
Back pain
1. Ant. decompression 
T12
Fibular strut graft
15 32° curve 
Light pain
30
Bladder impairment 
Spasticity
T11-L1 
2. Post, osteotomy 
HC rods and fusion
14 M 18 L1 1. Laminectomy 
and 1 HD rod 
without fusion
2. Post, fusion
52 45° curve
Paresis for 3 mo 
(needed crutches) 
Sphincter hypotonia 
Anesthesia of heels 
Back pain
1. Ant. decompression
L1
Iliac strut graft 
T12-L2 
Ant. Harrington 
instrumentation
2. Post, osteotomy 
HC rods and fusion
34 34° curve
No pain
Muscle improvement 
by 4 mo
Sensibility improved 
Sphincter tone 
unchanged 
Removed orthosis 2 
mo postop without 
permission
24
15 M 17 L4 Post, fusion and 
instrumentation 
by Roy-Camilie 
plates without 
correction of 
kyphosis
22 Loss of lumbar
lordosis with ant. 
projection of trunk 
and instability 
without crutches 
Muscle weakness 
below L3
Sphincter hypotonia 
Need for orthosis of 
both legs 
Low back pain
1. Ant. decompression
L4
Iliac strut graft 
L3-L5
2. Removal of plates
and screws 
Post, osteotomy 
HC rods and fusion
- 1 0  Restoration of normal 
lordosis with ability 
to stand without 
crutches and 
improved gait
25
16 F 30 L1 Bed rest and 14 40° curve (5° in 1 yr)
orthosis Back pain
Hypoesthesia ant.
aspects of thighs 
No muscle weakness 
Slight stenosis
1. Ant. release and iliac
strut graft T12-L2 
Ant. Harrington rods
2. Posterior
Harrington-Luque 
instrumentation with 
fusion
8 Pain improved 
Back to normal 
activities
24
HD =  Harrington distraction, HC =  Harrington compression, ant. =  anterior, post. =  posterior, +  =  positive.
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from a mean of 12° to 7° (range 
from — 10° to 20°).
Postoperatively, there was an av­
erage loss of correction of 3.5° 
(range from 0° to 17°).
In patient 15, lumbar lordosis 
was restored which greatly im­
proved his trunk balance.
Neurologically, the paresthesia 
and hypoesthesia disappeared or 
was greatly diminished soon after 
the operation in the seven patients 
noted to have these problems. Ra­
dicular pain and a positive Lasegue 
sign disappeared in patient 8. Pyra­
midal syndrome disappeared in pa­
tient 2 and was markedly improved 
in patients 10 and 13, but it re­
mained unchanged in patient 1.
Muscle strength returned to nor­
mal in patient 10 and improved in 
three others; it was unchanged in 
patient 1. Ataxic gait resolved in 
patients 2 and 10. Sphincter func­
tion returned to normal in two 
patients (6 and 10) but was un­
changed in patients 1, 13, 14 and 
15.
Eight patients returned to work. 
Patient 11, who complained of pain, 
would not return to work even
though he had a solid fusion, nor­
mal spinal curve and no neurologic 
symptoms. As a result, his eligibili­
ty for sought-after compensation 
has been difficult to assess.
Four patients were still too dis­
abled to resume physical activities 
and were not expected to improve. 
Two patients (nos. 4 and 13) re­
sumed light work.
Case Report
The following case report is a 
representative example of our 16 
patients who suffered post-trauma- 
tic kyphosis.
A 30-year-old woman (patient 16) 
sustained a fracture of LI in a car 
accident. The fracture was first 
treated by bed rest and application 
of a body jacket. Fourteen months 
later she was referred to our institu­
tion. She complained of back pain 
and hypoesthesia over the anterior 
aspect of both thighs. Preoperative 
assessment revealed a sharp 40° 
kyphosis from T12 to L2 (Fig. 1). 
This deformity had increased 5° 
over the previous year. Myelogra­
phy (Fig. 2) demonstrated only 
slight stenosis at the fracture level. 
An anterior release and iliac strut 
grafting from T12 to L2 with ante­
rior Kostuik-Harrington instrumen­
tation was carried out. The kypho­
sis was reduced to 8° (Fig. 3), and 
no late loss of correction was ob­
served at follow-up 24 months later.
Discussion
Three main factors contribute to 
the progression of post-traumatic 
kyphosis:27 failure of the anterior 
elements under compressive load­
ing, failure of the posterior ele­
ments under tensile loading and 
increased physiological load after 
“healing” because of increased mo­
ment arm proportional to the mag­
nitude of the kyphosis.
These factors make burst frac­
tures particularly prone to a pro­
gressive kyphotic deformity,9 espe­
cially if the initial angulation is 
more than 30°;2 multiple-level frac­
tures are even more susceptible.2-7
Laminectomy, done initially in 
patients 4 and 14, further destabil-
FIG. 1. Anteroposterior and lateral views showing kyphosis of 40° from T12-L2.
FIG. 2. Myelogram demonstrates slight 
stenosis at LI.
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izes the spine and is ineffective in 
decompressing neural elements, ex­
cept in rare instances when the 
fractured laminae have moved ante­
riorly, compressing the neural ele­
ments. 2- 4-6.8.1(U2.M,15.17-19.21-24
Posterior instrumentation and fu­
sion to stabilize the curve is some­
times the only procedure required; 
when pain is the sole complaint and 
the curve is slight, it has proven 
effective.3
We believe that a solid fusion 
should be the ultimate aim in most 
cases of post-traumatic kyphosis. 
For example, in case 2 correction 
was entirely lost when the upper 
hooks dislodged 4 months after 
surgery. However, this patient had 
complete neurologic recovery and 
was able to resume work when 
fusion was finally achieved 2 
months later. This phenomenon has 
been attributed to correction of 
microinstability.1
To demonstrate spinal canal en­
croachment and the need for de­
compression it is important to ob­
tain a laminagram,3 myelogram2-3 
and computed tomogram.21017 
Compression is anterior, due to
a bony fragment at the apex of the 
curve, so decompression must be 
anterior.2-3-8-10-11-14-15-17-18-21-24-28 Mild­
er deformities can be corrected with 
posterior instrumentation and fu­
sion.10-16 In patients previously op­
erated on, who have severe deformi­
ty, a posterior osteotomy is helpful.
In patients not previously operat­
ed on, distraction rods using the 
three-pressure-point method are ef­
fective.2 Distraction must be mini­
mal to prevent overstretching the 
cord2-8 and the rods should be con­
toured; square-ended rods are used 
in the lumbar area.10 Compressive 
devices are more effective but carry 
the risk of pushing bony elements 
into the spinal canal; these devices 
should be used only if an anterior 
decompression was performed ini­
tially.
Anterior grafting is essential in 
severe kyphosis for biomechanical 
reasons.8-9-17"20-22-25-27-28 A rib strut 
graft is mechanically weak, hence 
fibular or iliac strut grafting with 
anterior instrumentation is suggest­
ed.
The anterior approach provides 
the best exposure for decompres­
sion2-3-14-19-21-23-24 and anterior strut 
grafting. The posterolateral ap­
proach is inadequate.11-21
Solid fusion is imperative. For 
example, our patient 5 was treated 
initially by anterior decompression 
and rib strut grafting. Because the 
fusion was not solid, the correction 
obtained at surgery was lost and 
the original neurologic deficit reap­
peared. Subsequent use of Harring­
ton compression rods and posterior 
fusion resulted in partial neurologic 
recovery.
We agree with the recommenda­
tion of others2-3-18-24 that a posterior 
fusion be performed in all cases, 
including those who have an anteri­
or fusion.
In the future, anterior decom­
pression and fusion may be safe 
enough and strong enough to pre­
clude the use of the posterior meth­
od in the treatment of post-traumat­
ic kyphosis, but at present this is 
not the case.
When neurologic improvement is 
not achieved by anterior decompres­
sion, myelography or computed to­
mography, or both, should be re­
peated.
No major surgically related com­
plication occurred in this series and 
most patients returned to their pre­
vious employment. Even some of 
the very disabled with ataxic gait, 
muscle weakness and spasticity, re­
turned to full work and sports 1 
year after the procedure.
Effective correction of symptom­
atic post-traumatic kyphosis is pos­
sible, even when a neurologic defi­
cit has been present for several 
m onths.2-3-11 14-19-23-24-28 Corrective 
surgery should be considered when 
a deformity progresses after a spi­
nal fracture, whatever the initial 
treatment. This is especially true if 
there is concomitant progressive 
neurologic deficit.
We thank Doctor Guy Paiement for his 
help in reviewing this paper.
FIG. 3. Anteroposterior and lateral views show kyphosis reduced to 8° with 
anterior and posterior instrumentation and posterior fusion.
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Perioperative Chemotherapy for Primary Sarcoma of Bone
Ka Wah Chan, MB, FRCPC;* M. Knowling, MD, FRCPC;t C.P. Beauchamp, MD, FRCSCJ
►
►
Preoperative chemotherapy for primary osteosarcoma has usually been accompanied 
by a prolonged delay between withdrawal before operation and resumption after. 
This is because animal studies showed impaired wound healing associated with 
perioperative chemotherapy. Clinical studies, however, have not shown this to be 
the case. The authors describe their experience in eight patients who had 
osteosarcoma and Ewing’s sarcoma of the extremities and received one to three 
cycles of chemotherapy preoperatively. Chemotherapy consisted of Adriamycin, 
cis-platinum and vincristine. Definitive surgery on the primary tumour was done 1 
to 4 days after the last dose. Amputation was performed on seven patients and 
tumour resection for limb salvage on one. No wound healing or infectious 
complications were encountered. The ensuing course of chemotherapy was not 
delayed by the surgical procedure. The authors conclude that it is feasible to 
combine neoadjuvant chemotherapy and early surgery in the management of 
high-grade primary bone sarcoma.
La chimiotherapie preoperatoire des osteosarcomes primitifs est habituellement 
accompagnee d’un delai prolonge entre l’interruption medicamenteuse avant l’opera- 
tion et la reprise du traitement apres. Ceci decoule d’etudes animales qui ont montre 
une alteration du mecanisme de cicatrisation de plaie reliee a la chimiotherapie 
preoperatoire. Toutefois, les etudes cliniques n’ont rien revele de similaire. Les 
auteurs decrivent le traitement de huit patients souffrant d’osteosarcome ou de 
sarcome d’Ewing des extremites, qui re?urent de un a trois cycles de chimiotherapie 
preoperatoire. Le traitement etait compose d’Adriamycine, de cis-platine et de 
vincristine. L’operation definitive eut lieu de 1 a 4 jours apres la derniere dose. Une 
amputation fut pratiquee chez sept patients, alors que le dernier subissait une 
resection tumorale visant a sauvegarder le membre. Aucune complication infectieuse 
ou de cicatrisation ne fut observee. La poursuite du traitement de chimiotherapie ne 
fut pas retardee par l’intervention chirurgicale. Les auteurs concluent que, dans le 
traitement des osteosarcomes primitifs au stade avance, il est possible d’associer 
chimiotherapie “neoadjuvante” et chirurgie precoce.
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C hemotherapy before definitive treatment of a primary malig­
nant tumour has become popular in 
the past decade. The advantages of 
this “neoadjuvant” approach in­
clude early eradication of systemic 
micrometastases and in-vivo sensi­
tivity testing of tumour cells to 
specific antineoplastic agents, thus 
allowing early modification of che­
motherapy regimens.1 This ap­
proach has been used successfully 
to treat osteosarcoma and has been 
proposed for the management of 
operable Ewing’s sarcoma.23 Sur­
gery on the primary tumour usually 
is performed 3 to 4 weeks from the 
last course of chemotherapy to 
allow recovery from its side effects. 
Chemotherapy is seldom resumed 
for another 2 to 3 weeks, until the 
surgical wound has healed com­
pletely. The patient, therefore, may 
not receive systemic therapy for 6 
or more weeks during the early, 
critical period of antineoplastic 
therapy. This delay was considered 
inevitable because animal experi­
ments4-5 showed that perioperative 
chemotherapy significantly impaired 
wound healing. On the other hand, 
most clinical studies6-7 have shown 
little effect of adjuvant chemothera­
py on postsurgical recovery. In this 
report we describe our experience in 
carrying out surgery on primary 
bone tumours immediately after 
chemotherapy without deleterious 
effect on wound healing.
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Patients and Materials
Between May 1985 and August 
1987, eight patients with primary 
bone sarcoma of the extremities 
were given chemotherapy before de­
finitive surgery (Table I). Chemo­
therapy was administered over 2 
days. One to three courses were 
given and surgery was scheduled 
within 1 to 4 days of the last dose 
of cytotoxic therapy. The choice of 
surgical procedure was not affected 
by perioperative chemotherapy. 
Postoperative chemotherapy was 
scheduled to resume 3 weeks from 
the start of the last course before 
surgery, provided blood counts had 
returned to a satisfactory level (ab­
solute neutrophil count of 1.0 X 
109/L  and platelets of 100 X 
109/L ) and the surgical wound ap­
peared healed. All patients were 
followed up regularly to assess 
complications at the surgical sites.
Findings
The median age of patients at the 
time of diagnosis was 16.5 years 
and all were male. Five patients 
with osteosarcoma received one to 
three cycles of cis-platinum- 
Adriamycin preoperatively. Two 
boys (nos. 4 and 5) received one 
cycle of high-dose methotrexate a 
week earlier, followed by cis- 
platinum-Adriamycin. The man
with Ewing’s sarcoma received vin­
cristine and Adriamycin immediately 
before tumour resection and inser­
tion of a prosthesis. He had re­
ceived one course each of vincris- 
tine-Adriamycin and vincristine- 
cyclophosphamide previously. The 
median time to surgery from the 
last dose of chemotherapy was 2.2 
days. No immediate postoperative 
complication was encountered. No 
wound infection, fever or hematoma 
was noted. All patients were dis­
charged 5 to 10 days (median 7 
days) after surgery. Moderate neu­
tropenia (absolute neutrophil count 
between 0.2 and 0.5 X 109/L ) was 
encountered in all patients, but 
thrombocytopenia of less than 100 
X 109/L  was found in only one. 
Chemotherapy was resumed 3 
weeks from the last treatment in all 
patients except no. 3, whose treat­
ment was delayed for 1 week be­
cause of neutropenia. No wound 
dehiscence or impairment of healing 
was found and the mean follow-up 
was 28 months (range from 5 to 45 
months).
Discussion
The effects of antineoplastic 
agents on wound healing have been 
investigated extensively. Controver­
sy exists as to the importance of 
findings in animal experiments and 
their applicability to clinical prac­
tice. Devereux and colleagues45 ad­
ministered Adriamycin 6.0 mg/kg 
intravenously to rats at various 
times before and after surgery. Seri­
ous impairment of wound tensile 
strength resulted because of defec­
tive collagen synthesis. The most 
deleterious effect was observed 
when treatment was given preopera­
tively or intraoperatively, and the 
addition of local radiotherapy po­
tentiated the impairment.8 Lawrence 
and associates9 reported a similar 
finding and postulated that 
Adriamycin-induced myelosuppres- 
sion resulted in a decreased amount 
of local chemotactic and growth 
factors normally derived from gra­
nulocytes and platelets. This in turn 
led to decreased wound cellularity 
and collagen accumulation. In con­
trast, an earlier study10 showed that 
Adriamycin up to a dose of 10 
m g/kg had no adverse effect on 
wound healing regardless of the 
time of treatment in relation to the 
time of injury. Cis-platinum, when 
given at 5.0 mg/kg, impaired 
wound healing,11 but studies1213 
using one-third to one-half of this 
dosage showed no noticeable effect 
on healing of skin wounds or intes­
tinal anastomoses in animals.
The clinical effects of adjuvant 
chemotherapy on wound healing 
were more acceptable. Patients with 
advanced breast cancer received 
several courses of Adriamycin and 
cyclophosphamide before mastecto-
T a b le  1. Clinical Characteristics of Patients
P atien t
no.
Age,
yr
Tu m o u r
ty p e * Location
P erio p era tive
c h e m o th e ra p y t
In terval to 
surgery , 
d
S urg ica l
procedure
1 16 OS Fibula CA 1 Above-knee amputation
2 21 OS Femur CA 3 High thigh amputation
3 17 OS Tibia CA 4 Above-knee amputation
4 13 OS Femur M/CA 2 Above-knee amputation
5 8 OS Femur M/CA 3 Above-knee amputation
6 13 ES Humerus VA/VC/VA 2 Limb salvage
7 23 OS Tibia CA X 3 2 Above-knee amputation
8 23 OS Tibia CA X 3 1 Above-knee amputation
*0S =  osteosarcoma, ES =  Ewing’s sarcoma.
tCA =  cis-platinum, 100 m g/m 2, d 1, Adriamycin, 35.0 m g/m 2, d 1 and 2; M =  methotrexate 8.0 g /m 2, d 1 with folinic acid rescue; VA =  vincristine, 
1.5 m g/m 2, d 1, Adriamycin, 75 m g/m 2, d 2; VC =  vincristine, 1.5 mg/m2, d 1, cyclophosphamide 1.4 g /m 2, d 2 . _________________________________
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my and had no increase in wound 
complications.6 However, surgery 
was not usually performed until 3 
or more weeks after the end of 
chemotherapy. Nissen-Meyer and 
associates7 administered a single 
course of cyclophosphamide (5.0 
m g/kg daily for 6 days) within 
several days of mastectomy and 
found no increase in the wound 
complication rate compared with 
control patients who underwent 
surgery only. The effect of preoper­
ative chemotherapy on wound heal­
ing in skeletal tumours has been 
reported. Bertermann and col­
leagues14 summarized the experi­
ence of the T4, T7 and T10 proto­
cols from New York’s Memorial 
Hospital, where high-dose metho­
trexate and Adriamycin were given 
to osteosarcoma patients, the last 
dose being given 1 to 2 weeks 
before limb-salvage surgery. No in­
crease in wound complications was 
seen, but 6% of the patients re­
quired amputation because of 
wound infection.
The addition of radiotherapy to 
preoperative chemotherapy seems 
to increase the risk of wound com­
plications. Denton and associates15 
administered Adriamycin intra­
arterially and local radiotherapy 
preoperatively to 30 patients with 
bone and soft-tissue sarcoma. Poor 
wound healing necessitated amputa­
tion in two patients. Two others 
had wound necrosis requiring 
debridement and skin grafting. A 
randomized trial of perioperative 
brachytherapy showed a substantial 
increase in wound complication rate 
compared with control patients. 
The addition of Adriamycin at 60.0 
m g/m 2 did not increase the wound 
problems, but most patients re­
ceived chemotherapy more than 2 
weeks after surgery.16 Similarly, 
preoperative cis-platinum therapy 
and radiotherapy in patients with 
head and neck tumours led to a 
25% increase in hospital stay be­
cause of slow wound healing, but 
only 1 of the 28 patients suffered 
wound dehiscence.17
The present study showed no 
deleterious effect on wound healing 
when Adriamycin, cis-platinum and 
vincristine were administered in 
standard doses several days before 
surgery. It is, therefore, possible to 
continue neoadjuvant chemothera­
py without interruption to treat 
micrometastases and also to include 
surgery for local disease control. 
This is especially important in the 
case of highly proliferative tu­
mours; Goldie and Coldman18 illus­
trated a steep quantitative relation 
between tumour size and the likeli­
hood of cure. We used a similar 
approach to treat one child with a 
large malignant sacrococcygeal ter­
atoma obstructing the rectum. The 
child received cis-platinum 120 
m g/m 2, VP-16 (etoposide) 360 
m g/m 2, vincristine 2.0 mg/m2 and 
bleomycin 50 m g/m 2 2 days before 
tumour resection and no complica­
tions developed. Similarly, if the 
primary tumour has progressed 
during preoperative chemotherapy 
with other cytotoxic agents (such 
as high-dose methotrexate for os­
teosarcoma), alternative treatment 
with Adriamycin and cis-platinum 
may be given immediately without 
awaiting recovery from surgery. An­
other advantage of administering 
chemotherapy before surgery is the 
avoidance of treatment in the early 
postoperative period, when compli­
cations such as atelectasis and mal­
nutrition are frequently present and 
drains and catheters are in place.19
However, one must be careful in 
extrapolating the results of this 
small series to other chemothera­
peutic agents and surgical proce­
dures used in the treatment of dif­
ferent neoplastic diseases. The 
problem of wound healing with pe­
rioperative chemotherapy may be 
more frequent when complicated 
surgical procedures are performed.
Our patients were healthy without 
other adverse factors such as sep­
sis, steroid use and local irradiation 
during chemotherapy and surgery. 
Further clinical observations and 
comparative trials are necessary to 
evaluate the effect of perioperative 
chemotherapy in other malignant 
tumours.
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sMEFOXIN®
(sterile cefoxitin sodium, MSD Std.)
ANTIBIOTIC
ACTION
In vitro studies demonstrate that the bactericidal 
action of cefoxitin, a cephamycin derived from 
cephamycinC, results from the inhibition of 
bacterial cell wall synthesis. Evidence suggests 
that the methoxy group in the 7a position is 
responsible for the resistance of cefoxitin to 
degradation by bacterial beta-lactamases.
INDICATIONS AND CLINICAL USES 
TREATMENT
The treatment of the following infections when 
due to susceptible organisms:
1 - Intra-abdominal infections such as peritonitis
and intra-abdominal abscess
2 - Gynecological infections such as endo­
metritis and pelvic cellulitis
3 - Septicemia
4 - Urinary tract infections (including those
caused by Serratia marcescens and 
Serratia spp.)
5 - Lower respiratory tract infections
6 - Bone and jo in t infections caused by
Staphylococcus aureus
7 - Soft tissue infections such as cellulitis,
abscesses and wound infections 
Appropriate culture and susceptibility studies 
should be performed to determine the suscepti- 
b ility  of the causative  organism (s) to 
MEFOXIN®. Therapy may be started while 
awaiting the results of these tests, however, 
modification of the treatment may be required 
once these results become available.
Organisms particularly appropriate for therapy 
with MEFOXIN® are:
Gram positive
Staphylococci, penicillinase producing and 
non-producing
Streptococci excluding enterococci
Gram negative (beta-lactamase producing and 
non-producing strains)
E. coli
Klebsiella species (including K. pneumoniae) 
Proteus, indole positive and negative 
Haemophilus influenzae 
Providencia species 
Anaerobes 
Bacteroides fragilis
MEFOXIN® may also be appropriate for the 
treatment of infections involving susceptible 
strains of both aerobic and anaerobic bacteria.
MEFOXIN® is not active against Pseudomonas, 
most strains of enterococci, many strains of 
Enterobacter cloacae, and methicillin-resistant 
staphylococci and Listeria monocytogenes.
Clinical experience has demonstrated that 
MEFOXIN® can be administered to patients who 
are also receiving carbenicillin, gentamicin, 
tobramycin, or amikacin (see PRECAUTIONS 
and ADMINISTRATION).
Intravenous Administration
The intravenous route is preferable for patients 
with bacteremia, bacterial septicemia, or other 
severe or life-threatening infections, or for 
patients who may be poor risks because of 
lowered resistance resulting from such debili­
tating conditions as m alnutrition, trauma, 
surgery, diabetes, heart failure, or malignancy, 
particularly if shock is present or impending. 
PROPHYLACTIC USE
MEFOXIN® may be administered periopera- 
tively (preoperatively, intraoperatively and post- 
operatively) to patients undergoing vaginal or 
abdom inal hysterectom y and abdominal 
surgery when there is a significant risk of 
postoperative infection or where the occurrence 
of postoperative infection is considered to be 
especially serious.
In patients undergoing cesarean section, intra­
operative (after clamping the umbilical cord) 
and postoperative use of MEFOXIN® may 
reduce the incidence of surgery related post­
operative infections.
Effective prophylactic use depends on the time 
of administration. MEFOXIN® usually should be 
iven one-half to one hour before the operation, 
rophylactic administration should usually be 
stopped within 12 hours. It has been generally46 VOL. 32, NO. 1, JANUARY 1989
reported that continuing administration of any 
antibiotic beyond 24 hours following surgery 
increases the possibility of adverse reactions 
but, in the majority of surgical procedures, does 
not reduce the incidence of subsequent 
infection.
If signs of postsurgical infection should appear, 
specimens for culture should be obtained for 
identification of the causative organism(s) so 
that appropriate therapy may be instituted.
CONTRAINDICATIONS
MEFOXIN® is contraindicated in persons who 
have shown hypersensitivity to cefoxitin or to 
the cephalosporin group of antibiotics.
WARNINGS
Before therapy with MEFOXIN® is instituted, 
careful inquiry should be made to determine 
whether the patient has had previous hyper­
sensitivity reactions to MEFOXIN®, cephalo­
sporins, penicillins or other drugs. MEFOXIN® 
should be given with caution to penicillin- 
sensitive patients.
There is some clinical and laboratory evidence 
of partia l c ross-a lle rgen ic ity  between 
cephamycins and the other beta-lactam anti­
biotics, penicillins and cephalosporins. Severe 
reactions (including anaphylaxis) have been 
reported with most beta-lactam antibiotics.
Pseudomembranous colitis has been reported 
with virtually all antibiotics. This colitis can 
range from mild to life threatening in severity. 
Antibiotics should therefore be prescribed with 
caution in individuals with a history of gastro­
intestinal disease, particularly colitis. It is 
important to consider a diagnosis of pseudo­
membranous colitis in patients who develop 
diarrhea in association with antibiotic use. While 
studies indicate that a toxin produced by 
Clostridium difficile is one primary cause of 
antibiotic-associated colitis, other causes 
should also be considered.
Any patient who has demonstrated some form of 
allergy, particularly to drugs, should receive 
antibiotics including MEFOXIN® with caution.
If an allergic reaction to MEFOXIN® occurs, 
administration of the drug should be discon­
tinued. Serious hypersensitivity reactions may 
require treatment with epinephrine and other 
emergency measures.
PRECAUTIONS
The total daily dosage should be reduced when 
MEFOXIN® is administered to patients with 
transient or persistent reduction of urinary 
output due to renal insufficiency (see DOSAGE 
AND ADMINISTRATION) because high and 
prolonged serum antibiotic concentrations can 
occur from usual doses.
In patients treated with MEFOXIN® a false­
positive reaction to glucose in the urine may 
occur with Benedict’s or Fehling's solutions but 
not with the use of specific glucose oxidase 
methods.
Using the Jaffe Method, falsely high creatinine 
values in serum may occur if serum concen­
trations of cefoxitin exceed 100/zg/mL. Serum 
samples from patients treated with MEFOXIN® 
should not be analyzed for creatinine if with­
drawn within two hours of drug administration.
Increased nephrotoxicity has been reported 
following concomitant administration of 
cephalosporins and aminoglycoside antibiotics.
The safety of MEFOXIN® in the treatment of 
infections during pregnancy has not been 
established. If the administration of MEFOXIN® 
to pregnant patients is considered necessary, its 
use requires that the anticipated benefits be 
weighed against possible hazards to the fetus. 
Reproductive and teratogenic studies have been 
performed in mice and rats and have revealed no 
evidence of impaired fertility or harm to the fetus 
due to MEFOXIN®.
Cefoxitin has been observed in the milk of 
nursing mothers receiving the drug.
Prolonged use of MEFOXIN® may result in the 
overgrowth of non-susceptible organisms. 
Repeated evaluation of the patient’s condition is 
essential and if superinfection occurs during 
therapy, appropriate measures should be taken. 
Should an organism become resistant during 
antibiotic therapy, another antibiotic should be 
substituted.
In children 3 months of age or older, higher 
doses of MEFOXIN® (100 mg/kg/day and
above) have been associated with an increased 
incidence of eosinophilia and elevated SGOT.
ADVERSE REACTIONS
MEFOXIN® is generally well tolerated. Adverse 
reactions rarely required cessation of treatment 
and usually have been mild and transient.
Local Reactions
Thrombophlebitis has occurred with intra­
venous administration. Some degree of pain and 
tenderness is usually experienced after intra­
muscular injections using water. Induration has 
occasionally been reported.
Allergic
Maculopapular rash, urticaria, pruritus, eosino­
philia, fever and other allergic reactions have 
been noted.
Gastrointestinal
Symptoms of pseudomembranous colitis can 
appear during or after antibiotic treatment. 
Nausea and vomiting have been reported rarely. 
Blood
Transient eosinophilia, leukopenia, neutropenia, 
hemolytic anemia, and thrombocytopenia have 
been reported. Some individuals, particularly 
those with azotemia, may develop positive direct 
Coombs tests during therapy with MEFOXIN®. 
Liver Function
Transient elevations in SGOT, SGPT, serum 
LDFf, and serum alkaline phosphatase have 
been reported.
Kidney
Elevations in serum creatinine and/or blood 
urea nitrogen levels have been observed. As 
with the cephalosporins, acute renal failure has 
been reported rarely. The role of MEFOXIN® in 
changes in renal function tests is difficult to 
assess, since factors predisposing to prerenal 
azotemia or to impaired renal function have 
often been present.
TREATMENT OF OVERDOSE
Other than general supportive treatment, no 
specific antidote is known. MEFOXIN® can be 
eliminated by dialysis in patients with renal 
insufficiency.
DOSAGE AND ADMINISTRATION
MEFOXIN® may be administered intravenously 
or intramuscularly when required. (See 
complete monograph on ADMINISTRATION 
and RECONSTITUTION.)
TREATMENT DOSAGE 
Adults
The usual adult dosage is 1 g or 2 g of 
MEFOXIN® every 6 to 8 hours. Dosage and route 
of administration should be determined by 
severity of infection, susceptibility of the 
causative organisms, and condition of the 
patient. The usual adult dosages are shown in 
the Table below.
Usual Adult Dosage
T y p e  o f 
in fe c t io n
D a ily
D o s a g e
F re q u e n c y  
a n d  R o u te
U n c o m p lic a te d  
fo rm s* o f in ­
fe c tio n s  such  as 
p n e um o n ia , 
u r in a ry  tra c t 
in fe c tio n , so ft 
t issu e  in fe c tio n
3-4  g 1 g eve ry  6 -8  h 
I.V. o r  I.M .
M o d e ra te ly  
severe o r  severe 
in fe c t io n s
6-8 g 1 g every  4 h 
o r
2 g  e ve ry  6 -8  h I.V.
In fe c tio n s  
c o m m o n ly  
ne e d in g  a n ti­
b io tic s  in  h ig h e r 
dosa ge  (e.g. gas 
gan g re ne )
1 2 9 2 g every  4  h
o r
3 g eve ry  6 h I.V.
• I n c l u d in g  p a t ie n ts  
a b s e n t  o r  u n l ik e ly
in  w h o m b a c t e r e m ia  is
Therapy may be started while awaiting the 
results of susceptibility testing.
Antibiotic therapy for group A beta-hemolytic 
streptococcal infections should be maintained 
for at least 10 days to guard against the risk of 
rheumatic fever or glomerulonephritis. In 
staphylococcal and other infections involving a 
collection of pus, surgical drainage should be 
carried out where indicated.
Adults with Impaired Renal Function
MEFOXIN® may be used in patients with 
reduced renal function but a reduced dosage
should be employed and it is advisable to 
monitor serum levels in patients with severe 
impairment.
In adults with renal insufficiency, an initial 
loading dose of 1 g to 2 g should be given. After 
a loading dose, the following recommendations 
for maintenance dosage may be used as a guide:
R E N A L C R E A T I N I N E
F U N C T IO N C L E A R A N C E D O S E F R E Q U E N C Y
m L / m ln
M ild
im p a irm e n t
M oderate
50-30 1-2 g e v e ry  8 -12  h
im pa irm en t 29-10 1-2 g eve ry  12-24 h
Severe
im pa irm en t
E ssen tia lly
9-5 0.5-1 g e v e ry  12-24  h
no  fu n c tio n < 5 0.5-1 g e ve ry  24-48  h
In the patient undergoing hemodialysis, the 
loading dose of 1 - 2 g should be given aftereach 
hemodialysis, and the maintenance dose should 
be given as indicated in the Table above. 
Neonates (Including Premature Infants), Infants 
and Children (See WARNINGS for Neonates 
under ADMINISTRATION in the complete 
monograph.)
P re m a tu re  In fa n ts  
w ith  B o d y  W e ig h ts  
A b o v e  150 0  g 20 -40  m g /k g  eve ry  12 h I.V.
N e o n a te s
0 -  1 week o f age
1- 4  weeks o f age
20 -40  m g /k g  e v e ry  12 h I.V. 
20-40  m g /k g  eve ry  8 h I.V.
In fa n ts
1 m on th  to  2 ye a rs  
o f age
20-40  m g /k g  e v e ry  6  h o r 
e v e ry  8 h I.M . o r  I.V.
C h ild re n 20 -40  m g /k g  e v e ry  6  h o r  
eve ry  8 h I.M . o r  I.V.
In severe infections, the total daily dosage in 
infants and children may be increased to 
200mg/kg, but not to exceed 12 g per day. 
MEFOXIN® is not recommended for the therapy 
of meningitis. If meningitis is suspectecf, an 
appropriate antibiotic should be used.
At present there is insufficient data to 
recommend a specific dosage for children with 
impaired renal function. However, if the 
administration of MEFOXIN® is deemed to be 
essential the dosage should be modified 
consistent with the recommendations for adults 
(see Table above).
PROPHYLACTIC USE
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Above-Knee Femoropopliteal 
Reconstruction With 
Polytetrafluoroethylene: a Good 
Alternative to Saphenous Vein Bypass
F. Laurendeau, MD, FRCSC;* J. Lassonde, MD, FRCSCt
Over 6Vi years, 64 femoropopliteal bypasses were done on 55 patients, using 
polytetrafluoroethylene (PTFE). The PTFE was chosen because previous surgery or 
small diameter prohibited the use of saphenous vein. The distal anastomoses were 
always placed above the knee. Patency rates were 92% at 1 month, 76% at 1 year, 
72% at 2 years and 59% at 3 years, and then reached a plateau of 55% at 4 years. 
When autogenous vein is not available, PTFE is the material of choice for 
femoropopliteal reconstruction. The results compare favourably with those using 
saphenous vein in an above-knee situation.
Sur une periode de 6V2 ans, 64 derivations femoro-poplitees ont ete pratiquees chez 
55 patients a l’aide de tubulures de polytetrafluoroethylene (PTFE). Le PTFE etait 
choisi quand une chirurgie anterieure ou le petit calibre des vaisseaux interdisait 
l’emploi d’une veine saphene. Les anastomoses distales ont toujours ete faites 
au-dessus du genou. Les taux de permeabilite ont ete de 92% a 1 mois, de 76% a 1 
an, de 72% a 2 ans et de 59% a 3 ans, pour ensuite atteindre un plateau de 55% 
apres 4 ans. Quand il est impossible d’utiliser une veine autogene, le PTFE est le 
materiau de premier choix pour la reconstruction femoro-poplitee. Les resultats se 
comparent favorablement a ceux des saphenes dans les obliterations au-dessus du 
genou.
It is generally agreed that autolo­gous saphenous vein is the best 
material to use for reconstruction in 
femoropopliteal disease, especially
when the distal anastomosis is 
below the knee joint. However, in a 
number of patients, the vein is 
either absent, due to previous sur­
gery, or of inferior quality. In this 
context, it is suggested that polytet­
rafluoroethylene (PTFE) may func­
tion as well as the saphenous vein 
in above-knee reconstruction. We 
report our experience with PTFE 
over a 78-month period.
Patients and Methods
The records of patients who un­
derwent femoropopliteal bypass 
grafting for arterial occlusive dis­
ease at the Hopital Maisonneuve- 
Rosemont between Jan. 1, 1979 
and July 1, 1985 were reviewed. 
Sixty-four above-knee PTFE grafts 
were placed in 55 patients (48 men 
and 7 women) who ranged in age 
from 45 to 86 years (mean age 62 
years) (Fig. 1). In all patients, the
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saphenous vein was either absent or 
of insufficient diameter (less than 4 
mm). The operations were per­
formed for ischemic problems with 
rest pain or trophic changes, or 
both (34), and for claudication 
alone (30). This inordinately high 
frequency of patients operated on 
for claudication alone was due to a 
more liberal use of the procedure in 
the early part of the study. We are 
more conservative now. Preopera- 
tively, all patients underwent aor- 
tofemoral angiography and nonin- 
vasive hemodynamic assessment 
with segmental pressure and pulse 
volume recordings. Follow-up, com­
plete for all but two patients, 
ranged from 12 to 84 months. Graft 
occlusion was determined by clini­
cal, noninvasive or angiographic 
methods.
Fifteen patients were diabetic, 
but only 5 were insulin dependent. 
A previous vascular procedure had 
been performed on 17 patients, 10 
of whom had a thrombosed venous 
femoropopliteal graft (Table I).
The PTFE grafts measured 6 mm 
in diameter in 27 patients, 8 mm in 
32 and 10 mm in 5. Use of the 
10-mm graft has been discontinued.
Results
By life-table analysis the cumula­
tive patency rates were 92% at 30 
days, 76% at 1 year, 72% at 2 years 
and 59% at 3 years; they reached a 
plateau of 55% at 4 years. There 
was no statistical difference wheth­
er the bypass was performed for
Table I. Previous Vascular Procedures
No. of
Procedure patients
Failed venous femoropopliteal
bypass 10
Aorto-bifemoral bypass 4
Aorto—bi-iliac bypass 1
Aortic endarterectomy 1
Common femoral
endarterectomy 1
claudication or ischemic rest pain.
There were five early thromboses 
(within 30 days). In all of these 
cases, the surgery was performed 
for ischemic rest pain and with an 
outflow tract of poor quality, that is 
with only one patent vessel distally. 
Three of the distal anastomoses had 
been placed on an isolated popliteal 
artery. Only one of these graft 
failures was followed by amputa­
tion.
There were three late throm­
boses, at 2, 5 and 24 months 
respectively; they were successfully 
thrombectomized, and the grafts 
remained patent thereafter. Three 
other late thromboses, at 4, 7 and 
60 months were followed by a 
major amputation.
There were no operative deaths. 
Eight patients died between 2 
months and 6 years postoperatively, 
five of myocardial infarction and 
three of lung carcinoma. Late mor­
tality was 15%.
One patient presented with a 
graft infection and was found to 
have a false aneurysm which 
prompted removal of the graft with­
out loss of the limb.
Discussion
The PTFE graft was first used in 
1974,1 and other reports detailed 
early and intermediate patency 
rates.2-3 Aneurysmal dilatation was 
noted early in the initial series4 and 
corrected by an additional layer 
around the graft. Since then, the 
material has been used extensively. 
However, application of the findings 
from previous reports has been hin­
dered by differences in patient selec­
tion and reporting methodology. It 
is generally agreed that the ideal 
conduit for leg revascularization 
should have an adequate diameter, 
compliance characteristics similar 
to the recipient arteries, a perma­
nent nonthrombogenic surface and
resistance to biodegradation by ath­
erosclerosis.5
There is clear evidence that the 
saphenous vein provides the best 
results when used in infrapopliteal 
anastomoses.6 Recently, there has 
been a resurgence of reports show­
ing excellent results with the non- 
reversed in-situ saphenous vein.7 
However, some investigators8 have 
noted the unsuitability of the saphe­
nous vein in 3% to 21% of patients. 
Szilagyi and colleagues9 have dem­
onstrated that the quality of the 
vein, determined by its diameter, 
presence of varices, fibrotic valves 
and diffuse sclerosis, has correlated 
well with long-term patency. In 
many patients, the saphenous vein 
is absent due to previous surgery.
Reports10-11 show that a PTFE 
graft may function as well as the 
saphenous vein when the distal 
anastomosis lies above the knee.
Christenson and colleagues12 
found a significantly higher cumu­
lative patency rate when the distal 
anastomosis of a PTFE graft was 
placed above the knee than below. 
Their findings corresponded with 
earlier reports by Kidson and asso­
ciates13 and Raithel and Groitl.14
Some15 have recommended the 
use of PTFE in preference to the 
autologous vein graft in the above- 
the-knee situation, arguing that 
this preserves the saphenous vein 
for treatment of distal occlusive 
disease which might subsequently 
develop. Since the requirements for 
autologous saphenous vein assume 
greater importance as smaller ca­
libre vessels are reached, the argu­
ment for its preservation for use in 
bypassing to the level of the tibial 
vessels seems rational, but we are 
not yet ready to adopt this policy.
In our series, indications for 
using the PTFE graft were absence 
of the saphenous vein or insuffi­
cient diameter of the vein. More­
over, the distal anastomosis was 
always performed above the knee.
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Our data confirm the observation of 
other investigators that PTFE may 
safely be used for above-knee femo- 
ropopliteal bypass with the expecta­
tion of results equivalent to those 
achieved with saphenous vein. Al­
though experience with the syn­
thetic graft has increased, both 
early thrombosis and late graft oc­
clusion continue to pose serious 
problems. Anastomotic neointimal 
hyperplasia and progression of the 
disease are mainly responsible for 
late failure. There is increasing evi­
dence that antiplatelet treatment 
can lessen the thrombogenicity of 
the graft.16 It is also well known 
that PTFE bypasses are unique in 
that thrombectomy alone can some­
times restore long-term patency 
after early thrombosis.17
Only longer follow-up and ran­
domized patient selection will deter­
mine whether PTFE is superior to 
autogenous saphenous vein for 
lower extremity bypass.18 In cases 
of severe ischemia and in the rarer 
cases of disabling claudication, 
when the distal anastomosis can be 
performed above the knee, saphe­
nous vein should be the first choice. 
However, if the vein is not available, 
PTFE seems to be a durable and 
dependable long-term alternative.
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Adrenal Myelolipomatous Nodules 
Mimicking Adrenal Neoplasms: Report of 
Three Cases
D.V. Bautista, MD;* M. Asch, MD;f K. Kovacs, MD, PhD, FRCPC, FCAP, FRCPath;* 
D. Murray, MB, BS, FRCPath*
The authors describe three cases of adrenal myelolipoma. In the first two, unilateral 
adrenal masses, assumed to represent adrenal neoplasms, were found during 
urologic examination; the correct diagnosis was made by frozen-section examination 
during operation. The third case involved bilateral adrenal lesions diagnosed at 
autopsy in a patient suspected to have metastatic cancer. Histologic, 
immunohistochemical and electron microscopic studies revealed polyclonal lesions 
composed of hematopoietic cells and fat cells. Radiologic recognition and fine-needle 
biopsy of these lesions are important to avoid unnecessary surgery in asymptomatic 
cases. Since the lesions cannot be regarded as true neoplasms, the authors suggest 
that the name myelolipoma should be replaced by the term myelolipomatous nodule.
Les auteurs decrivent trois cas de myelolipomes surrenaliens. Dans les deux 
premiers cas, une masse surrenalienne unilateral prise pour un cancer de la 
surrenale fut decouverte a l’examen urologique; le diagnostic exact fut pose a 
l’examen des coupes en congelation. Le troisieme cas comprenait des lesions 
surrenaliennes bilaterales qui furent diagnostiquees a l’autopsie chez un patient 
soupconne d’etre atteint d’un cancer metastatique. Les examens histologiques, 
immunohistochimiques, ainsi que la microscopie electronique, revelerent des lesions 
polydonales composees d’elements hematopoietiques et de cellules adipeuses. 
L ’identification radiologique et la ponction-biopsie a l’aiguille fine de ces lesions 
sont de premiere importance si Ton veut eviter une chirurgie inutile dans les cas 
asymptomatiques. Puisque ces lesions ne peuvent pas etre considerees comme de 
veritables neoplasies, les auteurs suggerent de remplacer le vocable de myelolipome 
par celui de nodule myelolipomateux.
A drenal myelolipomas, rare le­sions unassociated with hor­
mone production, are composed of 
hematopoietic cells and fat cells 
resembling bone marrow. They 
were first described by Gierke in
19051 and were named “myelolipo­
mas” by Oberling in 1929.2
These lesions are usually found 
incidentally or at autopsy in 0.08%3 
to 0.2%4 of cases. The first case of 
surgically removed myelolipoma
was reported by Dyckman and 
Freedman5 in 1957. Subsequently, 
several other cases of myelolipomas 
have been described.6-8 Ultrasonog­
raphy and, especially, computed to­
mography are helpful in identifying 
a fat-containing mass, suggesting 
the diagnosis, but are not patho­
gnomonic of myelolipoma.9
We present two patients who had 
myelolipomas removed surgically 
and in whom the preoperative diag­
nosis was adrenal neoplasm; in a 
third patient, bilateral adrenal mye­
lolipomas suspected to be metasta­
tic cancer were found at autopsy.
Case Reports
Case 1
A 55-year-old obese woman was 
admitted for investigation of a left 
suprarenal mass, discovered during 
evaluation of recurrent urinary tract 
infection. She complained of de­
creased energy and a weight gain of 
4.5 kg over the past 3 months. 
Symptoms of feeling hot and 
sw eaty, su ggestin g  a pheo- 
chromocytoma, were attributed to 
menopause. In the past she had 
been involved in a motor vehicle 
accident and had sustained verte­
bral fractures and hepatic and sple­
nic lacerations necessitating sple­
nectomy. She was being treated for 
long-standing hypertension and hy-
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pothyroidism. On examination she 
was in no distress, her blood pres­
sure was 130/90 mm Hg and optic 
fundi showed grade II hypertensive 
changes.
Blood cell count, electrolyte val­
ues, renal and liver function test 
results and serum calcium and 
phosphorus levels were all normal. 
Thyroid function tests on thyroxine 
supplementation gave normal re­
sults. Intravenous pyelography re­
vealed a large left intra- or suprare­
nal lesion, which was shown on 
ultrasonography to be a solid adre­
nal mass measuring 5 X 6  cm. This 
was confirmed by computed tomog­
raphy. Angiography showed the 
mass to be avascular. An adrenal 
pheochromocytoma was suspected, 
although catecholamine and vanil- 
lylmandelic acid values in a 24-hour 
urine specimen were normal. Elec­
tive left adrenalectomy was per­
formed and examination of a fro­
zen-section led to the diagnosis of 
myelolipoma.
Case 2
A 58-year-old moderately obese 
man was admitted for investigation 
of a right adrenal mass discovered 
by ultrasonography during exami­
nation for long-standing hyperten­
sion. He was asymptomatic and his 
blood pressure was 170/100 mm 
Hg. No abnormality was found on 
physical examination.
Blood cell count, electrolyte val­
ues, renal and liver function test 
results and serum calcium and mag­
nesium levels were normal. Cate­
cholamine and vanillylmandelic acid 
levels in a 24-hour urine specimen 
were normal. Levels of testosterone, 
androstenedione, dehydroepiandros- 
terone sulfate, adrenocorticotropic 
hormone (ACTH), cortisol and 
17-ketosteroids were within the 
normal range. A chest x-ray film 
showed a moderately enlarged heart 
and the electrocardiographic find-
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ings were consistent with an old 
anterior myocardial infarction. Ul­
trasonography revealed an echogen- 
ic right suprarenal mass measuring 
6.5 X 7.2 cm, which was shown by 
computed tomography (Fig. 1) to be 
attached to the adrenal gland. It 
had a low CT number of —60 to 
— 70, suggestive of a fat-containing 
lesion. There was also suggestion 
of a mass of similar attenuation 1.5 
cm in diameter associated with the 
left adrenal gland. A nonfunction­
ing adrenocortical adenoma was 
suspected. Elective resection of the 
mass and right adrenal gland was 
performed and the diagnosis of 
myelolipoma was made by frozen- 
section examination.
Case 3
A 56-year-old man was admitted 
with pneumonia due to Haemo­
philus sp. Relevant history included 
alcohol abuse complicated by pan­
creatitis, liver disease, a perforated 
ulcer 21 years previously requiring 
gastrectomy and vagotomy, hyper­
tension and, more recently, open 
reduction and internal fixation for a 
fractured humerus, complicated by 
osteomyelitis. On physical examina­
tion he was afebrile and had a blood 
pressure of 120/80 mm Hg. Find­
ings on chest examination were 
consistent with the diagnosis of 
pneumonia.
Laboratory investigation revealed 
leukocytosis (leukocyte count 29.6 
X 109/L), hyponatremia (114 
mmol/L), hypocalcemia (1.74 
mmol/L), normal serum amylase 
(75 U/L), hypoproteinemia (total 
protein 40 g/L) and hypoal- 
buminemia (albumin 19 g/L). Ul­
trasonography was technically poor 
and revealed no abnormality. A 
chest x-ray film demonstrated bilat­
eral pleural effusions, consolidation 
of the left lung and a normal-sized 
heart. A computed tomogram re­
vealed bilateral pleural effusions, a
mass suggestive of a pancreatic 
pseudocyst, enlargement of both 
adrenal glands to about 3.5 cm with 
attenuation values suggestive of 
soft-tissue and retroperitoneal lym- 
phadenopathy. These findings sug­
gested metastatic carcinoma, with 
lung or pancreas as possible pri­
mary sites.
The patient’s respiratory failure 
progressed and he died. At autopsy, 
bilateral adrenal myelolipomas were 
found. Death was attributed to a 
pancreatic pseudocyst, extending to 
the thoracic cavity with serofibri­
nous pericarditis and massive bila­
teral pleural effusions causing the 
respiratory failure.
Examination of the Specimens
For light microscopy, tissue sam­
ples were fixed in 10% formalin and 
embedded in paraffin. Sections 4 to 
6 /xm thick were stained with hema­
toxylin and eosin, Gordon-Sweet 
silver and Giemsa methods. For 
immunohistochemical analysis, the 
avidin-biotin-peroxidase complex 
(ABC) technique1011 was used. Sec­
tions were stained for Factor VIII, 
lysozyme, leukocyte common anti­
gen, immunoglobulins and light 
chains. For electron microscopy, 
small pieces of tissue were fixed in 
2.5% glutaraldehyde, osmicated, 
dehydrated in graded alcohol, pro­
cessed through propylene oxide and 
embedded in an Epon-Araldite mix-
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ture. Semithin sections were stained 
with toluidine blue, and appropriate 
areas were selected for ultrastruc- 
tural study. Ultrathin sections were 
stained with uranyl acetate and lead 
citrate and investigated with a Phi­
lips-410 LS electron microscope.
Gross Findings
The specimen from case 1 con­
sisted of an adrenal gland and at­
tached fat weighing 97.5 g and 
measuring 7 X 7 X 4 cm. The cut 
surface was hemorrhagic, firm and 
brown with areas of yellow, fatty 
tissue.
In case 2 the specimen consisted 
of an adrenal gland with an at-
FIG. 2. Encapsulated soft mass ( 4 X 3  
X 1.5 cm) attached to lower pole of left 
adrenal gland.
tached, encapsulated, soft mass 
weighing 103 g and measuring 8.5 
X 5.5 X 4 cm. The attached mass 
was round, red-yellow and mea­
sured 7 X 4.5 X 4 cm. The cut 
surface was dark red with yellow, 
fatty areas. Incorporated in the cap­
sule were foci of attenuated adrenal 
cortex.
The right adrenal gland in case 3 
weighed 8.5 g. Attached to the 
lower pole was an encapsulated, 
soft mass measuring 2.5 X 5.5 X 
7.5 cm. The left adrenal gland 
weighed 12.5 g and also had an 
encapsulated, soft mass, measuring 
4 X 3 X 1.5 cm, attached to its 
lower pole (Fig. 2). The cut surfaces 
were hemorrhagic and red-brown.
Histologic Findings
Each lesion consisted of hemato­
poietic cells and fat cells in variable 
amounts (Fig. 3). Areas of residual 
zona fasciculata and zona glomeru- 
losa cells were seen under the adre­
nal capsule. Scattered foci of zona 
fasciculata and zona reticularis cells 
were noted throughout the lesions.
In case 1, the lesion was located 
within the cortex, expanding it.
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FIG. 3. Hematopoietic and fat cells 
with adjacent residual adrenal cortex 
(hematoxylin and eosin, original mag­
nification X 100).
FIG. 4. Immunohistochemical stain for 
lysozyme showing immunoreactivity in 
monocytes, neutrophils and their pre­
cursors (ABC stain, original magnifica­
tion X 250).
Adipose tissue was predominant. In 
case 2, the lesion was a discrete, 
encapsulated mass which was 
slightly more cellular than in case 
1. Both lesions in case 3 were 
discrete, encapsulated masses and 
were more cellular than the lesions 
in the other two patients. They 
showed extensive hemorrhage and 
hemosiderin deposit.
The composition of the hemato­
poietic cells was identical in all 
three cases. Megakaryocytes were 
prominent. Scattered collections of 
lymphocytes and cells of the ery- 
throid series were seen. Myeloid 
elements in which the Giemsa stain 
demonstrated cytoplasmic granules 
were present in various phases of 
development. The Gordon-Sweet 
silver stain revealed a delicate reti- 
culin framework and occasional 
small vascular channels. No calcifi­
cation was present.
Immunohistochemical Findings
Staining for Factor VIII was posi­
tive in megakaryocytes and endo­
thelial cells lining vascular chan­
nels. Immunoreactivity for lysozyme 
was seen in monocytes, neutrophils 
and their precursors (Fig. 4). Im- 
munostaining was especially strong 
in patients 1 and 3. Staining for 
leukocyte common antigen was dif­
fusely positive in all cases. Staining 
for immunoglobulins IgG, IgA and 
IgM and light chains showed focal 
positivity in the lesions, indicating 
the presence of plasma cells.
Electron Microscopic Findings
Case 3 was not studied because 
of postmortem autolysis. The adre­
nal cortical cells in case 2 showed 
typical ultrastructural features of 
steroid-producing cells with abun­
dant cytoplasm containing numer­
ous lipid droplets, smooth endoplas­
mic reticulum membranes, parallel
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arrays of rough endoplasmic reticu­
lum, many mitochondria exhibiting 
characteristic cristae and occasional 
electron-dense granules.
Electron microscopy of the le­
sions gave findings consistent with 
those of light microscopy (Figs. 5 
and 6). Cells representing all three 
hematopoietic lines were observed. 
Irregularly shaped erythrocytes 
were seen within vascular channels 
as well as within cellular areas 
which also contained megakaryo­
cytes, lymphocytes and granulo­
cytes in various stages of matura­
tion. Megakaryocytes with large, 
multilobed nuclei and abundant cy­
toplasm were identified. Lympho­
cytes were recognized by small, 
round nuclei with indented chroma­
tin, microvilli and sparse organelles. 
Neutrophils, basophils and eosino­
phils were identified by their char­
acteristic nuclei and cytoplasmic 
granules. Endothelial cells, fat cells, 
fibroblasts and interspersed colla­
gen bundles were also seen.
Discussion
Adrenal myelolipomas are endo- 
crinologically nonfunctioning. Our 
light microscopic, immunohisto- 
chemical and electron microscopic 
studies showed that they are com­
posed of hematopoietic cells and fat 
cells resembling bone marrow.
The size of myelolipomas varies 
from microscopic to 8 cm diameter, 
and giant myelolipomas have been 
reported.12' 14 The clinical presenta­
tion and morphologic features have 
previously been described by Del 
Gaudio and Solidoro.6 As in our 
three patients, most of the previ­
ously described lesions were discov­
ered incidentally during gastrointes­
tinal or urologic examination. Most 
patients were middle-aged; the 
youngest reported was a 12-year- 
old girl with bilateral adrenocorti­
cal hyperplasia and hypertension.15
Many clinical associations have 
been noted, including obesity, hy­
pertension, chronic systemic dis­
ease (e.g., malignant disease, car­
diovascular disease, osteomyelitis, 
pyelonephritis), serious burns and 
endocrinopathies.16
The pathogenesis of myelolipo­
mas is unclear. Most3-12 agree that 
they are derived from undifferentiat­
ed stromal cells within the adrenal 
cortex which undergo myeloid 
metaplasia and proliferate to form a 
tumour-like mass. Alternatively, 
myeloid metaplasia may develop 
within pre-existing adrenocortical 
nodules. Collections of myeloid cells 
and fat cells have been described in 
the adrenal gland, in nonfunction­
ing adrenal nodules and in associa­
tion with adrenocortical nodular hy­
perplasia, such as in Cushing’s dis­
ease.817 Boudreaux and colleagues12 
reported a sequential proliferative 
process resulting in the formation 
of a myelolipoma in a hyperplastic 
adrenal cortex. As with myelolipo­
mas, these accumulations are asso­
ciated with increasing age and have 
also been seen in patients with 
elevated blood ACTH levels and 
those under stress. They are rare in
FIG. 5. Ultrastructure of adrenal corti­
cal cells showing abundant cytoplasm 
and lipid droplets (uranyl acetate and 
lead citrate stain, original magnifica­
tion X 2400).
children and have not been noted in 
healthy young patients who have 
died suddenly. Their polyclonal 
character, emphasized by our im- 
munohistochemical and electron mi­
croscopic studies, indicates that 
myelolipoma is a misnomer since 
this implies a neoplasm. We sug­
gest that the term myelolipoma be 
replaced with that of myelolipoma- 
tous nodule, which is more consis­
tent with the nature of the lesion.
The stimulus causing prolifera­
tion of hematopoietic and fat cells 
remains enigmatic. The hypothesis 
of Olsson and colleagues3 that tis­
sue necrosis is the basic stimulus, is 
supported by the finding of myeloli- 
pomatous change in adrenal glands 
of patients dying from severe burns. 
Tumour necrosis and fat necrosis in 
obese patients, especially those with 
hypertension, may also stimulate 
cell proliferation. A review of 10 
patients by Ayyat and associates18 
showed associations with tissue ne­
crosis. Two cases, one of a myeloli­
poma associated with 17-hydroxy­
lase deficiency19 and another with 
Cushing’s disease,20 suggest that 
hormonal dysfunction may play an 
etiologic role in the development of
FIG. 6. Ultrastructure of lesions show­
ing endothelial cell, erythrocytes, two 
granulocyte precursors and small lym­
phocyte (uranyl acetate and lead citrate 
stain, original magnification X 2400).
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the lesion. Selye and Stone21 pro­
duced myelolipomatous changes in 
adrenal cortices of rats injected 
with necrotic tumour extracts, 
testosterone and thyroxine, and 
proposed that tissue necrosis in the 
presence of ACTH is important in 
the pathogenesis of this disease. 
Boudreaux and colleagues12 empha­
sized the etiologic role of humoral 
agents released during tissue necro­
sis, increased ACTH secretion and 
androgenic stimulation.
In this series, patients 1 and 2 
were middle-aged, obese and suf­
fered from hypertension. Our first 
patient had a history of hypothy­
roidism and was receiving thyrox­
ine. She also had a history of 
trauma to the same side as the 
adrenal lesion. Endocrinologic in­
vestigations were normal in this 
case and in case 2, and the involved 
adrenal gland in each case con­
tained no other lesions. Case 3 was 
a middle-aged man with chronic 
pancreatitis and a history of hyper­
tension and osteomyelitis.
Local tissue necrosis combined 
with thyroxine may have been re­
sponsible for the development of 
the myelolipoma in case 1. In case 
3, extensive tissue necrosis associ­
ated with stress-induced elevated 
ACTH levels may have contributed 
to the development of bilateral le­
sions. Fat necrosis associated with 
obesity and hypertension, as de­
scribed previously,3 may have 
played a role in case 2; however, no 
endocrinologic disturbance was 
demonstrated. The common factor 
appears to be tissue necrosis; the 
role of hormones may be to aug­
ment or modify the effect of the 
necrosis. Selye and Stone21 pro­
duced myeloid tissue in the adrenal 
glands of rats injected with crude 
anterior pituitary extracts rich in 
ACTH. With the addition of testos­
terone, myeloid and adipose tissue 
developed. Thyroxine had a syner­
gistic effect.
As with previously reported 
cases,6 adrenal neoplasms were sus­
pected and surgical excision was 
performed to establish the diagno­
sis. Radiologic investigations may 
reveal a radiolucent mass with dis­
placement of the kidney and there 
may be associated areas of calcifica­
tion.622 When fatty components 
predominate, ultrasonography typi­
cally shows an echogenic mass;6 
similarly, computed tomography 
will demonstrate a fat-containing 
tumour.23 These appearances vary 
depending on the proportion of fat 
to myelogenous components. If 
nonfatty components predominate, 
heterogeneous atypical images will 
result.6 Angiography reveals an 
avascular lesion. Radiologic recog­
nition is important since surgical 
excision is not necessary for small, 
asymptomatic lesions.6 These pa­
tients must be followed radiological- 
ly. Fine-needle aspiration guided by 
computed tomography may be used 
to diagnose this lesion620-23 when 
the differentiation from malignant 
disease is difficult.
We thank Debbie Lietz, May Wong and 
the Medical Photography Department 
of St. Michael’s Hospital for their assis­
tance.
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T h e Risk of Occult Invasive Breast 
Cancer After Excisional Biopsy Showing 
In-Situ Ductal Carcinoma of Comedo 
Pattern
P.D.J. Hardman, MB, ChB, FRCR;* A. Worth, MD, FRCPC;t U. Lee*
Between Jan. 1,1985 and Aug. 31,1987, 62 in-situ ductal carcinomas with a 
predominantly comedo pattern were identified in 61 patients in British Columbia 
from excisional biopsy of a palpable or mammographically demonstrable lesion of a 
breast. The biopsies were intended to remove the lesion completely. Fifty-seven 
(92%) of the 61 patients required wide re-excision or total mastectomy, usually 
within a month of the initial biopsy. Occult invasive disease was demonstrated in 14 
of the re-excision specimens (24.5%) and residual in-situ carcinoma was present in a 
further 24 (42.1%), giving an overall rate of residual disease of 66.6%.
Axillary lymph nodes were sampled in 54 cases. Metastases were found in two 
cases (3.7%) and each was associated with occult infiltrating ductal carcinoma in the 
breast. This suggests that in-situ ductal carcinoma having a predominant comedo 
pattern may be more widespread and associated with a higher incidence of invasive 
ductal carcinoma than is generally believed.
En Colombie-Britannique, du ler janvier 1985 au 31 aout 1987, 62 cas de cancer in 
situ des canaux galactophores de type comedon ont ete identifies chez 61 patientes a 
partir de la biopsie-exerese d’une tumeur mammaire palpable et visible a la 
mammographie. Les biopsies visaient a eliminer les tumeurs completement. 
Cinquante-sept (92%) des 61 patientes ont necessity une re-excision plus large ou 
une mastectomie totale, habituellement moins d’un mois apres la biopsie initiale. Un 
cancer invasif occulte fut demontre dans 14 prelevements de re-excision (24.5%) et 
un carcinome in situ residuel etait present chez 24 autres (42.1%), pour un taux 
global de cancer residuel de 66.6%.
Des prelevements de ganglions axillaires furent pris dans 54 cas. Dans deux cas, 
des metastases etaient presentes et, chaque fois, elles etaient reliees a un cancer 
invasif occulte des canaux galactophores. Ces donnees indiquent que les carcinomes 
in situ des canaux galactophores de type comedon sont possiblement plus repandus 
et associes a une incidence plus elevee de cancers invasifs qu’on l’imagine 
generalement.
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S creening programs designed to identify carcinoma of the breast 
at an early stage will result in the 
diagnosis of more preinvasive duc­
tal carcinomas. When intraductal 
carcinoma has been identified by 
biopsy, management decisions must 
be based upon the likelihood of 
occult invasive carcinoma being 
present and on the future risk of 
invasive disease in the same breast.
Intraductal carcinoma can be 
classified morphologically into crib­
riform, comedo, papillary, solid and 
clinging forms,1 the cribriform and 
comedo groups being the most 
common. It has been stated2 that 
there is little value in distinguishing 
between these variants. The inci­
dence of occult invasive ductal car­
cinoma following repeat biopsy or 
total mastectomy has been reported 
to range from 6% to 21%.3-6 Fur­
thermore, it is known that approxi­
mately 1% of patients with intraduc­
tal carcinoma and no evidence of 
infiltration on microscopy have ipsi- 
lateral axillary lymph-node metasta­
ses.7
Thymidine-labelling studies have 
suggested that the morphologic 
subgroups of intraductal carcinoma 
have significantly different cell ki­
netics.8 It is interesting that come- 
docarcinoma has a relatively high 
rate of proliferation and apparently 
a greater malignant potential than
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cribriform-papillary intraductal car­
cinoma.
At the Cancer Control Agency of 
British Columbia, patients with 
comedocarcinoma are believed to be 
at higher risk of harbouring occult 
invasive disease than those with 
other forms of intraductal carcino­
ma. To demonstrate conclusively a 
real difference in the incidence of 
occult invasion between the mor­
phologic subgroups of in-situ carci­
noma would require the simulta­
neous comparison by a small group 
of tumour pathologists of all sub­
groups of in-situ carcinoma seen in 
a given period. Before embarking 
upon such a study we considered it 
necessary to examine the incidence 
of occult invasive ductal carcinoma 
found in a subsequent wider exci­
sion specimen after the initial biop­
sy diagnosis of in-situ ductal carci­
noma of predominant comedo pat­
tern. We considered a comparative 
study of all variants justified only if 
the incidence of occult invasive car­
cinoma for in-situ comedocarcinoma 
was higher than generally accepted. 
In this paper we describe our expe­
rience.
Patients and Methods
Available records in the cancer 
registry showed that in British Co­
lumbia between Jan. 1, 1985 and 
Aug. 31, 1987, 4476 patients were 
found to have invasive or preinva- 
sive breast cancer. Of this number, 
3137 (70%) were referred to the 
Cancer Control Agency of British 
Columbia from hospitals through­
out the province. At this institution 
all available histopathology sections 
are reviewed by a small number of 
reference tumour pathologists 
whenever a new patient is seen. 
During the study period, 55 pa­
tients were referred to the agency 
having a diagnosis of in-situ ductal 
carcinoma of the breast of predomi­
nant comedo pattern (50% or more 
of the observed disease) following 
excisional biopsy. Patients with me- 
tastases or Paget’s disease of the 
nipple were excluded.
Six patients with in-situ comedo­
carcinoma, not referred to the agen­
cy, were identified from the cancer 
registry. For each, histopathology 
sections were available and were 
reviewed. They met our criteria and 
were included in the study.
Thus, 61 patients with in-situ 
comedocarcinoma of the breast 
were eligible for further study. In 
all, the biopsy was undertaken to 
remove all disease present. If a 
mammographically detected lesion 
was removed using fine-wire localiz­
ing techniques, a postoperative 
mammogram was obtained to con­
firm that all detectable disease had 
been removed. One patient under­
went simultaneous biopsy of each 
breast and was found to have bilat­
eral comedocarcinoma. This patient 
was considered as two separate 
cases, giving a total of 62 biopsies 
(cases); this represents 1.4% of all 
cases of invasive and preinvasive 
breast cancer known to have oc­
curred in British Columbia during 
the study period.
From a review of the clinical 
records, the following information 
was extracted: age at diagnosis, 
mode of presentation, palpability of 
the lesion and mammographic Find­
ings.
The initial biopsy specimens were 
re-examined before entering the pa­
tients into the study. A diagnosis of 
in-situ ductal carcinoma of predomi­
nant comedo pattern was confirmed 
if 50% or more of the in-situ carci­
noma was associated with central 
necrosis. Specimens with evidence 
of stromal invasion were excluded. 
Completeness of excision was based 
on resection margins; the extent of 
observed disease was not quantified.
If it was thought that the dis­
eased tissue was not completely
excised, the patient underwent ei­
ther wide local re-excision or total 
mastectomy. Irrespective of the ini­
tial surgical procedure, low-level ax­
illary node dissection was per­
formed. Any subsequent excision 
specimens were reviewed and the 
following features recorded: evi­
dence of invasive disease, the pres­
ence of residual disease (disease in 
the same quadrant as the excisional 
biopsy), the presence of multifocal 
disease (disease in a different quad­
rant), an assessment of the excision 
margins, evidence of axillary node 
metastases and the number of axil­
lary nodes harvested.
Findings
The mean age of the 61 patients 
at presentation was 53.6 years 
(range from 28 to 80 years). The 
presenting features were a breast 
lump in 31 cases (50%), mammo­
graphic abnormalities in 25 (40%) 
and nipple discharge in 6 (10%).
Treatment Method
Because of doubt concerning the 
adequacy of the original excision, 
41 total mastectomies and 16 wide 
local re-excisions were performed. 
Infiltrating carcinoma was found in 
four of the latter necessitating total 
mastectomy in three; the fourth had 
radical radiotherapy to the breast. 
The definitive surgical procedures 
performed, therefore, were 44 total 
mastectomies and 13 wide local 
re-excisions. The five remaining 
cases for which the patient did not 
undergo further surgical treatment 
after the initial biopsy were exclud­
ed from the remainder of the study. 
In 55 (89%) cases sampling of the 
axillary lymph nodes provided tis­
sue suitable for staging. Of the 57 
carcinomas for which the patient 
required re-excision or total mastec-
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tomy, the surgery was performed 
within 1 month of the initial exci- 
sional biopsy in 47 (82%). In seven 
(12%) cases the second operation 
was performed within 2 months and 
in three (5%) more than 2 months 
from the time of the original biopsy.
One patient underwent further 
surgery only when recurrent disease 
at the original biopsy site and in the 
ipsilateral axilla became clinically 
apparent 11 months after the inci­
sional biopsy. The re-excision re­
vealed infiltrating carcinoma in the 
breast and axillary lymph nodes. It 
is impossible to determine whether 
occult invasive disease was present 
at the time of the original biopsy, 
but it was considered likely so the 
patient was classified accordingly.
Pathological Features of the 
Biopsy Specimen
All the excisional biopsy speci­
mens were confirmed as showing 
in-situ comedocarcinoma, without 
evidence of stromal invasion. The 
excision margins could not be eval­
uated in 34 cases. In 21 specimens 
the in-situ ductal carcinoma in­
volved the excision margin so the 
lesions were deemed to have been 
incompletely excised. Seven speci­
mens had excision margins clear of 
disease.
Pathological Features of the 
Wide Excision or Mastectomy 
Specimen
13 wide excision specimens, no re­
sidual or multifocal in-situ ductal 
carcinoma was evident in 19 
(33.3%) cases. Residual in-situ duc­
tal carcinoma was found in the 
same quadrant as the biopsy site in 
24 (42.1%), and in 14 other cases 
(24.5%) infiltrating ductal carcino­
ma was found at the biopsy site 
together with in-situ ductal carcino­
ma. There was, therefore, residual 
ductal carcinoma within the breast 
after the original biopsy in 38 cases 
(66.6%).
The histologic findings in these 
specimens were compared with the 
clinical presenting features (Table 
I). Patients presenting with nipple 
discharge appeared at highest risk 
for subsequent residual (33%) or 
infiltrating (50%) carcinoma.
Multifocal in-situ ductal carcino­
ma was observed in 12 (27%) of the 
44 total mastectomy specimens. All 
cases of multifocal in-situ ductal 
carcinoma in the initial biopsy spec­
imen were associated with residual 
in-situ or infiltrating ductal carcino­
ma in the wider excision specimen 
also.
Axillary Lymph-Node 
Involvement
The number of nodes harvested 
was specified in 47 of the 55 cases; 
a mean of 9.2 nodes were obtained 
from each patient (range from 1 to 
30). Excluding the patient in whom 
re-excision and axillary node dissec­
tion were delayed until she present­
ed with recurrent disease, thereIn the 44 total mastectomy and
Table I -  Histologic Findings of Mastectomy or Re-excision Specimen Compared With Clinical
Presentation
Presenting features, no. (%) 
Mammographic Nipple
Histologic findings Lump abnormalities discharge
No. residual carcinoma, n =  19 10(34) 8(36) 1 (16)
Residual in-situ carcinoma, n =  24 13 (45) 9 (41) 2 (33)
Infiltrating carcinoma, n =  14 6 (21) 5 (23) 3 (50)
Totals 29 22 6
were two cases of axillary node 
metastases in the 54 patients who 
underwent axillary node dissection 
within 1 month of excisional biop­
sy. All cases of axillary node metas­
tases were associated with occult 
invasive carcinoma in the re-exci- 
sion specimen.
Discussion
We believe that this is the first 
report on the incidence of occult 
invasive breast cancer after an ini­
tial diagnosis of in-situ ductal carci­
noma of predominant comedo pat­
tern. Residual in-situ carcinoma was 
present in 42.1% of the re-excision 
specimens and infiltrating carcino­
ma was present in a further 24.5% 
of the study population, for a total 
incidence of residual disease of 
66.6%. When no attempt is made to 
stratify the disease into morpholog­
ic subgroups, the incidence of oc­
cult invasive carcinoma is higher 
than the generally quoted range of 
6% to 21%.
There was no demonstrable dif­
ference in the pathological findings, 
whether the patient presented with 
a palpable breast lump or with a 
mammographic abnormality. The 
association between nipple dis­
charge and infiltrating carcinoma is 
probably due to random variation in 
a small subgroup. Otherwise, clini­
cal presentation was of no value in 
predicting the subsequent need for 
mastectomy or re-excision.
Rosen and colleagues3 reported a 
series of 129 excisional biopsies 
from 121 patients having a frozen- 
or paraffin-section diagnosis of non- 
invasive breast cancer. Of this 
group, 103 required total mastecto­
my, and occult invasive cancer was 
subsequently diagnosed in 6%.
Carter and Smith4 reported a se­
ries of 38 patients shown to have 
intraductal carcinoma on biopsy; 7 
(18%) had invasive carcinoma in the
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subsequent mastectomy specimen. 
Thirty-six patients underwent defin­
itive surgery within 1 month of the 
biopsy, but the remaining two had a 
treatment interval of 20 months and 
63 months, raising the possibility 
that the invasive disease developed 
after the original biopsy.
Lagios and associates5 reported a 
series of 80 breast biopsies, the 
specimens of which were found to 
contain in-situ ductal carcinoma; in 
53 cases the breast was subsequent­
ly resected. Occult invasive cancer 
was seen in 21% of the resected 
breasts and multicentric disease in 
32%. One lymph-node metastasis 
(2%) was found. This report sug­
gests that the size of the original 
lesion was an important predictive 
factor for the presence of both 
occult invasion and multicentric 
foci of disease in the resected 
breast.
Fentiman and associates6 exam­
ined 82 mastectomy specimens, 
which were previously shown to 
contain in-situ ductal carcinoma. 
Overall, 13 breasts (16%) contained 
invasive disease and no case of 
axillary node metastasis was ob­
served. It is of interest that the 
results were tabulated with specific 
reference to the morphologic sub­
group of in-situ disease. The data 
clearly showed that in-situ disease 
of comedo pattern made up 25% of 
the original biopsy specimens and 
yet accounted for 46% of the occult 
invasive cancers. This result is not 
statistically significant but does 
suggest that in-situ comedocar- 
cinoma is associated with a higher 
incidence of occult infiltrating carci­
noma.
Until recently, total mastectomy 
was accepted as the treatment of 
choice for in-situ ductal carcinoma 
because most patients treated in 
this way were cured of their disease. 
However, in the case of small infil­
trating breast cancers, local exci­
sion and radical radiotherapy have
produced results comparable to 
those of the various forms of radical 
mastectomy.910 This has led to the 
paradox that women with infiltrat­
ing carcinoma may be treated by 
breast-conserving techniques, but 
those who present with in-situ duc­
tal carcinoma undergo total mastec­
tomy. It has been suggested911"16 
that conservative breast techniques 
be evaluated in the management of 
in-situ ductal carcinoma. Clearly, 
each case should be judged on its 
suitability for breast conservation. 
The criteria that are usually used 
are familiar, from application in the 
management of infiltrating ductal 
carcinoma (i.e., breasts are easy to 
examine, follow-up must be reliable 
and resection margins clear of dis­
ease). However, in this series, 
66.6% of patients with in-situ come- 
docarcinoma had residual disease in 
the re-excision specimen and 24.5% 
of them had occult infiltrating car­
cinoma. In all cases, the surgeon 
performing the excisional biopsy at­
tempted to remove all diseased tis­
sue, yet in two-thirds of patients the 
diseased tissue was only partially 
excised. We suggest that in-situ 
comedocarcinoma may be a mor­
phologic variant of in-situ carcino­
ma in which the disease is suffi­
ciently widespread and likely to be 
associated with occult invasive car­
cinoma that either a very wide local 
excision or total mastectomy is 
necessary. If wide local excision is 
to be considered as a treatment 
option, it is recommended that all 
excised specimens be carefully 
marked to facilitate pathological as­
sessment of the excision margins 
and that if the lesion was detected 
mammographically, the findings on 
a postoperative mammogram 
should be within normal limits. Ide­
ally, this should be performed about 
1 month postoperatively when the 
reactive changes secondary to sur­
gery have subsided. Any patient 
treated conservatively should be fol­
lowed up closely with regular physi­
cal examination and screening 
mammography.
Conclusions
There is no evidence to suggest 
that in-situ comedocarcinoma car­
ries a worse prognosis than other 
forms of in-situ ductal carcinoma. 
However, it appears to be more 
widespread and associated with a 
higher incidence of occult invasive 
carcinoma than has previously been 
accepted. This observation is con­
sistent with the hypothesis that 
in-situ comedocarcinoma is a more 
kinetically active variant of intra­
ductal disease and may progress to 
invasive disease over a shorter time.
When considering conservative 
procedures for this type of breast 
cancer, the surgeon should bear in 
mind that residual in-situ or inva­
sive ductal carcinoma in close prox­
imity to the excision biopsy cavity 
was found in 66.6% of breasts re­
quiring re-excision in this series. 
The pathologist should take great 
care when assessing the excision 
margins before concluding that 
conservative breast surgery is ade­
quate. If the adequacy of excision of 
an in-situ ductal carcinoma of pre­
dominant comedo pattern is in 
doubt, then further surgery, either 
wide local excision or total mastec­
tomy combined with low-level node 
dissection is advised.
We thank Colleen Mackie for clerical 
assistance and Patricia Thomas for help 
preparing the manuscript.
References
1. McDivitt RW, Stewart FW, Berg JW: 
Tumors of the breast. In F irmincer HI 
(ed): Atlas o f Tumour Pathology, Armed 
Forces Institute of Pathology, Washing­
ton, 1968:22-49
2. Azzopardi JG, Ahmed A, Millis RR: 
Problems in breast pathology. Major 
Probl Pathol 1979; 11: 1-466
VOL. 32, NO. 1, JANU ARY 1989 59
HARDMAN, ET AL.
3. Rosen PP, Senie R, Schottenfeld D, et 
al: Noninvasive breast carcinoma: fre­
quency of unsuspected invasion and 
implications for treatment. Ann Surg 
1979; 189: 377-382
4. Carter D, Smith RR: Carcinoma in situ 
of the breast. Cancer 1977; 40: 1189— 
1193
5. Lagios MD, W estdahl PR, Margolin 
FR, et al: Duct carcinoma in situ. Rela­
tionship of extent of noninvasive disease 
to the frequency of occult invasion, 
multicentricity, lymph node metastases, 
and short-term treatment failures. Can­
cer 1982; 50: 1309-1314
6. Fentiman IS, Fagg N, Millis RR, et al: 
In situ ductal carcinoma of the breast: 
implications of disease pattern and treat­
ment. Eur J Surg Oncol 1986; 12: 261 — 
266
7. Rosen PP, Braun DW jr , Kinne DE: 
The clinical significance of pre-invasive 
breast carcinoma. Cancer 1980; 46 (4 
suppl): 919-925
8. Meyer JS: Cell kinetics of histologic
BOOK REVIEWS
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Fla.; W.B. Saunders Company Canada 
Limited, Toronto, 1986. $88.25. ISBN 
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This monograph is an interesting and 
comprehensive review of the many as­
pects of renal transplantation associated 
with cyclosporine therapy. Every con­
ceivable treatment of the kidney trans­
plant is covered in this book and it 
provides convincing evidence that cy­
closporine has been a major advance in 
the management of transplant rejection. 
However, the criteria used for monitor­
ing a patient being treated with cyclos­
porine, the best time to start the drug 
and the duration of treatment are still 
controversial. The field is advancing so 
rapidly that with the advent of the 
monoclonal antibody immunoassay 
technique the methods for measuring 
cyclosporine levels are probably outdat­
ed. Therefore, many of the figures and 
levels quoted in this monograph will 
probably no longer apply. In spite of
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this, this book conveys the importance 
of careful monitoring of cyclosporine 
levels in the first few months after 
transplantation and that a critical deci­
sion must be made regarding the main­
tenance level of cyclosporine required to 
prevent rejection but avoid nephrotox­
icity.
After reading this monograph I was 
not quite sure which regimen is pre­
ferred initially to prevent kidney rejec­
tion — ALG and prednisone followed by 
cyclosporine, or cyclosporine both pre- 
operatively and intraoperatively. Excel­
lent results can be obtained from the 
use of both regimens. No doubt better 
assay techniques will help answer this 
question.
Although the use of cyclosporine 
represents a major advance in the pre­
vention of rejection, important factors 
such as the technical skill of the sur­
geon, short ischemic times of the donor 
kidneys and good matches between 
donor and recipient are still of great 
importance in the success of transplan­
tation programs.
This book makes excellent reading 
for physicians associated with renal 
transplantation. At the same time it will
be of interest to other physicians who 
use cyclosporine.
E.Z. Rabin, MD, FRCPC, PhD
Division o f Nephrology,
Ottawa Civic Hospital,
1053 Carling Ave.,
Ottawa, Ont.
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HAIR TRANSPLANTATION. 2nd edi­
tion. Edited by Walter P. Unger and 
Rolf E.A. Nordstrom. 768 pp. Illust. 
Marcel Dekker, Inc., New York, 1988. 
$125.00 (US). ISBN 0-8247-7724-7.
Drs. Unger and Nordstrom have provid­
ed an excellent reference work to state 
of the art hair transplantation. This 
greatly expanded second edition in­
volves many authors, each an expert in 
his field. In addition, most authors 
include the contributions of other trans­
plant surgeons. This, along with 
thoughtful editorial comments, gives 
the text excellent balance.
The major strength of this book is
continued on page 64
60
ORIGINAL ARTICLES
Management of Gallstone Ileus
Roderick G. Syme, MD, FRCSC
A recent case of recurrent gallstone ileus prompted a retrospective review of 14 
cases of the disease seen at St. Joseph’s Hospital, Hamilton, between 1970 and 
1986. The condition is uncommon and usually occurs in elderly women who have a 
history of gallbladder disease and concomitant medical illness. Twelve patients 
underwent surgery; 1 who had a “ one-stage”  enterolithotomy, cholecystectomy and 
repair of fistula died postoperatively. Nine patients who had enterolithotomy alone 
experienced notable morbidity; they included three who had recurrent biliary tract 
problems, all of which were managed successfully. The author concludes that 
enterolithotomy alone should be the standard procedure for gallstone ileus. 
Cholecystectomy and repair of cholecyst-enteric fistula should be done later only if 
there are continuing or recurrent symptoms.
A l’occasion de la recidive d’un ileus cause par des calculs biliaires, on a procede a 
l’etude retrospective de 14 cas similaires qui ont ete vus entre 1970 et 1986 a 
l’hopital St-Joseph de Hamilton. Cette affection est peu frequente et survient 
habituellement chez des femmes agees qui ont des antecedents de calculs biliaires et 
une maiadie coexistante. Douze malades furent operes; 1 patiente qui subit une 
intervention “ en un temps”  comprenant enterolithotomie, cholecystectomie et 
reparation de fistule, mourut apres l’operation. Neuf patientes qui avaient subi une 
enterolithotomie seule, presentment une morbidite marquee dont trois cas de 
recidive des problemes biliaires, complications qui purent toutes etre reglees. 
L’auteur conclut que l’enterolithotomie seule doit etre consideree comme l’interven- 
tion standard dans les cas d’ileus calculeux. La cholecystectomie et la reparation des 
fistules cholecysto-enteriques doivent etre differees et pratiquees seulement s’il y a 
persistance ou recidive des symptomes.
G allstone ileus (mechanical ob­struction of the gastrointesti­
nal tract by one or more gallstones 
in the bowel lumen) was first de­
scribed by Bartholini in 1654.1 In 
1890, Courvoisier2 reported 131 
cases of gallstone ileus, with a 
death rate of 44% from the 125 
related operations. Although the 
condition is rare, causing only 1% 
to 3% of all intestinal obstruc­
tions,3-5 gallstone ileus is reported 
to be the cause of nonstrangulating 
obstruction in 24% o f patients over 
65 years of age.6-9 Despite improve­
ments in surgical technique and 
postoperative care, both morbidity 
and mortality from the disease re­
main high.8 Reports of recurrent 
gallstone ileus, cholangitis, carcino­
ma of the gallbladder and other 
postenterolithotomy biliary tract
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problems10-16 have prompted so- 
me8'17-22 to recommend “ one-stage” 
enterolithotomy, cholecystectomy 
and repair of cholecyst-enteric fis­
tula. A recent case o f recurrent 
gallstone ileus after enterolithotomy 
prompted a review of our 17-year 
experience with gallstone ileus.
Case Report
A 75-year-old obese woman com­
plained of vomiting, crampy upper 
abdominal pain and distension and 
no bowel movement for 72 hours. 
Her medical history included appen­
dectomy, inguinal herniorrhaphy, 
hypertension and arthritis. On ex­
amination, she was afebrile, nonict- 
eric and in mild distress. Bowel 
sounds were present and there was 
minimal tenderness with guarding 
in the left lower quadrant o f the 
abdomen. Plain abdominal x-ray 
films (Fig. 1) demonstrated air in 
the biliary tree and dilated loops of 
bowel containing a gallstone.
At laparotomy, a gallstone 2.5 
cm in diameter was removed from 
the terminal ileum. No other stones 
were palpated, and an inflammatory 
mass in the right upper quadrant 
was not interfered with. The patient 
did well and was discharged home 2 
weeks later on a full diet.
Six days after discharge, she re­
turned to hospital with a 12-hour 
history o f vomiting and abdominal 
pain. Repeat plain abdominal x-ray 
films (Fig. 2) demonstrated dilated 
loops of bowel containing another 
gallstone. Careful review o f her pre­
vious abdominal films (Fig. 1) re-
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vealed the outline of a stone in the 
gallbladder.
At repeat laparotomy, a gallstone 
4.5 cm in diameter was removed 
from the upper jejunum and the 
nonresolving inflammatory mass in 
the right upper quadrant was not 
disturbed. When the two stones 
were placed together (Fig. 3), they 
formed a cast of the gallbladder, a 
picture similar to that published by 
Raiford17 25 years ago. The patient 
had a minor wound infection after 
the second operation but was well 
at follow-up 18 months later.
FIG. 1. Abdominal film, first admis­
sion, showing obstructed loops of bow­
el, air in biliary tree (small black 
arrows), gallstone causing obstruction 
(white arrow) and second gallstone in 
gallbladder (large black arrow).
FIG. 2. Abdominal film, second admis­
sion shows bowel obstruction with sec­
ond gallstone (arrow).
Our Experience
The medical records of 14 pa­
tients (13 women, 1 man) who had 
a diagnosis of gallstone ileus and 
were seen at St. Joseph’s Hospital, 
Hamilton, between January 1970 
and December 1986 were reviewed. 
Demographic characteristics, clini­
cal presentation, laboratory and ra­
diology reports as well as operative 
findings, procedure and outcome 
were abstracted for analysis.
The patients ranged in age from 
58 to 97 years (mean 75.7 years). 
Six (42.8%) had a history of gall­
bladder disease and seven had con­
comitant medical disease (diabetes 
mellitus five, hypertension three, 
heart disease two, airway disease 
one). Although all patients had pain 
and vomiting and in over 70% there 
was abdominal tenderness, the his­
tory and physical findings were 
nonspecific. The commonest bio­
chemical abnormality, leukocytosis, 
was evident in only eight cases. 
Delay in presentation was common; 
it ranged from 0.5 to 7.0 days 
(mean 4.2 days) from the onset of 
symptoms.
Plain x-ray films of the abdomen 
were obtained and records were 
assessed in all cases for the pres­
ence of Rigler’s23 four signs of 
gallstone ileus (Table I). A correct 
radiologic diagnosis was made pre- 
operatively in 64.2% of patients.
Two patients did not undergo
FIG. 3. Two gallstones together form­
ing cast of gallbladder.
surgery. A 97-year-old woman who 
was moribund on admission, de­
clined surgery and died within 48 
hours; the second had severe respi­
ratory disease and the obstruction 
resolved with the passage of a stone 
per rectum. Of the 12 patients who 
underwent surgery, 9 had enteroli- 
thotomy alone and 1 had an en- 
terolithotomy, cholecystectomy and 
repair of the fistula (“one-stage” 
procedure). The two remaining pa­
tients had clinical and radiologic 
findings of gallstone ileus, but at 
laparotomy, no stone was evident. 
In one, the gallbladder was removed 
and the fistula repaired; in the other 
the fistula was not taken down.
Stones were found in the termi­
nal ileum in six patients and in the 
jejunum in four. Their diameter 
ranged from 2.5 to 7.0 cm (mean 
4.2 cm). Two patients had more 
than one stone and 11 had an 
inflammatory mass in the right 
upper quadrant at laparotomy.
There were two deaths (14.2%); 
the 97-year-old woman already 
mentioned and the patient who un­
derwent the “one-stage” procedure. 
The latter, a 79-year-old woman, 
had intra-abdominal sepsis requir­
ing repeat laparotomy for drainage 
of abscesses. Despite aggressive 
treatment including zipper installa­
tion for peritoneal toilet, she ac­
quired the adult respiratory distress 
syndrome followed by multisystem 
organ failure and died 1 month 
postoperatively.
The most common complication 
was wound infection, which oc­
curred in six patients, only one of 
whom had received antibiotics pre-
T a b le  1. R ig le r ’s R a d io lo g ic  S ig n s  of 
G a lls to n e  Ileus
Sign No. o l pa tien ts  (% )
A ir in  th e  b il ia ry  tre e 9  (6 4 .3 )
B ow e l o b s tru c tio n 1 4 (1 0 0 )
S tone  v isu a lize d 3 ( 2 1 .4 )
C hange in p o s it io n  
o f a p re v io u s ly  
o b se rved  s to n e
2 ( 1 4 .3 )
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operatively. Of the nine patients 
who underwent enterolithotomy 
alone, only two were problem-free 
postoperatively. Five had wound in­
fections, which led in one case to 
dehiscence and in another to late 
incisional hernia. Three of this 
group had recurrent biliary tract 
problems: one had a common-bile- 
duct stone managed successfully by 
endoscopic retrograde cholangi­
opancreatography and sphincteroto­
my; one had recurrent biliary colic 
managed by cholecystectomy, ex­
ploration of the common bile duct 
and repair of the cholecyst-enteric 
fistula 3 months after enterolithoto­
my; and one (our case report) had 
recurrent gallstone ileus managed 
with repeat enterolithotomy.
Discussion
This study, consistent with other 
published series,24-29 shows that 
gallstone ileus is an uncommon 
disease of elderly women, approxi­
mately half of whom have a history 
of gallbladder disease. There is 
often a delay of several days in 
seeking medical attention and they 
frequently have concomitant medi­
cal conditions complicating man­
agement. Unfortunately, history, 
physical findings and laboratory 
data are of little help in diagnosis. 
Radiologic criteria, as put forward 
by Rigler,23 allowed us to make a 
correct preoperative diagnosis of 
gallstone ileus in 64.2% of patients, 
which compares favourably with the 
less than 50% reported in most 
other series.22 2527
Most gallstones entering the in­
testine are small enough to be 
passed uneventfully. As in other 
series,24-29 we found no stone smal­
ler than 2.5 cm in diameter causing 
obstruction of the bowel. In over 
90% of our patients operated on (11 
of 12), an inflammatory mass was 
noted in the right upper quadrant,
raising the controversial issue of 
appropriate management: enteroli­
thotomy alone or enterolithotomy 
in combination with cholecystecto­
my and closure of the fistula (“one- 
stage” procedure). In our small se­
ries, the one patient who underwent 
the latter procedure died and anoth­
er (in whom the stone appeared to 
have passed) underwent cholecys­
tectomy and repair of fistula with­
out enterolithotomy and survived. 
The nine patients who underwent 
enterolithotomy alone all survived 
but not without morbidity, which 
included recurrent biliary tract 
problems in three. Nevertheless, all 
complications in the enterolithoto­
my group were successfully ma­
naged using standard approaches, 
including endoscopy and open sur­
gery. Although this series is too 
small to be of statistical signifi­
cance, we, as surgeons, are often 
forced to make decisions based on 
such reports when dealing with 
conditions as uncommon as gall­
stone ileus.
The “one-stage” procedure of en­
terolithotomy, cholecystectomy and 
repair of fistula was first suggested 
by Holz30 in 1929 and later by 
Fraser31 in 1954 and Welch and 
associates32 in 1957, each reporting 
a single case. The rationale was to 
prevent recurrent gallstone ileus, 
cholangitis, carcinoma of the gall­
bladder and other biliary tract prob­
lems, reported to occur in up to 
30% of patients after enterolithoto­
my alone.10-16 Between 1962 and 
1975, seven more papers817-22 ap­
peared, supporting the “one-stage” 
procedure, but they totalled only 23 
cases. In the largest of these series, 
Cooperman and associates20 report­
ed one death in eight patients who 
underwent the “one-stage” proce­
dure and no deaths (but three re­
currences) in six patients who un­
derwent enterolithotomy alone. Ka- 
sahara and colleagues24 reported 66 
patients of whom 50 underwent
enterolithotomy alone and 16 the 
“one-stage” procedure; the death 
rates were 12% and 19% respective­
ly. Of the patients who underwent 
enterolithotomy alone, 14% had re­
current biliary tract problems, 
which, as in our series, were dealt 
with successfully. VanLandingham 
and Broders26 reported nine cases of 
gallstone ileus in which the only 
death, as in our series, was a pa­
tient who underwent the “one- 
stage” procedure. However, their 
collected literature of 191 cases (35 
“one-stage” procedures) failed to 
show a statistically significant dif­
ference in mortality between en­
terolithotomy (11%) and “one- 
stage” procedure (20%) (p < 0.2). 
Deitz and colleagues29 carried out 
four “one-stage” procedures with 
no deaths and reported three deaths 
amongst 18 patients who under­
went enterolithotomy alone.
Proponents of the “one-stage” 
procedure stress careful patient se­
lection so that only those able to 
withstand the more extensive sur­
gery will be considered. Given the 
age of the patients, concomitant 
medical illnesses and frequent delay 
in presentation, few would be suit­
able candidates. One must also bear 
in mind that the majority of pa­
tients do not have further problems 
after enterolithotomy and that 
those problems that do develop can 
usually be dealt with later, success­
fully, under more favourable condi­
tions. This relatively benign course, 
coupled with the often precarious 
physiologic status of the elderly 
patient who has acute obstruction, 
argues strongly for enterolithotomy 
alone as the standard of care for 
gallstone ileus, with cholecystecto­
my and repair of the fistula done 
later and only for continuing symp­
toms.
The advice and support of Drs. Ken 
O’Brien, E.J. Thomas and Caroline Tall- 
madge are gratefully acknowledged.
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that it guides the reader through all the 
stages of hair transplantation from the 
initial interview, through harvesting 
and planting of plugs, to postoperative 
care and problems. I found Alt’s contri­
bution on the donor site to be exhaus­
tive and most useful. Also, Unger’s 
excellent chapter on the recipient site 
has been enlarged to include hair trans­
plantation in early androgenetic alope­
cia, in women, in blacks and in orien­
tals. The most important recent ad­
vances in hair transplantation, including 
alopecia reduction, unigrafts, micro­
grafts, and quarter-grafts are well re­
viewed. The alternative to hair trans­
plantation, flap surgery, is discussed 
thoroughly.
The generous use of photographs 
and diagrams enhances the reader’s 
understanding of the text. The only 
error I found was in Table I on page 
119.
I highly recommend this textbook for 
both the novice and expert hair trans­
plant surgeon. Let us hope that we will 
not have to wait another 9 years for the 
next edition.
N. Kanigsberg, MD, FRCPC
Ste. 401,
340 McLeod St..
Ottawa, Ont.
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MANAGEMENT OF ABDOMINAL 
HERNIAS. H. Brendan Devlin. 222 pp. 
Illust. Butterworth & Co. (Publishers) 
Ltd., London, 1988. Price not stated. 
ISBN 0-407-00348-7.
Brendan Devlin is a general surgeon at 
Stockton-on-Tees in northeast England. 
His stated intention to produce “a neat, 
practical book on hernia, not an ex­
haustive text” is fulfilled, although it is 
not clear for which audience this book 
is intended. As a result of large type, 
logical British style and multiple clear 
illustrations, this book is easy to read. 
Although it is only 200 pages long, it 
covers a large volume of material and at 
a size of 23 X 28 cm it will not likely fit 
into the pocket.
The book gives a brief but useful 
history of hernia surgery and includes, 
at the end, biographical notes on pio­
neers in the field such as Bassini, 
Cooper and McVay. Canadians will be 
pleased to observe the credit given to 
Earle Shouldice and Frank Glassow in 
the development of hernia surgery. In 
fact, the Shouldice repair is emphasized 
throughout the book. Mr. Devlin points 
out that hernia repair is poorly per­
formed by many general surgeons and 
that recurrence rates are unacceptably 
continued on page 73
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Popliteal Aneurysms: an Index of 
Generalized Vascular Disease
C.Wm. Cole, MD, FRCSC; A.M. Thijssen, MD; G.G. Barber, MD, FRCSC; N.V. McPhail, MD, FRCSC; 
T.K. Scobie, MD, FRCSC
A review of 59 popliteal aneurysms in 38 patients seen over 10 years revealed that 
34 (58%) aneurysms were symptomatic. Symptoms included gangrene (15%), 
ischemia due to thrombosis (38%) and embolism (5%). Patients with unilateral 
aneurysms (45%) were a median of 7 years younger than those with bilateral lesions 
(55%). The latter group had more frequent manifestations of occlusive disease, 
which included previous myocardial infarction, coronary artery bypass grafting and 
stroke. They also had more concomitant aneurysms, those of the abdominal aorta 
and femoral and iliac arteries being the most common. Management consisted of 
bypass grafting in 34 limbs and immediate amputation in 9; 16 inoperable limbs 
remained viable. At last follow-up (median 32 months) or time of death, 30 of 34 
grafts were patent. Four grafts occluded, one perioperatively and the others at 4, 5, 
and 32 months respectively, resulting in two amputations. The cumulative patency 
rate in the asymptomatic group was 94% compared with 81% in the symptomatic 
group. These data illustrate that patients with popliteal aneurysms may have 
associated vascular disease, the likelihood of which is increased when aneurysms are 
bilateral.
La revue de 59 cas d’anevrismes poplites observes chez 38 patients au cours d’une 
periode de 10 ans revele que 34 (58%) de ces anevrismes etaient symptomatiques. 
Gangrene (15%), ischemie post-thrombotique (38%) et embolies (5%) faisaient partie 
des symptomes. Les patients souffrant d’un anevrisme unilateral (45%) avaient un 
age median de 7 ans plus jeune que ceux qui avaient des lesions bilaterales (55%).
Ce dernier groupe presentait plus frequemment des manifestations de maladies 
ischemiques comprenant infarctus du myocarde anciens, pontages aortocoronariens 
et accidents cerebrovasculaires. Ils avaient egalement plus souvent des anevrismes 
concomitants, ceux de l’aorte abdominale et des arteres femorale et iliaque etant les 
plus frequents. II y eut 34 pontages de 9 amputations immediates; 16 membres 
inoperables furent conserves. Au dernier examen de surveillance (mediane de 32 
mois) ou au moment du deces, 30 des 34 greffes etaient permeables. Quatre 
derivations se sont bouchees, une durant la periode peroperatoire et les autres apres 
respectivement 4, 5 et 32 mois, entrainant deux amputations. Le taux cumulatif de 
permeabilite etait de 94% pour le groupe asymptomatique, comparativement a 81% 
pour les patients symptomatiques. Ces resultats illustrent que les patients souffrant 
d’anevrisme poplite peuvent avoir des vasculopathies associees avec une probability 
qui croit en presence d’anevrismes bilateraux.
From the Division o f  Vascular Surgery, University o f Ottawa, Ottawa, Ont.
Presented at the 9th annual meeting o f the Canadian Society for Vascular Surgery, held in 
conjunction with the 56th annual meeting o f  the Royal College o f  Physicians and Surgeons o f 
Canada, Winnipeg, Man., Sept. 12, 1987
Accepted for publication Aug. 12, 1988
Reprint requests to: Dr. C.Wm. Cole, Ottawa Civic Hospital, 1053 Carling Ave., Ottawa, Ont. 
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W ith justification, popliteal an­eurysms have been termed 
the “sinister harbinger of sudden 
catastrophe”.1 Left untreated, the 
majority will cause complications, 
and in roughly one-third of pa­
tients, limb amputation, usually 
above the knee, will be required.2 
Management of a patient with bilat­
eral popliteal aneurysms, one of 
which is thrombosed, presents the 
surgeon with a dilemma concerning 
the order of surgical treatment, 
because the asymptomatic aneu­
rysm may thrombose while atten­
tion is focused on the other limb. 
This dilemma prompted us to re­
view our experience with popliteal 
aneurysms to clarify our approach 
to this clinical problem.
Patients and Methods
Most authorities1-4 accept that a 
vessel diameter of more than 2 cm 
is diagnostic of an aneurysm of the 
popliteal artery.
Thirty-eight patients (1 woman, 
37 men) with 59 popliteal artery 
aneurysms were treated at the Otta­
wa Civic Hospital between 1976 
and 1987; the aneurysms were doc­
umented by angiography or ul­
trasonography in all cases.
Comparison of reported series is 
difficult because of patient classifi­
cation according to complications 
and symptoms.1 In this study it was 
not always possible to identify the 
initial complaint, so patients were 
classified according to the complica­
tions that had developed when the
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popliteal aneurysm was diagnosed. 
A classification of asymptomatic 
was applied to patients who had 
only local discomfort or a popliteal 
mass, the aneurysm being unrecog­
nized by the patient before it was 
discovered by the physician.
Follow-up was by regular clinic 
visits using noninvasive Doppler 
pressures and waveform analysis in 
most cases. When travel or distance 
was a problem the information was 
acquired by telephone.
Findings
Of the 59 aneurysms, 25 were 
asymptomatic; they included 1 that 
had thrombosed, presumably for 
some time before the patient sought 
help for symptoms in the opposite 
limb. Thirty-four aneurysms were 
symptomatic. The symptoms or 
signs included gangrene in 9, isch­
emia due to thrombosis in 22 and 
distal ischemic changes as a result 
of emboli originating in the aneu­
rysm in 3.
The cumulative graft patency 
rate in asymptomatic limbs was 94% 
and graft failure did not lead to 
amputation. In contrast, there was 
a graft patency rate of 81% in 
symptomatic limbs, with two ampu­
tations.
Follow-up was complete for 31 
patients (50 popliteal aneurysms); 
the other 7 (9 popliteal aneurysms) 
were lost to follow-up after several 
months.
Of the 38 patients, 17 had unilat­
eral and 21 bilateral aneurysms. 
Patients with unilateral aneurysms 
were a median of 7 years younger 
than those with bilateral aneurysms 
(63 years versus 70 years). In two 
patients who had unilateral aneu­
rysms, another aneurysm developed 
in the opposite leg, after 5 and 7 
months respectively; they are in­
cluded in the bilateral group. Asso­
ciated occlusive vascular disease
VOL. 32. NO. 1, JANUARY 1989
and additional aneurysms were 
more common in those who had 
bilateral popliteal artery aneurysms 
than in those with unilateral lesions 
(Table I).
Unilateral Aneurysms
Three of the 17 unilateral popli­
teal artery aneurysms were throm­
bosed, two patients requiring above­
knee amputation; the other limb 
remained viable although function­
ally impaired. Eleven symptomatic 
and 3 asymptomatic limbs were 
suitable for bypass grafting (Table 
II). Patency rates of grafts to 
asymptomatic aneurysms were su­
perior to those of symptomatic an­
eurysms. Two grafts occluded, one 
at 5 months resulting in a below- 
knee amputation and the other at 
32 months resulting in a compro­
mised but viable limb. Both grafts 
were of reversed saphenous vein.
Bilateral Aneurysms
In this group of 21 patients, 
treatment generally was directed 
first to the symptomatic limb.
The aneurysm was asymptomatic
on one side in 12 patients and on 
both sides in 6. Two asymptomatic 
aneurysms, though not throm­
bosed, were associated with severely 
impaired circulation in the tibial 
vessels and were unsuitable for by­
pass grafting; neither aneurysm was 
symptomatic on follow-up averag­
ing 44 months. Bypass grafts were 
inserted in 5 of 24 asymptomatic 
limbs because the symptomatic limb 
was not amenable to vascular re­
construction. One of the five grafts 
(saphenous vein) occluded in the 
perioperative period, but did not 
lead to amputation.
After surgical treatment on the 
symptomatic limb, 17 opposite 
asymptomatic limbs were subjected 
to a period of observation. Bypass 
grafting was later carried out on 
10 of them; 6 remained under ob­
servation for a variety of reasons 
relating to the general health of the 
patient or an unwillingness to un­
dergo surgical repair. In one case 
an asymptomatic aneurysm throm­
bosed while the patient recovered 
from bypass surgery for a throm­
bosed aneurysm in the opposite 
limb; this resulted in a below-knee 
amputation of the previously 
asymptomatic limb.
Table 1. Associated Vascular Occlusive Disease and Other Aneurysms
Patients, %
Unilateral Bilateral
Associated disease/ aneurysm aneurysms
aneurysm (n =  17) (n =  21)
Myocardial infarction 24 33
Coronary artery bypass grafting 6 10
Stroke 12 19
Abdominal aortic aneurysm 24 38
Femoral/iliac aneurysm 18 29
Table II. Cumulative Graft Patency Rates After Bypass of Popliteal Artery*
Asymptomatic Symptomatic
Vein ePTFE Vein ePTFE
Total patients/ 
total grafts
Unilateral
Bilateral
3/3
13/14 1/1
9/11
3/4 1/1
12/14
18/20
Totals 
Patency, %
17/18
94
13/16
81
30/34
88
*Follow-up ranged from 3 to 112 months (median 32 months). Vein =  reversed saphenous vein, 
ePTFE =  expanded polytetrafluoroethylene.
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Three patients had thrombosis of 
both popliteal aneurysms and two 
required bilateral above-knee ampu­
tation; one had inoperable yet viable 
limbs despite bilateral vascular im­
pairment. Seven patients had an­
ticoagulation therapy until elective 
angiography could be done to deter­
mine their suitability for surgical 
treatment; 5 of the 14 limbs were 
treated with bypass grafting, the 
remainder were not suitable. Five of 
the latter eventually required ampu­
tation some months later. Graft 
material was saphenous vein in four 
and expanded polytetrafluoroe- 
thylene (ePTFE) in one.
Three of nine patients who died 
had patent bypass grafts at the time 
of death, and graft failure led to an 
above-knee amputation in another 
but was not a direct cause of death.
Discussion
Aneurysms occur in the popliteal 
artery with a frequency that is sec­
ond only to those of the abdominal 
aorta, and their presence indicates 
the high probability of another an­
eurysm, either in the contralateral 
popliteal artery or elsewhere.1' 13 
This study and others (Table III) 
support this observation, and the
fact that bilateral aneurysms in­
crease that probability. Data show 
that the coronary or cerebral circu­
lation is more likely to be occlud­
ed in patients with bilateral lesions 
and should the popliteal trifurcation 
be similarly affected, it is considered 
a predictor of myocardial infarction 
after vascular reconstruction.14 
Therefore, patients who have popli­
teal aneurysms should undergo 
careful cardiac and cerebrovascular 
assessment. In this study, the differ­
ence in median age of 7 years 
between the two groups is probably 
only one of several factors,1 includ­
ing a strong genetic predisposition 
to affect men.4
Our experience with respect to 
graft patency rate is consistent with 
that of other series41' 13 and reaf­
firms that the results of surgical 
treatment are substantially better 
when undertaken before thrombosis 
or embolism limits the outflow bed 
distal to the aneurysm. Once the 
popliteal aneurysm has thrombosed, 
the need for eventual amputation 
may not differ whether the limb is 
suitable for bypass grafting or not.3 
In patients with a thrombosed pop­
liteal aneurysm and asymptomatic 
disease in the other limb, manage­
ment must be individualized, and 
the indications for surgery will de­
pend on the severity of symptoms. 
However, the surgeon should be 
alert to the perilous situation the 
patient may be in if the asymptom­
atic aneurysm thromboses while at­
tention is focused on the symptom­
atic leg. When thrombosis does not 
produce symptoms, surgical repair 
is not indicated and when resulting 
symptoms are tolerable, without 
limb-threatening ischemic changes, 
a short delay while the asymptomat­
ic aneurysm is dealt with will not 
alter the eventual outcome. Vessels 
patent distal to the thrombosed an­
eurysm will not be affected by a 
delay of a few weeks during which 
elective repair of the asymptomatic 
fellow may avoid thrombosis and 
amputation in more than one-third 
of cases. As a consequence of our 
immediate attention being focused 
on the symptomatic limb in patients 
with bilateral lesions, one patient 
had thrombosis of the asymptomat­
ic aneurysm while convalescing at 
home after bypass grafting of the 
thrombosed symptomatic limb.
Ischemia due to acute thrombosis 
may threaten limb viability, and in 
such cases immediate efforts must 
be made to salvage the limb. Explo­
ration of the vessel below the aneu­
rysm and thrombectomy with a Fo­
garty catheter may open a major
Table III. Reported Series of Popliteal Aneurysms
Series
No. of 
patients
Male*
Associated occlusive 
disease, %
Other aneurysms, %
AAA
Iliac/
femoral
Bilateral
poplitealfemale Ml CABG Stroke
Edmunds and associates, 1965s 82 _ 32 _ 13 36 =>15 32
Baird and associates, 19666 51 - =>30 - 22 12 =>10 42
Crichlow and Roberts, 19667 42 42:0 10 - 7 14 =>12 36
Wychulis and associates, 19708 152 37:1 21 - 18 35 =>50 59
Bouhoutsos and Martin, 19749 71 - - - 10 32 13 -
Tompkins and associates, 1977'° 18 17:1 - - _ 28 33 45
Inahara and Toledo, 197811 30 14:1 - - 7 37 27 47
Guvendik and associates, 198012 20 20:0 - - _ 30 - 33
Szilagyi and associates, 19812 62 - - - - 40 =>39 40
Vermilion and associates, 19813 87 - 25 - 3 40 =  55 68
Reilly and associates, 19834 159 15:1 - - 14 21 =  23 35
Whitehouse and associates, 19831 61 30:1 =>33 - 5 62 37 44
Anton and associates, 198613 110 54:1 - 15 - 29 32 61
Present series, 1987 38 37:1 29 8 16 32 24 55
= Approximate determinations based on data reported. Ml =  myocardial infarction, CABG = coronary artery bypass grafting, AAA = abdominal aortic
aneurysm.
ft
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outflow vessel9 but does not relieve 
thrombosis in the capillary network. 
Direct intra-arterial thrombolytic 
therapy intraoperatively has had 
some success15 and may be a help­
ful addition to operative thrombec­
tomy of distal vessels; in this situa­
tion, tibial artery thrombosis is as­
sociated with a 70% limb loss.16 
However, reports of success are few 
and uncontrolled, and there are no 
long-term follow-up studies.
The rationale for an aggressive 
surgical approach to asymptomatic 
popliteal aneurysms lies in “the 
threat of unforeseeable grave com­
plications”2 associated with them. 
We recommend, as others9 have, 
that in patients who have bilateral 
popliteal aneurysms, one throm­
bosed and one asymptomatic, the 
asymptomatic limb should be ma­
naged first.
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SESAP V Critique
Item 218
With rare exceptions, aneurysms of the popliteal artery occur almost 
exclusively among men of advanced age. Complications include throm­
bosis with limb ischemia, as well as distal embolization producing the 
so-called "blue toe” syndrome. The incidence of associated aneurysmal 
disease, particularly contralateral popliteal aneurysms, which may be 
uncalcified and asymptomatic, as well as of abdominal aortic aneurysms, 
is high. Spontaneous rupture and hemorrhage is rare but may occur. All 
popliteal aneurysms should be treated surgically if the patient’s 
condition permits, even if they are asymptomatic, because of the high 
incidence of limb loss with initial symptoms. Proximal and distal ligation 
with bypassing of the aneurysm is preferred. The aneurysm may be 
resected, but injury to the popliteal vein and tibial nerve is a potential 
hazard. ,__,
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Complications and Functional Results 
After Limb-Salvage Surgery and 
Radiotherapy for Difficult Mesenchymal 
Neoplasms: a Prospective Analysis
R.S. Bell, MD, FRCSC;* B. O’Sullivan, MB, FRCPC;t F. Langer, MD, FRCSC;J 
J.L. Mahoney, MD, FACS, FRCSC;* S.V. Lichtenstein, MD, FACS, FRCSC;*
F.L. Moffat, MD, FRCSC;§ B.J. Cummings, MB, ChB, FRCR, FRACR, FRCPC;t 
N.V. Hawkins, MB. BS, FRCR, FRCPC;t V.L. Fornasier, MD, FRCPC1
Wide resection with adjuvant radiotherapy is generally accepted as the optimal 
treatment for patients with extremity soft-tissue sarcomas. However, there is a 
subset of patients with “difficult” tumours who sustain such marked loss of function 
from limb-salvage procedures that amputation might offer a superior functional 
alternative. To evaluate this issue, the authors prospectively designated 19 of 52 
patients registered in Toronto’s Princess Margaret Hospital Prospective Sarcoma 
Database in 1986 as “difficult” cases, on the basis of tumour size and anatomical 
location. Complications and functional results of wide resection and adjuvant 
radiotherapy were documented. The most frequent complication was related to 
wound healing (8 of 19 patients). Functional analysis at 1 year follow-up 
demonstrated that all 19 patients had results superior to those that would be 
expected with amputation.
Une resection large avec radiotherapie adjuvante est generalement consideree etre le 
traitement optimum pour les patients souffrant de sarcomes des tissus mous des 
extremites. Toutefois, il existe un sous-groupe de patients porteurs de tumeurs dites 
“difficiles” qui subissent une telle perte fonctionnelle a la suite d’une intervention 
visant a sauvegarder le membre, que l’amputation pourrait offrir une alternative 
superieure. Afin d’etudier cette question, les auteurs ont designe, de fa?on 
prospective, 19 des 52 patients inscrits en 1986 au Registre prospective des 
sarcomes du Princess Margaret Hospital de Toronto, comme des cas “difficiles” 
d’apres la faille et l’emplacement anatomique des tumeurs. Les complications et les 
resultats fonctionnels de la resection large avec radiotherapie adjuvante ont ete 
evalues. La complication la plus frequente se rapportait a la cicatrisation de la plaie 
(8 des 19 patients). L’analyse fonctionnelle effectuee apres 1 an de surveillance 
demontre que chacun des 19 patients presente des resultats superieurs a ceux qu’on 
aurait pu anticiper d’une amputation.
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Oncology, The Princess Margaret Hospital, the f  Division o f  Orthopaedic Surgery, M ount Sinai 
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S urgical treatment of patients having locally aggressive mes­
enchymal tumours has improved 
substantially in the past 15 years. 
Enneking’s original anatomical 
studies of soft-tissue sarcoma dem­
onstrated that its characteristic in­
vasion of peripheral muscle resulted 
in microaggregates of malignant 
cells penetrating beyond the pseu­
docapsule of the primary lesion.1 
This meant that potentially con­
taminated tissue had to be resected 
if local control was to be achieved 
by surgery alone. According to En- 
neking, this necessitated removal of 
the entire limb compartment in­
volved by tumour, either by radical 
resection or amputation proximal to 
the origin of muscles inside the 
fascial compartment.1-3
Recognition that high-dose radia­
tion can eliminate microscopic 
spread of soft-tissue sarcoma has 
modified the surgical management 
of this disease. Several studies have 
demonstrated that resection of the 
gross tumour mass with a limited 
margin of normal tissue (wide resec­
tion) combined with adjuvant radio­
therapy is adequate for local con­
trol.4-9
Despite the obvious functional 
benefits of conservative, limb-spar­
ing surgery, combined treatment
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(surgery and high-dose radiothera­
py) can result in considerable imme­
diate local disability,910 especially 
after extensive surgical dissection 
because of the anatomic site or size 
of the lesion. Indeed, it has been 
suggested that the soft-tissue dis­
ability after the combined treatment 
of soft-tissue sarcoma can be so 
severe that primary amputation may 
have provided a superior functional 
result.10
In this paper we consider the 
complications and functional results 
after surgery combined with the 
radical radiotherapy, by prospective­
ly reviewing the clinical course of 
19 patients with large aggressive 
mesenchymal neoplasms. Because 
of tumour size or its anatomic loca­
tion these patients might be consid­
ered candidates for amputation.
Patients and Methods
There were 19 patients in the 
study (11 men and 8 women). They 
ranged in age from 20 to 70 years 
(mean 45.2 years). All were fol­
lowed up after operation for at least 
16 months (range from 16 to 26 
months).
Patient Selection
All cases of soft-tissue sarcoma 
or aggressive fibromatosis, treated 
by members of the University of 
Toronto Sarcoma Group, are regis­
tered prospectively in The Princess 
Margaret Hospital Prospective Sar­
coma Database. During 1986, 19 of 
52 patients registered (11 men, 8 
women) were characterized as hav­
ing “difficult” tumours, based on 
the following criteria:
•  Tumour size more than 20 
cm.
•  Tumour extension within the 
true pelvis.
•  Encasement of the iliac or 
common femoral vessels.
•  Tumour origin distal to the 
knee or elbow, with involvement of 
bone, muscle and skin that would 
necessitate extensive tissue transfer 
and skeletal reconstruction after 
adequate wide resection.
•  Axillary location with invasion 
of the chest wall.
In the literature there are no 
accepted characteristics to define a 
subset of “difficult” or virtually 
unresectable lesions, but the criteria 
listed encompass tumours that re­
quire long, complex procedures for 
limb salvage.
Pathological Analysis
The protocol for pathological ex­
amination of the resected specimen, 
established by the University of To­
ronto Sarcoma Surgery Group, has 
the following guidelines, adhered to 
in all cases to determine if local 
resection has been adequate:
•  Preoperative evaluation of the 
diagnostic biopsy and computed to­
mogram by the surgical pathologist 
managing the case.
•  Examination of the resected 
specimen in the operating room for 
orientation by the surgeon and pa­
thologist.
•  Painting of the resection mar­
gins.
•  Sectioning of the tumour in 
the pathology suite adjoining the 
operating room.
•  Oriented frozen section from 
any resection margin with less than 
1 cm of normal tissue covering the 
pseudocapsule.
•  Extensive sampling of the 
margins for permanent sections to 
determine whether microscopic dis­
ease was present at any resection 
surface.
Representative samples from the 
diagnostic biopsy and resected spe­
cimens were reviewed by an expe­
rienced musculoskeletal patholo­
gist (V.L.F.) who determined both 
the histologic subtype and grade of
the tumour. The Musculo-Skeletal 
Tumour Society definition of histo­
logic grading was used.1
Radiotherapy
The protocol for radiotherapy at 
The Princess Margaret Hospital 
consists of radical treatment of 55 
to 65 Gy at 10 Gy/wk, five frac­
tions per week, for soft-tissue sar­
coma. Treatment is either preopera­
tive (40 to 50 Gy in 4 to 5 weeks 
before surgery, with any remaining 
dose administered postoperatively 
using a shrinking-field technique) 
or wholly postoperative after wound 
healing is complete. Aggressive fi­
bromatosis is generally treated with 
a total dose of 55 Gy. Part of the 
circumference of the limb should be 
excluded to reduce the risk of encir­
cling fibrosis and distal edema.
Postoperative Complications
Soft-tissue complications were 
defined as necrosis of the wound 
edge, dehiscence or drainage that 
required dressings for longer than 7 
days. Wound drainage was cultured 
and isolation of the same organism 
on more than one sample was ac­
cepted as evidence of infection. Vas­
cular, neurologic and skeletal com­
plications were also included in this 
review.
Function
A detailed functional analysis rat­
ing (modified from that of the Mus­
culo-Skeletal Tumour Society1) was 
determined prospectively, before 
surgery and at follow-up 3, 6, 12 
and 18 months after. For the pur­
pose of this presentation, only the 
ambulatory status of patients with 
lower extremity tumours and the 
presence of pain persisting more 
than 3 months after the completion 
of treatment will be considered.
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Results
Pathologic Features and Treatment
Sixteen patients presented with 
high-grade sarcomas: malignant fi­
brous histiocytoma in 9, synovial 
sarcoma in 2, liposarcoma in 2, 
fibrosarcoma in 1, soft-tissue chon­
drosarcoma in 1 and a chondrosar­
coma originating in bone with mas­
sive soft-tissue extension in 1. 
Three patients had aggressive fi­
bromatosis that had recurred locally 
at least twice before the described 
operative procedure. Ten patients 
presented with extensive thigh sar­
comas; 3 of them required intraop­
erative vascular resection and re­
construction. Three patients had 
pelvic sarcomas and four distal tu­
mours involving bone, muscle and 
skin that required composite resec­
tion and reconstruction using skele­
tal stabilization and microvascular 
free tissue transfer. Two patients 
who had axillary tumours required 
composite en-bloc resection of the 
chest wall.
Of the 19 patients, 11 had previ­
ously undergone incomplete tu­
mour resection. In each case gross 
tumour remained at the end of the 
procedure. Six of these had resec­
tion and irradiation at the time of 
local recurrence; the other five 
underwent further resection imme­
diately and received radiotherapy.
The operative procedures were 
long and complex; those for thigh 
tumours averaged 5.8 hours, for 
pelvic tumours 8.2 hours, for distal 
extremity lesions 4.2 hours and for 
axillary lesions 8.2 hours.
Three patients had undergone 
radical radiotherapy for residual 
gross disease more than 1 year 
before definitive management. Eight 
patients received preoperative radio­
therapy (40 to 50 Gy) with a post­
operative boost to 55 to 65 Gy. Six 
patients underwent postoperative 
radiotherapy only.
Complications
Eight of 13 patients with thigh 
or pelvic sarcomas suffered major 
wound complications that required 
secondary procedures. In two, small 
areas (less than 5 X 5  cm) of skin 
necrosis developed but healed rapid­
ly after split-thickness skin graft­
ing. Three patients had larger areas 
of necrosis (greater than 10 X 10 
cm) that required debridement and 
grafting; of these, wounds were 
healed in two 3 months and in the 
third 9 months after surgery. The 
patient with delayed healing had 
chemotherapy postoperatively for a 
lung metastasis.
Three patients with thigh and 
pelvic sarcomas required vascula­
rized tissue transfer for extensive 
wound dehiscence which developed 
after vascular reconstruction in 
two.
None of the patients who had 
axillary or distal extremity tumours 
managed by primary reconstruction 
with free tissue transfer suffered 
wound complications.
The timing of radiotherapy and 
surgery did not seem to affect the 
incidence of wound complications; 
6 of 13 patients who had preopera­
tive radiotherapy suffered wound 
complications compared with 2 of 6 
patients who had postoperative ra­
diotherapy.
All wound complications were 
treated immediately and aggressive­
ly.
Vascular complications occurred 
in five patients. One who had a 
large thigh tumour, sustained 
thrombosis of the superficial femo­
ral artery immediately after resec­
tion of the lesion; thrombectomy 
was successful. Two patients who 
underwent vascular resection and 
reconstruction suffered major 
wound dehiscence which required 
debridement and vascularized tissue 
transfer for limb salvage. Chronic 
arterial insufficiency was not en­
countered. Two patients now suffer 
from chronic venous insufficiency 
and wear compression hose while 
walking.
Six patients had neurologic com­
plications postoperatively. Three 
had complete, permanent, motor le­
sions of the sciatic nerve, requiring 
the use of an ankle-foot orthosis. 
Two required a cane when walking. 
Three other patients had substantial 
loss of the femoral nerve during 
anterior thigh resections. Two of 
these required a drop lock knee 
brace for stability while walking and 
the third learned to walk with a 
knee recurvatum gait.
Three patients who underwent 
bone resection during tumour re­
moval later suffered pathologic frac­
tures in the area. Two required 
reoperation and internal fixation; 
the third fracture healed in a cast.
Function and Follow-up
All but one patient, who had a 
pathologic fracture of the tibia, had 
stopped the regular use of narcotic 
analgesics within 3 months of sur­
gery. Two who had pelvic resection 
required codeine when active and 
two (one who underwent thigh re­
section and the other a distal ex­
tremity resection) required anti­
inflammatory medications regularly. 
The others, including the patient 
with a pathologic fracture, required 
no analgesics at 1 year.
All of the 16 patients who had 
lower extremity lesions were fully 
ambulatory within 6 months. Eight 
of the 10 patients who had resec­
tion of a thigh sarcoma were com­
munity ambulators and required no 
walking aids; two required a cane. 
Because the abductor musculature 
had been resected, two of three 
patients who had pelvic tumours 
excised required two canes for 
walking; the third walked without 
aids.
It should be remembered that
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alternative procedures in these pa­
tients would have been hemipelvec- 
tomy or hip disarticulation. Adults 
rarely accomodate to prostheses 
after such amputations and general­
ly use either a wheelchair or two 
crutches for walking.14 All patients 
who had distal lower extremity tu­
mours resected were able to walk 
without aids.
Of three patients treated for 
upper extremity tumours, two re­
turned to work that would have 
been impossible after amputation — 
a chef and a welder. The third who 
had a soft-tissue sarcoma of the 
axilla had insufficient active shoul­
der movement to resume work as a 
hairdresser but since her elbow and 
hand function was virtually normal 
she retrained as a secretary.
No patients had local recurrence. 
Relapse occurred at distant sites in 
six patients (five with thigh tu­
mours). Two died of metastatic dis­
ease. At the time of writing one was 
alive with extensive metastases and 
three had undergone resection of 
the metastases and were disease 
free.
Discussion
The goal of treatment in soft-tis­
sue sarcoma is to provide local 
control of the lesion yet maintain 
function. Over the past 25 years, 
treatment has progressed from sim­
ple excision with a 60% to 70% 
local relapse rate1112 to radical re­
section,1-3 to conservative surgery 
with high-dose adjuvant radiothera­
py.3 Several studies4-9 have demon­
strated that a combination of sur­
gery and radiation has eliminated 
local disease in more than 90% of 
patients treated. Data from our in­
stitution suggest that the most im­
portant factor in determining local 
control is the adequacy of the local 
resection.13
If it is accepted that conservative
resection combined with radiation 
offers a reasonable chance of local 
tumour control in soft-tissue sarco­
ma, then associated complications 
and residual function become im­
portant secondary considerations. 
There is no point in saving the limb 
if the patient is left with chronic 
pain, a draining wound or a useless 
extremity. The high early postoper­
ative complication rate with com­
bined treatment has been cited as a 
reason for performing primary am­
putation.10 In this review, we have 
attempted to identify, prospectively, 
patients with difficult soft-tissue 
sarcomas who would have such 
severe complications and poor func­
tion that limb salvage should be 
avoided and amputation proposed 
as primary management.
Our patients in this study repre­
sent the most difficult subset of 
soft-tissue sarcomas, those most 
prone to postoperative complica­
tions, of which a delay in wound 
healing was the most common. In­
deed, wound complications were 
found in 8 of 13 patients with lower 
extremity or pelvic tumours. This is 
not surprising, since adequate tu­
mour resection required that large 
skin flaps be lifted off the deep 
fascia, interrupting the myocutane- 
ous vessels that provide skin vas­
cularity.14 Added insults are the 
effects of radiation on skin heal­
ing15 and dermal vascularity.16-17 
However, the high incidence of soft- 
tissue complications did not detract 
from the eventual functional results 
obtained in this study. All patients 
had healed wounds at 1-year follow­
up.
Neurovascular involvement was 
not a contraindication to limb sal­
vage. Although patients requiring 
vascular reconstruction frequently 
underwent a secondary procedure 
for wound complications, the end 
result was a functional limb in each 
case. It should also be noted that 
resection of the femoral or sciatic
nerve, sometimes necessary for wide 
resection, was compatible with rea­
sonable ambulatory function.
The results of this review suggest 
that almost all soft-tissue sarcomas 
can be managed by limb-salvage 
techniques with reasonable func­
tional outcome. In our current con­
secutive series of 86 patients with 
the disease, the only amputation 
performed was for a tumour involv­
ing the entire brachial plexes. This 
aggressive approach to limb salvage 
has also been reported by Karakou- 
sis and associates,4 with similar rea­
sonable functional results.
It should be emphasized that, 
before referral, 11 of the 19 pa­
tients in this series had undergone 
one or more inadequate surgical 
procedures which markedly in­
creased the difficulty of definitive 
surgery. We suggest that before 
operating on a subfascial mass, the 
surgeon should:
•  Carry out local and systemic 
staging studies and discuss com­
bined management of the case with 
a radiation oncologist skilled in sar­
coma management before perform­
ing a biopsy.
•  Determine a strategy to en­
sure adequate wide resection.
•  Consider appropriate tech­
niques for soft-tissue or skeletal 
reconstruction.
•  Ensure that pathology facili­
ties suitable for both the interpreta­
tion of biopsy and assessment of 
resection margins are available.
If these criteria cannot be met, 
we recommend that the patient be 
referred to a multidisciplinary man­
agement team before the first surgi­
cal procedure is done.
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good section on outpatient management 
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author favours the Shouldice technique, 
he and his patients prefer general anes­
thesia, and this would likely reflect the 
Canadian experience. However, tech­
niques of local anesthesia are well de­
scribed. The chapters on groin and 
umbilical hernias in children and on the 
differential diagnosis of groin lumps are 
useful and practical.
The section on inguinal hernias in 
adults covers the topic well and again 
emphasizes the Shouldice repair. The 
McVay repair is described more briefly 
and the use of Marlex mesh is also 
summarized. Older studies of hernia 
repair are analysed to show that follow­
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true recurrence rates. Results in many 
large centres are often poor, especially
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and there are short chapters on Spigeli­
an hernia and parastomal hernia. In a 
chapter on extraperitoneal or preperito- 
neal repair with mesh, the author rec­
ommends that only experienced sur­
geons use this technique in cases of 
very large or recurrent hernias. The list 
of 679 references is exhaustive but 
might be more helpful if a few key 
references were highlighted.
This text does not detail the work on 
hernias by Nyhus. Although the illus­
trations are useful teaching aids, the 
book contains too much detail for most 
medical students. Residents in general 
surgery would benefit from reading this 
book early in their training and keeping 
it for later reference. Although the 
emphasis is on hernia repair, there is 
much useful information on groin anat­
omy, wound healing and choice of 
sutures. It could also serve as a useful 
review and refresher course for the 
general surgeon who repairs hernias as 
part of a varied pratice. The emphasis 
on the Shouldice repair, on outpatient 
surgery and local anesthesia is useful
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for surgeons trained on a steady diet of 
Bassini and McVay repairs. The impor­
tance of long-term follow-up should be 
noted by all who repair hernias.
One may question a few details, such 
as the need for extensive shaving before 
hernia repair, the use of adherent plas­
tic during operation, or the avoidance 
of sutures for wound closure, but over­
all this is a brief, clear and logical 
review of hernias.
D.M. Grace, MD, FRCSC
Division o f  General Surgery,
University Hospital,
339 Windermere Rd.,
London. Ont.
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TOTAL HIP ARTHROPLASTY. Rob­
ert E. Booth, Jr., Richard A. Balders- 
ton, Richard H. Rothman. 310 pp. 
Illust. W.B. Saunders Company, Phila­
delphia, 1988. $108.00. ISBN 0-03- 
013328-9.
"Total Hip Arthroplasty” is a delight to 
read. It is concise and informative.
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Surgical Treatment of Fungal Mycetoma
R. Visvanathan, BM, BCh, FRCS(Ire), FRCS, FRCS(Edin), FWACS, FICS
Chemotherapy for chronic fungal infections is often ineffective, and the associated 
delay in surgical treatment may result in radical procedures being performed to 
effect a cure. The author describes four patients with chronic fungal lesions, three 
involving a foot and one the abdominal wall, all of which failed to respond to 
antifungal chemotherapy. The lesions were excised, using procedures aimed at 
preserving function. Infection recurred in two patients during a 9-month follow-up. 
The author concludes that surgical therapy should be instituted early in the disease 
to forestall spread to deeper structures and preserve functional integrity of the 
affected parts.
La chimiotherapie des infections fongiques chroniques s’avere souvent inefficace, et 
il en resulte un retard de chirurgie pouvant conduire a effectuer des interventions 
radicales dans le but d’obtenir la guerison. L’auteur decrit quatre patients souffrant 
d’infections fongiques chroniques, du pied dans trois cas et de la paroi abdominale 
dans un, chez qui la chimiotherapie antifongique avait echoue. Les lesions furent 
excisees par une technique visant la preservation fonctionnelle. Au cours d’une 
periode de surveillance de 9 mois, il y eut recidive infectieuse chez deux patients. 
L’auteur conclut a la necessity d’operer tot dans revolution de la maladie si l’on veut 
empecher sa dissemination a des structures plus profondes et conserver l’integrite 
fonctionnelle des organes touches.
Chronic fungal infections of the skin and subcutaneous tissue 
respond poorly to antifungal che­
motherapy. In most instances, the 
lesions progress during such treat­
ment and operative intervention is 
delayed with the result that radical 
surgical measures are often neces­
sary to achieve a cure. This is a 
report on four patients with fungal 
mycetoma (eumycetoma) in whom 
surgical therapy aimed at conserv­
ing function was undertaken when 
chemotherapy was found to be inef­
fective.
Case Reports
Case 1
A 27-year-old farm labourer was 
admitted to hospital with an 8-year 
history of progressive, relatively 
painless ulceration over his abdomi­
nal wall. There were fleshy, conflu­
ent, ulcerating lesions with multiple 
sinuses and plaque-like thickening 
of the subcutaneous tissue extend­
ing over the affected area (Fig. 1). 
Loss of serosanguineous fluid from 
the ulcerated surface reflected on
his hemoglobin (78 g/L ) and serum 
albumin (29 g/L ) levels. Multiple 
tissue biopsies revealed mycelial ele­
ments suggestive of Madurella 
mycetomi in a granulomatous in­
flammatory process with leukocytic 
cellular aggregations and giant 
cells. There was no indication of 
malignancy. He had no bowel symp­
toms and barium x-ray studies of 
both the small and large bowel were 
normal. The following treatment
FIG. 1. Case 1. Anterior and right 
lateral view of abdominal lesion. Previ­
ous biopsy scars are visible on flank.
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was begun: a 6-week course of 
procaine penicillin G 600 000 units 
and streptomycin sulfate 1 g intra­
muscularly daily; a 6-month course 
of Bactrim, two tablets orally twice 
a day (one tablet contains 80 mg 
trimethroprim and 400 mg sulfame­
thoxazole); dapsone 100 mg/d, 
7 which was reduced to 50 mg/d 
after 2 months, and griseofulvin 1 
g /d  which also was reduced after 2 
months to 750 mg/d.
FIG. 2. Case 2. Anterior and lateral 
views of right foot showing nodular 
recurrence 5 weeks after excisional 
surgery and skin grafting.
t
The anemia was corrected and 
his nutritional state improved dur­
ing 3 months in hospital, but there 
was no visible response to the che­
motherapy regimen at the end of 6 
months.
Under general anesthesia the ul­
cerated surface and subcutaneous 
tissue were removed en bloc from 
the anterior rectus sheaths and 
uninvolved external oblique aponeu­
roses. The denuded area was cov­
ered with meshed autologous skin 
grafts harvested from both thighs. 
He was discharged home 4 weeks 
after operation with satisfactory
FIG. 3. Case 3. Tumour-like mycotic 
lesion in right foot (top) and resulting 
defect following its removal (bottom).
FUNGAL MYCETOMA
healing of the grafted areas. Within 
9 weeks of his discharge three 
isolated recurrences in the form of 
small nodules appeared on his right 
flank and hypogastrium. These 
were widely excised and he has 
remained free of further infection 
during a 9-month follow-up.
Case 2
A 34-year-old man presented with 
a 4-year history of progressive ul­
ceration of the skin over the front 
of his right foot and ankle. The 
area involved was approximately 90 
cm2 with swelling, induration, ulcer­
ation and discharging sinuses af­
fecting the skin and subcutaneous 
tissue. Tissue biopsies revealed hy- 
phae consistent with M. mycetomi. 
There was no bony involvement and 
he had satisfactory extension of his 
toes. A 4-week course of daily intra­
muscular injections of procaine 
penicillin G and streptomycin was 
instituted and a 4-month course of 
oral dapsone, Bactrim and griseo­
fulvin in dosages similar to those in 
case 1. He failed to respond to this 
regimen, so the lesion was excised 
using an Esmarch bandage to re­
duce blood loss. Dissection was car­
ried down to the tendo-osseous 
plane and the diseased tissue re­
moved en bloc, preserving the ex­
tensor tendons. After adequate 
granulation, the residual area was 
covered with split-thickness autolo­
gous skin grafts. A nodular recur­
rence seen 5 weeks later was ex­
cised with 1 cm skin clearance (Fig. 
2). A second recurrence occurring 
after 3 weeks was similarly excised. 
No further recurrence was observed 
during the first 6 months of follow­
up.
Case 3
A man in his early twenties was 
admitted with a 3-year history of
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painless swelling of his right fore­
foot and discharging sinuses in the 
clefts on either side of his third toe, 
which was also very swollen (Fig. 
3). Because previous broad-spec­
trum chemotherapy had had no 
effect, an Esmarch bandage was 
applied and the mass removed en 
bloc with the third metatarsal bone 
and the involved toe (Fig. 3). The 
reconstructed foot healed well. The 
surgical specimen was a granuloma­
tous inflammatory mass with leuko­
cytic cell infiltrate and sinus tracts 
similar to those seen in the two 
previous patients. However, no fun­
gus was isolated from the specimen. 
The patient remained recurrence- 
free 9 months later.
Case 4
A 23-year-old man presented with 
a 3-year history of an ulcerating 
swelling on his right foot, similar 
to, but less extensive than, the 
lesion in patient 2; it covered an 
area of 55 cm2 on its dorsal and 
lateral aspects. Dark fungal parti­
cles were seen in the discharge and 
M. mycetomi was isolated. He was 
started on an initial 4-week course 
of intramuscular procaine penicillin 
G and streptomycin and a 4-month 
course of dapsone, Bactrim and 
griseofulvin, orally, in dosages simi­
lar to the first two patients. There 
was again no response to treatment. 
The lesion was excised and the 
denuded area grafted. The patient 
was free of recurrence for 6 months 
after operation.
Discussion
The causative agent of a chronic 
fungal lesion may elude detection.1 
Previous chemotherapy or an over­
growth of secondary invaders may 
suppress the proliferation of fungal 
elements. The morphologic picture
VOL. 32, NO. 1, JANUARY 1989
of granulomatous changes with in­
flammatory and giant cells, along 
with the characteristic clinical pic­
ture, usually suggests a fungal 
cause.
The poor response of fungal my­
cetoma (eumycetoma) to chemo­
therapy has led to the recommenda­
tion of surgical measures.23 The 
timing of surgery, either in con­
junction with or after drug ther­
apy, has yet to be clarified, though 
some guidelines have been drawn 
up.4 Broad-spectrum antimicrobial 
agents in conjunction with antifun­
gal therapy are aimed at reducing 
the secondary invading organisms, 
though their effect was not dramat­
ic in the patients studied. The an­
tifungal agents dapsone and griseo­
fulvin have some effect on eumyce­
toma.5-7
Newer agents, clotrimazole and 
ketoconazole, have been shown to 
be more effective and their toxic 
effects are being evaluated.7-9 Keto­
conazole in combination with sur­
gery has been used to treat fungal 
mycetoma and has given encourag­
ing results.10 The effectiveness of 
these agents in reducing postopera­
tive recurrence is, however, unde­
termined. Until their effectiveness 
and safety are established, surgery 
for fungal mycetoma should be car­
ried out as soon as the diagnosis is 
made.
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Correction
On page 415 of the November 1988 
issue, in the paper “Unusual gastric 
foreign body: a case report” by 
W.M. Kuzon, Jr., C.A. McFadyen 
and F.L. Moffat, there are two lines 
missing from the bottom of the 
middle column as follows: “and 
oversewing of the ulcer seemed jus­
tified. It could be argued that”. The 
two sentences involved should read, 
“Therefore, removal of the mass 
with partial thickness excision and 
oversewing of the ulcer seemed jus­
tified. It could be argued that, since 
this was a gastric foreign body, a 
more aggressive attempt to dislodge 
and remove the components of the 
mass endoscopically should have 
been attempted first.” We apologize 
to Dr. Kuzon and his colleagues and 
to our readers for this error.
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Anteromedial (Perineal) Dislocation of the 
Hip: a Case Report
J.C. Burrell, MD, FRCSC;* J.K. Lipinski, MD, FRCPC, FRCR(Lond)t
Anteromedial (perineal) dislocation of the hip is rare. The authors describe the case 
of a 13-year-old girl whose femoral head was dislocated into the vagina as a result of 
a motor vehicle accident. The hip could not be reduced by traction but was pushed 
through the vagina with moderate ease. When the patient was placed in the 
lithotomy position, the hip redislocated and further reduction was required. The 
vagina and soft tissues were repaired and the hip joint was irrigated and closed over 
a drain. Antibiotics were given for 10 days. The girl recovered completely.
La dislocation anteromediane de la hanche est rare. Les auteurs decrivent un cas 
chez une fillette de 13 ans dont la tete du femur avait perfore le vagin lors d’un 
accident d’automobile. La hanche ne put etre replacee par traction, mais elle fut 
poussee a travers le vagin avec relativement de facilite. Quand la patiente fut placee 
en position de lithotomie, la hanche se disloqua de nouveau et la luxation dut encore 
etre reduite. On repara le vagin et les tissus mous, et la hanche fut refermee apres la 
pose d’un drain. Des antibiotiques furent administres pendant 10 jours. La guerison 
fut totale.
A nterior dislocation of the hip is uncommon; when it occurs, 
the femoral head usually lies in the 
periarticular position. We report a 
rare case of traumatic anteromedial 
dislocation of the hip in which the 
femoral head punctured the vaginal 
wall.
Case Report
A 13-year-old girl was seen 8 
hours after she had been involved in 
a motor vehicle accident. She had
multiple injuries including a right 
brachial plexus palsy, fractures of 
the mandible and the right first rib 
and a closed head injury resulting 
in a decreased level of conscious­
ness.
The left leg was abducted and 
externally rotated at the hip. Swell­
ing and bruising were evident above 
the perineum on the left side and 
the skin was tense and discoloured 
(Fig. 1). There was moderate bleed­
ing from the vagina. The examining 
physician interpreted this finding as 
indicating a fracture of the pelvis.
On retraction of the labia (Fig. 2), 
however, the femoral articular sur­
face was clearly seen with the liga- 
mentum teres protruding through 
the introitus. A pelvic x-ray film 
confirmed the anteromedial position 
of the femoral head (Fig. 3).
Initial resuscitation was carried 
out in the emergency department. 
In the operating room under gener­
al anesthesia, the presenting liga- 
mentum teres and the attached 
fragment of bone were excised. No 
amount of traction would reduce 
the hip; however, a moderate push 
on the femoral head through the 
tear in the vagina reduced the head 
quite easily. Stability of the hip was 
good in all positions except abduc­
tion and external rotation. When 
the patient was placed in the lithot­
omy position to repair the vagina 
the hip redislocated. After further 
reduction, the leg was held in inter­
nal rotation which kept the joint 
reduced.
The soft tissues of the vagina and 
rectum were repaired and the pa­
tient was prepared and draped for 
an anterior approach to the hip 
joint. The joint was irrigated thor­
oughly and then closed over a 
drain. In addition to cefazolin, 
which was started in the emergency 
department, tobramycin and met­
ronidazole were given in appropri­
ate dosage for age and weight. The 
antibiotic therapy was continued for 
10 days. The drain was removed 4 
days after operation.
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The immediate postreduction 
films showed a near-anatomic posi­
tion of the greater trochanter and 
an acceptable position of the lesser 
trochanter fragment. Films obtained 
2 weeks after injury showed heal­
ing, callus formation and periosteal 
reaction, and the hip was in a 
normal location (Fig. 4).
When the girl was last seen, 6 
months after her accident, she had 
a full range of movement of the hip
and a normal gait. Radiologically, 
there were no signs of avascular 
necrosis.
Discussion
FIG. 1. Bruising and discolouration of 
left aspect of perineum.
FIG. 3. Anteromedial dislocation of left 
hip. Lesser and greater trochanters are 
in near-anatomic position.
FIG. 2. Femoral head and ligamentum 
teres are evident at introitus.
FIG. 4. Normal anatomic position of 
femoral head with healing of avulsed 
greater and lesser trochanters.
Dislocations of the femoral head 
are classified as posterior, anterior 
and central; the posterior type is 
the most common, accounting for 
85% of dislocations.1 Anterior dislo­
cations are usually pubic or inferior. 
We could find only one other report 
of a perineal dislocation.2 For such 
a displacement the mechanism 
would have to be external rotation 
and flexion, associated with a medi­
al blow to the femur. The avulsions 
of the lesser and greater trochan­
ters and disruptions of the soft 
tissues are an obvious association.
In our case, the joint was open 
and because of the vaginal and 
rectal disruptions, contamination 
was likely. Furthermore, separate 
drainage was considered indicated 
as a precautionary measure. One 
complication of these dislocations is 
avascular necrosis, which occurs 
much less frequently (less than 
10%) than in posterior dislocations.3 
The avascular necrosis may not be 
apparent for up to 24 months, so a 
long follow-up is necessary for 
these patients.
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BOOK REVIEWS
continued from page 73
The book reflects the bias of the 
authors who are followers of the Charn- 
ley school of hip arthroplasty. For ex­
ample, they still recommend the trans­
trochanteric approach for this proce­
dure even though it is almost obsolete 
in North America. The series on which 
they base their conclusions is small, 
comprising only about 600 cases, but 
the follow-up is long and thorough.
The authors have no experience with 
bipolar prostheses and freely admit it. 
The section on hip revision is somewhat 
dated and mentions little of the serious 
problems currently being experienced in 
the revision of noncemented implants 
and the bone loss encountered in ar­
throplasties being revised for the third 
or fourth time. Similarly, the section on 
noncemented hips reflects little of the 
recent advances in this field such as 
modular hip stems; comment is made 
on obsolete implants such as the origi­
nal Lord prosthesis which Lord himself 
abandoned 3 to 4 years ago. This 
section also contains a few errors. The 
screw cup shown on page 269 is an
Anderson cup on the x-ray film, but the 
illustration is of a Richards cup. Also, a 
number of chapters were obviously writ­
ten some time ago. A 2-day admission 
before hip surgery is recommended. In 
Canada, a 1-day admission is more 
usual and the advent of diagnostic 
related groupings (DRGs) has made 
same-day admission common in the 
United States.
Apart from these criticisms, I found 
this one of the best surgical texts I have 
seen. It is well written, lavishly illustrat­
ed and clearly thought out. The authors 
are to be congratulated. The section on 
radiologic patterns of osteoarthritis, 
which contains a thorough survey of 
the literature and the complications and 
results achieved in hip replacements for 
rare conditions such as Gaucher's dis­
ease and osteopetrosis, is of particular 
value.
The chapter on the patient/surgeon 
interview should be mandatory reading 
for all undergraduates and surgical resi­
dents. Indeed, this chapter could, with 
advantage, be reprinted separately and
circulated to all surgeons. The subject 
is a harsh and uncomfortable one for 
both the surgeon and the patient. The 
patient must be viewed in a global sense 
not simply as an arthritic hip. We 
surgeons are not gods and without the 
patient’s cooperation we can only do so 
much. As the authors of this book put 
it “denying hip replacement to an unde­
pendable, poorly motivated substance 
abuser is not an uncharitable act but 
rather an act of good judgement pre­
venting him from years of potential 
complications that would leave him 
more disabled in the future”. Those of 
us who must carry out revision on such 
patients know well the truth of this 
statement.
I heartily recommend this book for 
all surgeons who practise hip replace­
ment.
Hugh U. Cameron. MB, ChB, FRCSC
Ste. 318,
43 Wellesley St. E.
Toronto, Ont.
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Academic Surgical 
Oncologist
The University of Calgary Faculty of Medicine invites 
applications for a full time appointment in the Department 
of Surgery. Located at the Foothills Hospital and reporting 
to the Division Chief of Surgical Oncology, the incumbent 
will be part of a team developing an integrated cancer 
program at the site. Research will be a major focus of 
this position. Extensive funding opportunities exist at 
the local and provincial levels for basic research initia­
tives. Rank and salary are commensurate with experience 
and qualifications. The starting date is negotiable.
In accordance with Canadian immigration requirements, 
priority will be given to Canadian citizens and perma­
nent residents of Canada.
The University of Calgary is committed to employment 
equity.
Qualified applicants are invited to forward a curriculum 
vitae by February 28, 1989 to:
Dr. W. J. Temple
Chief, Division of Surgical Oncology 
Department of Surgery 
The University of Calgary 
1403 - 29 Street N.W.
Calgary, Alberta T2N 2T9 S89-05
Opportunity 
For Surgeon!!!
We are seeking a second General Surgeon to 
meet the health care needs of this rapidly 
expanding and vital young community. State 
of the art technology and a full range of 
diagnostic and procedural services are features 
of this fully accredited 300-bed hospital with 
I50 beds currently open with good availability. 
We boas t  an excel lent  referral base and 
anaesthetic support combined with six O.R. 
thea t re s  offe r ing flexible schedules  and 
minimal waiting time. Fort McMurray offers 
superb recreational, cultural, and educational 
facilities. Income potent ia l  is well above 
average. Call today for more information:
The President
Fort McMurray Regional Hospital 
Fort McMurray, Alberta T9H 1P2 
Phone (403)791-6161
Fort McMurray 
Regional
Hospital S89-04
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CLASSIFIED ADVERTISING
As a further service to its readers the Canadian Journal o f Surgery is pleased to accept suitable classified advertisements. The deadline is 1 
month before issue date. Regular classified rates (for each insertion): $45.00 for the first 40 words or less, additional words 600 each (additional 
$17.00 for frame). Special Display under 100 words, 2Vt in. X 2 in., $110.00. $6.00 charge (first insertion only) for CJS box numbers Display 
rates available on request.
Copy should be mailed to the Canadian Journal o f  Surgery, PO Box 8650, Ottawa, Ontario K1G 0G8.
HEAD. DIVISION OF ORTHOPEDICS: ON -
St. Michael's Hospital, a 700-bed active treat­
ment teaching hospital, fully affiliated with the 
University of Toronto, with a busy trauma 
service, invites applications for the position of 
Head, Division of Orthopedics. Located in 
downtown Toronto, the hospital is in close 
proximity to the University of Toronto and 
other major teaching and research activities. 
Essential requirements for the position include a 
clear commitment to patient care, demonstrat­
ed clinical and managerial expertise and proven 
leadership in teaching and research. Applicants 
must have certification by the Royal College of 
Physicians and Surgeons of Canada or equiva­
lent. The successful candidate will be jointly 
appointed to the Department of Surgery in the 
Faculty of Medicine at the University of Toron­
to. In accordance with Canadian immigration 
requirements, this advertisement is directed to 
Canadian citizens and permanent residents. 
Please apply with curriculum vitae by Feb. 28, 
1989 to: Dr. John C. Platt, vice president, 
Medical Affairs, St. Michael's Hospital, 30 
Bond St., Toronto, ON M5B 1W8. Tel: (416) 
864-5041. -S89-07
ADVERTISERS’ INDEX
Canadian Association of General 
Surgeons
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Maxon Outside Back Cover
Surgilene Inside Front Cover
Lederle
Corporate 22
Fibyrax 18, Inside Back Cover
Merck Sharp & Dohme Canada
Mefoxin 12 ,13 ,46 ,47
D E P A R T M E N T  O F  S U R G E R Y
Victoria Hospital, London, Ontario, a major tertiary 
care institution affiliated with the University of 
Western Ontario, is now accepting applications for 
Chief of the Department of Surgery.
Applications, accompanied by a current curiculum 
vitae and the names of three referees, should be 
sent to:
Dr. G. S. Bartlett
Vice President, Medical Services 
Victoria Hospital 
375 South Street 
London, ON N6A 4G5
Applications will close February 17,1989.
S-89-03
GENERAL SURGEON: SK — An opportunity 
exists for a general surgeon to join in busy 
practice of general surgery, university centre, 
western Canada. Please send CV to: Box 726, 
Canadian Journal of Surgery, PO Box 8650, 
Ottawa, ON K1G 0G8. -S89-01
GENERAL PRACTITIONER/ANESTHETIST:
AB -  Required by a well established 15-doctor 
group. Laboratory and x-ray facilities in clinic. 
Accredited 120-bed active treatment hospital in 
community of 12 000 and servicing the region­
al needs of 30 000 people. Camrose is a 
beautiful place to live; close, but not too close 
to Edmonton, with university accredited, active 
recreational, sports and cultural programs. Con­
tact: Mr. T. C. Ofrim, administrator. Smith 
Clinic, 4825-51 St., Camrose, AB T4V 1R9. 
Tel: (403) 672-2424. -S 89-08
UNIVERSITY CHAIRMAN, DIVISION OF 
NEUROSURGERY: ON — Required for Univer­
sity of Toronto as of July 1, 1989. The Head of 
the Division of Neurosurgery at the University of 
Toronto is responsible for the academic pro­
grams of five hospital divisions, including un­
dergraduate and postgraduate education re­
sponsibilities, and coordination of research. 
Candidates will be expected to have a reputa­
tion for clinical excellence, as well as accom­
plishment in the areas of teaching and research 
and leadership experience. In accordance with 
Canadian immigration requirements, this adver­
tisement is directed primarily to Canadian citi­
zens or permanent residents. Applicants should 
send a letter and accompanying curriculum 
vitae to: Dr. B. Langer, R.S. McLaughlin, 
professor and chairman. Department of Sur­
gery, University of Toronto, The Banting 
Institute. 100 College St., Toronto, ON M5G 
1 L5- -S89-02
BIOGRAPHY: — Material for biography of the 
late Professor J. C. B. Grant required. Personal 
memoirs, anecdotes, photographs, welcome. 
Information treated with discretion and material 
returned promptly. Reply to: Dr. Clayton Rob­
inson, 808 - 750 West Broadway, Vancou­
ver, BC V5Z 1H7. -S 88-39
HAND SURGERY FELLOWSHIP: ON -
Available, starting July 1, 1989. For infor­
mation contact: The office of Dr. J. H. 
Roth, (FRCSC), 345 Westminster Ave., 
London, ON N6C 4V3 Tel: (519)
439-0701. -S88-40
CLINICAL FELLOW 
IN NEUROSURGERY
Applications are invited for the position of clinical fellow in 
neurosurgery, Memorial University of Newfoundland. The post 
becomes vacant March 1, 1989 and is for a period of 1 year 
(renewable). The Provincial Neurosurgery Unit is based at the Health 
Sciences Centre. Previous experience in neurosurqery is reauired 
Salary - $42 960.
In accordance with Canadian Immigration requirements, priority 
will be given to Canadian citizens and permanent residents. Closinq 
date for this advertisement is January 31,1989.
For further information contact:
Dr. E.S. Wright, Chairman 
Discipline of Surgery 
Memorial University 
Health Sciences Centre 
St. John’s, NF
_________________ A1B3V6
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FIBYRAX" Tablets 
In the most convenient and 
acceptable form 
for fibre laxatives
Convenience they want with 
efficacy they need
Fibyrax® provides a mixture of 4 natural-source fibres 
chosen for maximum bulk and water-retention properties.
Fibyrax® Tablets increase fecal bulk to stimulate 
peristalsis and bind water in the colon to keep stools 
soft for easy passage.
Fibyrax® treats constipation gently and by 
natural means, avoiding the discomfort often 
associated with irritant-type laxatives.
And the tablets are more convenient to 
use, less trouble to take than powdered fibre 
laxatives.
Fibyrax® Tablets contain no sodium, 
sucrose, or glucose, and contain only one 
calorie, so they are particularly appropriate 
for hypertensives, diabetics and obese 
patients.
Fibl|HU< Tablets
All natural-source fibre from citrus fruits 
and bran
►
►
CONSUMER HEALTH PRODUCTS ® Registered trade mark | paab | | |
Toronto. Montreal
For prescribing information see page 18
polyglyconate monofilament absorbable suturew
The multi-faceted 
absorbable suture 
appearing in 
Plastic and 
General surgery 
theatres
everywhere. For a 
personal 
presentation call 
your D + G 
Representative 
today.
Cyanamid Canada Inc.
88 McNabb Street 
Markham, Ontario L3R 6E6 
(416) 470-3600 ©Registered trademark
